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S
 
AMENVATTING
 
Voor de ontwikkeling van meercellige organismen is het van belang dat
individuele celdelingen gecoördineerd worden met de groei en diffe-
rentiatie van het hele organisme. Hoewel veel bekend is over de mecha-
nismen die betrokken zijn bij de deling van een cel, is er relatief weinig
bekend over hoe signalen van buiten de cel die mechanismen beïnvloe-
den.
De rondworm 
 
Caenorhabditis elegans
 
 is een uniek diermodel om de
mechanismen te identificeren die het samenspel tussen celdeling en
ontwikkeling reguleren. Celdelingen kunnen 
 
in vivo
 
 gevolgd worden via
lichtmicroscopie. Bovendien is van elke cel het tijdstip van deling en de
bestemming van de dochtercellen bekend. Een ander voordeel van 
 
C.
elegans
 
 is dat er veel minder kans is op overlappende functies van meer-
dere genen in één familie. Zo codeert het genoom van 
 
C. elegans
 
 slechts
voor één homoloog van de retinoblastoma (Rb), Cycline D en CDK4/6
kinase families. Een laatste voordeel is de beschikbaarheid van krachtige
genetische technieken om de functies van genen in 
 
C. elegans
 
 te bestu-
deren. Hiertoe behoren ondermeer de identificatie van nieuwe genen
in “screens”, het inactiveren van al bekende genen via de RNA interfe-
rentie (RNAi) methode en het isoleren van chemisch geïnduceerde
deletie-allelen van specifieke genen met behulp van de polymeraseket-
tingreactie (PCR).
Alvorens 
 
C. elegans
 
 te kunnen gebruiken om de regulatie van celde-
lingen tijdens de ontwikkeling te bestuderen, moesten eerst de basale
mechanismen die nodig zijn voor celdeling in 
 
C. elegans
 
 worden opge-
helderd. In hoofdstukken 2 en 3 zijn de resultaten van mijn onderzoek
naar diverse regulatoren van de celcyclus in 
 
C. elegans
 
 beschreven. Aan-
getoond is dat hun functies sterk overeenkomen met die van hun tegen-
hangers in zoogdieren. De resultaten vormen de basis voor de
genetische experimenten beschreven in hoofdstukken 4 en 5, die de
identificatie van nieuwe regulatoren van de G
 
1
 
 fase van de celcyclus tot
doel hadden. Hieronder volgt een korte beschrijving van de inhoud van
elk hoofdstuk in dit proefschrift.
Hoofdstuk 1 is een algemene introductie van de mechanismen die de
deling van een cel bewerkstelligen, met nadruk op de regulatoren van
de G
 
1
 
 fase. In de tweede helft van dit hoofdstuk worden de functies in
diermodellen van Cycline D-CDK4/6 kinases, de Rb familie en E2Fs
bediscussieerd.
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Hoofdstuk 2 beschrijft het onderzoek naar de functie van het cycline
afhankelijke kinase 
 
ncc-1
 
. Het gen dat codeert voor 
 
ncc-1
 
 is nauw ver-
want aan de humane genen 
 
CDK1/Cdc2, CDK2 
 
en 
 
CDK3
 
, en de gist
genen 
 
CDC28
 
 en 
 
cdc2
 
+
 
. Het onderzoek toont aan dat 
 
ncc-1
 
 een gelijk-
soortige rol speelt als 
 
CDK1
 
 en 
 
CDC28
 
/
 
cdc2
 
+
 
, en nodig is voor M fase tij-
dens zowel meiose als mitose. Omdat 
 
ncc-1
 
 niet nodig is voor de G
 
1
 
/S
overgang, is het waarschijnlijk dat 
 
C. elegans
 
 meerdere CDK’s gebruikt
om de voortgang door de celcyclus te bewerkstelligen, net als andere
meercellige organismen. In verdere genetische 
 
screens
 
 identificeerden
we inderdaad een CDK die specifiek tijdens de G
 
1
 
 fase functioneert (zie
volgende paragraaf).
In Hoofdstuk 3 is het onderzoek naar de rol van de Cycline D-CDK4/6 -
pRb route tijdens de ontwikkeling van 
 
C. elegans
 
 beschreven. In een
genetische 
 
screen
 
 isoleerden we mutante allelen van 
 
cyd-1
 
 Cycline D en
 
cdk-4
 
 CDK4/6, respectievelijk de enige Cycline D en CDK4/6 kinase in
 
C. elegans
 
. Inactivatie van 
 
cyd-1
 
 of 
 
cdk-4
 
 resulteerde in blokkade van de
larvale celdelingen tijdens de G
 
1
 
 fase, terwijl de groei van cellen door-
ging tot lang na het tijdstip waarop de celdeling stagneerde. In 
 
C. elegans
 
zijn 
 
cyd-1
 
 en 
 
cdk-4
 
 dus voornamelijk nodig voor de voortgang door de G
 
1
 
fase.
Om te bepalen of inactivatie van leden van de retinoblastomafamilie
de enige functie is van 
 
cyd-1
 
 en 
 
cdk-4
 
 hebben we dubbelmutanten
gecreëerd, waarin zowel de retinoblastomafamilie als Cycline D-CDK4/
6 kinases volledig zijn geïnactiveerd. Inactivatie van 
 
lin-35
 
, het enige Rb
gen in 
 
C. elegans
 
, onderdrukte de celdelingsdefecten in 
 
cyd-1
 
 en 
 
cdk-4
 
mutanten. Dit gaf aan dat 
 
lin-35
 
 Rb een belangrijke negatieve regulator
van de G
 
1
 
/S overgang is. Bovendien toonde dit voor het eerst aan dat 
 
in
vivo
 
, de Cycline D-CDK4/6 kinases een essentiële rol spelen bij het
tegengaan van de celdeling remmende werking van de pRb familie.
In zoogdieren maken CDK-remmers van de Cip/Kip familie deel uit
van een tweede route die de voortgang door de G
 
1
 
 fase reguleert.
Daarom vergeleken we de rol van 
 
cki-1
 
 Cip/Kip in G
 
1
 
 regulatie met die
van 
 
lin-35
 
 Rb. Wij demonstreerden dat 
 
cki-1 
 
Cip/Kip snelheidsbeper-
kend is voor de G
 
1
 
/S overgang, en dat 
 
lin-35
 
 Rb en 
 
cki-1
 
 Cip/Kip allebei
bijdragen aan de regulatie van de G
 
1
 
 fase.
In Hoofdstuk 4 is het onderzoek beschreven naar de mechanismen
waarmee 
 
lin-35
 
 Rb  voortgang door de G
 
1
 
 fase remt. In eerste instantie
was 
 
lin-35
 
 Rb geïdentificeerd als één van de synthetische multivulva
(synMuv) genen, die betrokken zijn bij de vorming van de cellen van de
vulva. Om genen te vinden die samen met 
 
lin-35
 
 de voortgang door de
G
 
1
 
 fase reguleren, onderzochten we of andere synMuv genen betrokken
zijn bij de regulatie van de G
 
1
 
 fase. We vonden dat de E2F-homoloog 
 
efl-
1
 
 de voortgang door de G
 
1
 
 fase remt, terwijl de DP homoloog 
 
dpl-1
 
eigenschappen heeft van zowel een positieve als een negatieve regulator
 Samenvatting
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van de G
 
1
 
 fase. Waarschijnlijk blokkeren EFL-1 en DPL-1 in een com-
plex met LIN-35 de transcriptie van genen, terwijl DPL-1 met een
tweede E2F als activator van transcriptie zou kunnen werken. Dit model
komt overeen met de functies die toegeschreven worden aan E2Fs in
 
Drosophila
 
 en zoogdieren, en ondersteunt de theorie dat in meercellige
organismen E2Fs twee tegengestelde functies hebben.
Naast 
 
efl-1
 
 en 
 
dpl-1
 
 identificeerden we 
 
lin-9, lin-15
 
B en 
 
lin-36
 
 als
nieuwe remmers van de G
 
1
 
 fase. De celcyclus fenotypen van 
 
lin-35
 
 Rb en
 
lin-36
 
 komen sterk overeen, wat erop duidt dat 
 
lin-35
 
 Rb en 
 
lin-36
 
 bin-
nen dezelfde route voor G
 
1
 
 regulatie functioneren. Deze resultaten wij-
zen op een algemene rol voor een deel van de synMuv genen binnen de
regulatie van de G
 
1
 
 fase. Dit soort studies kan leiden tot de identificatie
van nieuwe bindingspartners voor 
 
lin-35
 
 Rb, met homologen in zoogdie-
ren die mogelijkerwijs tumorsuppressors zijn.
Tenslotte worden in Hoofdstuk 5 twee projecten beschreven die op dit
moment gaande zijn. Inactivatie van 
 
lin-35
 
 Rb onderdrukt de celcyclus
defecten in 
 
cyd-1
 
 en 
 
cdk-4
 
 mutanten niet volledig, wat aangeeft dat
Cycline D-CDK4/6 kinases nog andere doelwitten hebben naast de pRb
familie. Om deze doelwitten te identificeren voerden we een 
 
screen
 
 uit.
We isoleerden een interessante mutatie die in combinatie met inactiva-
tie van 
 
lin-35
 
 Rb resulteert in vruchtbare 
 
cyd-1
 
 mutanten. Deze mutatie
ligt op het X chromosoom, en we zijn bezig om het gen te identificeren
dat door deze mutatie is aangedaan. Dit onderzoek openbaart waar-
schijnlijk een tweede functie van Cycline D-CDK4/6 kinases die essen-
tieel is 
 
in vivo
 
.
Het tweede project is gericht op de identificatie van genen die
samenwerken met 
 
lin-35
 
 Rb tijdens de ontwikkeling van 
 
C. elegans
 
. In
een proef-
 
screen
 
 zijn al mutaties gevonden waarvan het fenotype onder-
drukt wordt door inactivatie van 
 
lin-35
 
 Rb. Ook is een mutatie gevonden
die zelf levensvatbaar is maar in combinatie met inactivatie van 
 
lin-35
 
 Rb
een steriel fenotype veroorzaakt. De genen die door deze mutaties aan-
gedaan zijn, kunnen betrokken zijn bij de regulatie van de G
 
1
 
 fase, of
samenwerken met 
 
lin-35
 
 op andere gebieden van de ontwikkeling (op
gelijksoortige wijze als de synMuv klasse A genen). 
Samenvattend hebben de in dit proefschrift beschreven experimenten
drie hoofddoelstellingen bereikt. Ten eerste hebben ze bijgedragen aan
het definiëren van de basale celcyclusmachinerie in 
 
C. elegans
 
. Daar-
naast is aangetoond dat voor de regulatie van de celcyclus in 
 
C. elegans
 
gelijksoortige mechanismen gebruikt worden als in zoogdieren. Deze
basis is tenslotte gebruikt om genetische 
 
screens
 
 uit te voeren om nog
onbekende genen te vinden die een rol spelen bij de regulatie van de
celdeling tijdens de ontwikkeling van 
 
C. elegans
 
.
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S
 
UMMARY
 
During development of multicellular organisms, cell divisions need to
be coordinated with the developmental program of the entire organ-
ism. Although the mechanisms that drive cells through the division
cycle are well understood, very little is known about the pathways that
link extracellular signals to the cell-intrinsic cell-cycle machinery. 
 
C. ele-
gans
 
 provides a unique animal model in which developmental controls
of cell-division can be identified genetically. Cell divisions can be fol-
lowed 
 
in vivo
 
 by light microscopy, and the nearly invariant cell-lineage of
 
C. elegans
 
 has been completely described. In addition, redundancy
between genes is limited in 
 
C. elegans
 
. For example, the 
 
C. elegans
 
genome encodes only single members of the retinoblastoma (Rb),
Cyclin D and CDK4/6 kinase families. Finally, powerful genetic tech-
niques are available in 
 
C. elegans
 
 to study gene function. These include
classic genetic screens, as well as reverse genetic approaches such as
RNA-mediated interference and the isolation of chemically induced
deletion alleles by PCR. 
To use 
 
C. elegans
 
 as a model system to identify developmental regula-
tors of cell-cycle progression, we first needed to identify the basic cell-
cycle machinery in 
 
C. elegans
 
. In Chapters 2 and 3 I describe several cell-
cycle regulators in 
 
C. elegans
 
 and demonstrate that they act highly simi-
larly to their mammalian counterparts. These results form the basis for
subsequent genetic studies described in Chapters 4 and 5, which were
aimed at identifying novel regulators of G
 
1 progression. Below follows a
brief description of the contents of each chapter in this thesis.
In Chapter 1, the general mechanisms that control cell-cycle progres-
sion are introduced, with emphasis on G1 regulators. The second half of
the chapter discusses the functions of Cyclin D-CDK4/6 kinases, the Rb
family and E2F/DP transcription factors in animal models.
In Chapter 2, we addressed the functions of the cyclin dependent kinase
ncc-1 in C. elegans. ncc-1 is closely related to human CDK1/Cdc2, CDK2
and CDK3, and yeast CDC28/cdc2+. We demonstrated that ncc-1 acts anal-
ogously to CDK1 and CDC28/cdc2+, and is specifically required for pro-
gression through M phase in meiotic as well as mitotic cell cycles. As ncc-
1 does not appear to be required for the G1/S transition, C. elegans likely
uses multiple CDKs to regulate progression through the cell cycle, simi-
lar to other metazoans. Indeed, we did identify another CDK with G1
specific functions in subsequent genetic screens (see below).
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In Chapter 3, we examined the function of the Cyclin D-CDK4/6 – pRb
pathway in C. elegans. In a genetic screen, we identified mutations in cyd-
1 cyclin D and cdk-4 CDK4/6, the single D-type cyclin and CDK4/6
kinase in C. elegans, respectively. Loss of cyd-1 or cdk-4 arrested postem-
bryonic cell divisions in G1 phase, but cell growth continues well beyond
the time point of arrest. Thus, C. elegans cyd-1 and cdk-4 primarily control
G1 progression. 
To determine whether cyd-1 and cdk-4 solely act to overcome G1 inhi-
bition by pRb family members, we constructed double mutants that
completely eliminate the function of the pRb family and cyclin D-
CDK4/6 kinases. Inactivation of lin-35 Rb, the single Rb-related gene in
C. elegans, substantially reduced the cell-division defects in cyd-1 and cdk-
4 mutant animals. This shows that lin-35 Rb is an important negative
regulator of G1 progression. Moreover, this is the first in vivo demonstra-
tion of an essential role for Cyclin D-CDK4/6 kinases in counteracting
cell-cycle inhibition by proteins of the pRb family.
In mammals, the Cip/Kip family of CDK inhibitors provides an addi-
tional level of control over G1 progression. Therefore, we compared the
functions of lin-35 Rb and cki-1 Cip/Kip in G1 regulation. We demon-
strated that cki-1 Cip/Kip, rather than lin-35 Rb, is rate limiting for G1/S
progression, and that lin-35 Rb and cki-1 Cip/Kip contribute nonover-
lapping levels of G1/S control in C. elegans.  
In Chapter 4 we examined the mechanism of negative regulation of G1
progression by lin-35 Rb. lin-35 Rb was originally identified as a member
of the synthetic Multivulva genes, which regulate vulval cell fate specifi-
cation. To identify genes that act with Rb in regulating G1 progression,
we examined the synthetic Multivulva genes for a role in G1 regulation.
We found that the E2F homolog efl-1 negatively regulates cell-cycle
entry, while the DP related gene dpl-1 acts both as a positive and nega-
tive regulator of G1 progression. EFL-1 and DPL-1 likely act as transcrip-
tional inhibitors in a complex with LIN-35, while DPL-1 and a second
E2F may act as transcriptional activators. This model is in agreement
with the proposed functions of E2Fs in Drosophila and mammals, and
provides further evidence that two opposing E2F functions are present
in vivo.
In addition to efl-1 and dpl-1, we identified a role for lin-9, lin-15B
and lin-36 as novel negative regulators of G1 progression. lin-35 Rb and
lin-36 showed very similar cell-cycle phenotypes, consistent with a model
in which these genes act together in G1 regulation. These results indi-
cated a role for a subset of the class B synMuv genes in the general regu-
lation of G1 progression. Some of these genes may be obligatory
partners of lin-35 Rb, and their mammalian counterparts may be candi-
date tumor suppressors.
Summary
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Finally, Chapter 5 describes two projects that are currently ongoing.
Loss of lin-35 Rb did not fully suppress the cell-cycle arrest of cyd-1 and
cdk-4 mutants, which indicates that Cyclin D-CDK4/6 kinases have tar-
gets outside the pRb family. Therefore, we performed a screen to iden-
tify such targets. We isolated an interesting mutation that, when
combined with inactivation of lin-35 Rb, confers viability to cyd-1
mutants. The mutation maps to the X chromosome and we are cur-
rently identifying the gene affected. These studies are likely to reveal a
second function of Cyclin D-CDK4/6 kinases that is essential in vivo.
The second project is aimed at identifying genes that cooperate with
lin-35 Rb during development of C. elegans. In a small-scale pilot version
of this screen, we already identified mutations whose phenotypes are
suppressed by loss of lin-35, as well as a mutation that is viable by itself,
but causes sterility in combination with inactivation of lin-35. These
mutations may define genes that act in G1 regulation, either upstream
of or in parallel to lin-35, and genes that interact with lin-35 Rb in other
developmental processes (analogous to the interaction between synMuv
class A genes and lin-35). 
In summary, the experiments described in this thesis accomplished
three major goals. First, they helped to define the basic cell-cycle
machinery used in C. elegans. Second, they demonstrated that cell-cycle
regulation in C. elegans is accomplished using mechanisms that are con-
served in mammals. Finally, building upon this foundation, forward
genetic screens were used to identify novel genes involved in develop-
mental control of cell division.
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I
 
NTRODUCTION
 
Research on cell division over the past decades has given us a detailed
understanding of the machinery that controls passage through the cell
division cycle. In most studies, cell division is examined in terms of how
the divisions of individual cells are controlled. However, regulating cell
division in a multicellular organism adds a whole new level of complex-
ity. Growth, proliferation and differentiation of individual cells need to
be coordinated with the development of the entire organism. The deci-
sion whether to divide or not is made largely in G
 
1
 
 phase of the
cell-cycle, and it is mainly during this phase that developmental cues
appear to affect progression through the cell cycle. Many of the players
that regulate progression through G
 
1
 
 phase have been identified. These
include the retinoblastoma protein family, the E2F transcription factors,
G
 
1
 
 cyclin dependent kinases and cyclin dependent kinase inhibitors.
Much of what is known about the function of these proteins comes from
studies of mammalian cells in tissue culture. More recently focus has
shifted somewhat toward examining the roles of these key G
 
1
 
 regulators
in the development of multicellular organisms. In this introduction, I
will first present an overview of the basic cell-cycle machinery and intro-
duce the major players of G
 
1
 
 regulation. In the other chapters of this
thesis, we studied the functions of several G
 
1
 
 regulators in 
 
C. elegans
 
.
These include 
 
C. elegans 
 
homologs of Cyclin D-CDK4/6, retinoblastoma
family members, and E2F/DP transcription factors. In the second part
of this chapter I will discuss the contributions that studies of these G
 
1
 
regulators in animal model systems have made toward our understand-
ing of the process of G
 
1
 
/S progression. Although homologs of G
 
1
 
 regu-
lators are present in a large variety of multicellular organisms, for the
purpose of this introduction I will focus on studies performed in mice,
 
Drosophila melanogaster
 
 and 
 
Caenorhabditis elegans
 
.
 
Fig. 1.
 
 Different Cyclin/CDK
complexes regulate progres-
sion through the various
phases of the cell cycle in
higher eukaryotes. A eukary-
otic cell cycle with the four
major phases is shown.
Cyclin D-dependent kinases
are proposed to act early in
G
 
1
 
 phase in response to
growth factor signaling.
Cyclin E/CDK2 kinases are
required for entry into S-phase. Cyclin A/CDK2 kinases are active during S-phase. Cyclins
A and B in combination with CDK1 are required for entry into mitosis. R = restriction
point.
 Chapter 1.
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T
 
HE
 
 
 
EUKARYOTIC
 
 
 
CELL
 
 
 
CYCLE
 
Cell division in eukaryotic organisms generally consists of two major
events (Nasmyth, 1996): the duplication of the genetic material during
S phase and the segregation of the two copies into sister cells during
mitosis. In a typical cell-division cycle, S-phase and mitosis are separated
by two gap phases, called G
 
1
 
 (before S-phase) and G
 
2
 
 (between S- and
M-phases). The time a cell spends in each phase varies between organ-
isms and between cell types, and can depend on the extracellular envi-
ronment. Variations on this general scheme do exist. For example, in
the fruit fly 
 
Drosophila melanogaster
 
 early embryonic divisions lack gap
phases (Edgar and Lehner, 1996). Many organisms also undergo spe-
cialized cell cycles where the DNA is replicated multiple times without
cell division to form polyploid nuclei (Edgar and Orr-Weaver, 2001).
 
Regulation of cell-cycle progression by Cyclin Dependent Kinases
 
The transitions between the successive phases of the cell cycle are con-
trolled by the activities of cyclin dependent kinases (CDKs) (Nigg,
1995). The founding members of the CDK family are the highly homol-
ogous 34kDa proteins encoded by the 
 
cdc2
 
 gene in the fission yeast
 
Schizosaccharomyces pombe
 
 and the 
 
CDC28
 
 gene in the budding yeast
 
Schizosaccharomyces cerevisiae
 
 (Beach 
 
et al
 
., 1982; Hartwell 
 
et al
 
., 1974;
Nurse and Bissett, 1981). The first vertebrate CDK was identified as the
catalytic subunit of the Maturation Promoting Factor complex (MPF),
which promotes progression through M phase in egg extracts from the
African clawed frog 
 
Xenopus laevis
 
. In addition to the CDK subunit,
active MPF complexes contain a regulatory subunit termed “cyclin”, as
its abundance varies throughout the cell cycle. MPF activity fluctuates
during the early cleavage stages of the 
 
Xenopus
 
 embryo, rising before
cells enter mitosis and falling as they leave mitosis. This periodicity is
controlled in part by the tightly controlled fluctuation in cyclin levels
(reviewed in Murray and Kirschner, 1989). 
In yeasts, a single CDK drives progression through the cell cycle in
combination with different cyclin subunits. In mammalian cells, multi-
ple CDK subunits have been identified in addition to a rather large fam-
ily of Cyclins. Fig. 1 illustrates the different CDKs and cyclins identified
in mammals and their proposed point of activity in the cell cycle
(reviewed in Nigg, 1995). Surprisingly, very few critical CDK targets have
been identified. This is probably because the effect of CDKs is achieved
by phosphorylation of a multitude of targets, each of which on their
own may not be rate limiting for cell-cycle progression. However, a few
critical targets have been identified, including the retinoblastoma
tumor suppressor product (pRb), which appears to be regulated by
CDKs acting in G
 
1
 
 phase (see below).
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Regulation of CDK activity
 
Consistent with their important role in cell cycle regulation, the activity
of Cyclin/CDK complexes is strictly controlled at several levels. The pri-
mary mechanism to control CDK activity is by regulating the levels of
cyclins. Both protein synthesis and protein degradation play an impor-
tant role in controlling the abundance of cyclins. Cyclin degradation is
controlled by specific ubiquitin conjugating complexes that target
cyclins for degradation by the 26S proteasome (Hershko, 1997; Hoyt,
1997). For example, the anaphase promoting complex (APC) targets
B-type cyclins for destruction in mitosis, and Cyclin E is targeted for
destruction by SCF (for Skp-1/Cullin/F-box) during S-phase (Peters,
1998; Winston 
 
et al
 
., 1999). A second level of control over Cyclin/CDK
activity is accomplished by CDK phosphorylation and dephosphoryla-
tion. Phosphorylation of p34
 
CDC2
 
 on threonine 14 and tyrosine 15 inhib-
its its kinase activity, and these inhibitory phosphorylations must be
removed by the dual specificity phosphatase CDC25 before a cell can
enter mitosis. In addition, phosphorylation on threonine 161, the third
phosphorylation site of p34
 
CDC2
 
, is required for kinase activity (see Nigg,
1995; Solomon, 1993 for reviews on CDK phosphorylation). Finally,
Cyclin/CDK activity can be blocked by CDK inhibitors. Two classes of
CDK inhibitors exist in mammalian cells (reviewed in Sherr and Rob-
erts, 1999). Members of the INK4 family specifically inhibit the D-type
cyclin activated kinases CDK4 and CDK6, while the Cip/Kip family of
kinase inhibitors likely blocks CDK2 activity primarily. Together, these
mechanisms ensure a tightly regulated peak of CDK activity at the
appropriate time.
 
Developmental control of cell-cycle progression
 
During development, multicellular organisms need to integrate individ-
ual cell divisions with the developmental program of the whole organ-
ism. One of the means by which multicellular organisms can control cell
divisions is through extracellular signals. A wide range of extracellular
factors determines the rate of proliferation of cells. For example, mat-
ing pheromone can induce yeast cells to withdraw from the cell cycle
and instead enter a sexual development program (Woollard and Nurse,
1995). In addition, yeast cells will stop cycling under conditions of lim-
ited nutrient availability. Similarly, mammalian cells in culture are
dependent on growth factors in their medium to proliferate and often
need to be anchored to a substrate (Pardee, 1989). A well known inhibi-
tory signal for tissue culture cells is contact with neighboring cells (con-
tact inhibition), which results in an arrest in G
 
1
 
 phase.
The importance of G
 
1
 
 phase for regulation of cell division was real-
ized early on from studies on mammalian cells in culture by Arthur Par-
dee and Howard Temin (Pardee, 1974; Temin, 1971). They
demonstrated that growth factor or nutrient withdrawal does not pre-
vent progression through the cell cycle past a certain point in G
 
1
 
 phase,
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which was termed the restriction point. A similar transition point exists
in yeast. At the onset of a new division cycle, both budding and fission
yeast have a choice between entering a mitotic cell cycle or undergoing
sexual development which entails a meiotic division. Past a certain point
in G
 
1
 
 phase, termed START, yeast cells are committed to the mitotic
cycle and can only enter sexual development once they reach the next
G
 
1
 
 phase (reviewed in Woollard and Nurse, 1995). In addition, nutrient
availability no longer affects cell-cycle progression once cells have
passed START. 
It is now generally accepted that many extracellular signals affect
progression through the cell cycle during a window of opportunity in G
 
1
 
phase, and that cells past the restriction point are relatively unrespon-
sive to extracellular stimuli. As is usually the case in biology, exceptions
do exist. For example, many developmental signals in 
 
Drosophila
 
 affect
entry into mitosis rather than S phase (Duronio, 1999).
 
Control of progression through G
 
1
 
 phase by the Retinoblastoma family
 
To ensure that cells only enter a cell division cycle at the appropriate
time, an elaborate system of checks and balances has evolved that regu-
lates progression through G
 
1
 
 into S phase. The importance of these con-
trol mechanisms is underscored by the fact that most, if not all, human
tumor cells have defects in one or more of the pathways that control G
 
1
 
progression (Sherr, 1996). The product of the retinoblastoma gene,
pRb, plays a pivotal role in the regulation of cell proliferation. Rb was
originally identified as the gene mutated in familial retinoblastomas, a
malignant tumor of the retina. Since somatic mutations that inactivate
Rb have been found in a variety of different tumors, these and other
studies have established that pRb acts as a tumor suppressor which nor-
mally restricts proliferation (reviewed in Cobrinik 
 
et al
 
., 1992).
 pRb can exist in several phosphorylation states. The hypophosphory-
lated form of pRb acts as a negative regulator of cell cycle progression,
as indicated by a number of different observations. First, viral oncopro-
teins produced by several DNA tumor viruses specifically bind to and
inactivate hypophosphorylated pRb (Cobrinik 
 
et al
 
., 1992). Second, in
cells synchronously released from G
 
1
 
 arrest,  pRb proteins become
hyperphosphorylated around the time of passage through the restric-
tion point, and remain hyperphosphorylated until sometime in late
mitosis (reviewed in Weinberg, 1995). Finally, hypophosphorylated pRb
was found to specifically bind to and control a number of cellular pro-
teins, most notably the E2F transcription factors (Weinberg, 1995).
These observations led to the now generally accepted conclusion that
pRb phosphorylation is an essential step in progression from G
 
1
 
 into S
phase. 
In mammals, three Rb family members exist: pRb, p107 and p130
(see Classon and Dyson, 2001 for a review on the similarities and differ-
ences between pRb, p107 and p130). All three proteins are structurally
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very similar, especially in the domains bound by viral oncoproteins. In
addition, all three family members are excellent substrates for phospho-
rylation by CDKs 
 
in vitro
 
, and all three associate with members of the
E2F family of transcription factors (see below). Despite these similari-
ties, several differences do exist. First, the expression patterns are differ-
ent for each family member, with pRb being expressed fairly constantly
throughout G
 
1
 
, p130 being expressed highly in G
 
0
 
 and early G
 
1
 
, and
p107 levels rising at the end of G
 
1
 
. Second, as described below, differ-
ences exist in the members of the E2F family bound by each pRb-related
protein. Finally, p107 and p130 can bind to Cyclin A and Cyclin
E-dependent kinase complexes. Most of the studies described in this
chapter focus on the function of pRb, as this is the most extensively
studied member of the pRb family, and the only one found to act as a
tumor suppressor.
 
Phosphorylation of pRb by cyclin dependent kinases
In vitro
 
, both Cyclin D-dependent kinases and Cyclin E/CDK2 are able
to phosphorylate pRb (reviewed in Mittnacht, 1998). Cyclin E/CDK2
kinase activity peaks just before the onset of S-phase, and this activity is
essential for entry into S-phase (Ekholm and Reed, 2000; Sherr, 1993).
Transcription of Cyclin E during the G
 
1
 
/S transition is controlled by
E2F/DP transcription factors, which are negatively regulated by pRb
(see below). As pRb itself is a target for Cyclin E/CDK2, this allows a
feed-forward loop, with pRb inactivation increasing Cyclin E/CDK2
activity resulting in further inactivation of pRb.
In contrast to Cyclin E, the levels of Cyclin D remain fairly constant
throughout the cell cycle. However, in response to growth factor with-
drawal the levels of Cyclin D drop rapidly (see Sherr, 2000 for a review).
In addition, growth factors posttranscriptionally regulate assembly of
D-type cyclins with their catalytic CDK partners. D-type cyclins are,
therefore, often referred to as growth factor sensors.
Cyclin D- and Cyclin E-dependent kinases phosphorylate pRb at dis-
tinct but overlapping subsets of sites, and phosphorylation of pRb
appears to happen in a sequential fashion by first Cyclin D-CDK4/6 and
then Cyclin E/CDK2 (Mittnacht, 1998). In one model of pRb inactiva-
tion, initial phosphorylation by Cyclin D-CDK4/6 inactivates pRb
repressor complexes (see below), while subsequent phosphorylation by
Cyclin E/CDK2 inhibits the ability of pRb to bind to and inactivate
E2F/DP transcriptional activators (Harbour 
 
et al
 
., 1999). It should be
noted however that the exact mechanisms of pRb inactivation by CDKs
remain the subject of intense study and speculation.
 
The regulation of E2F transcription factors by pRb
 
The most widely studied effectors of pRb are the E2F transcription fac-
tors, and many of the effects of pRb on cell cycle progression are
thought to be mediated by E2F (see Beijersbergen and Bernards, 1996
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and; Dyson, 1998 for in depth reviews of E2F transcription factors).
Although referred to as E2F, these transcription factors are actually het-
erodimers consisting of an E2F subunit and a DP subunit. In mammals,
at least six E2F and two DP family members exist, and homologs of E2F
and DP have been identified in many other organisms. 
Hypophosphorylated pRb family members can stably bind E2F/DP
complexes, and specific combinations are preferentially formed during
particular phases of the cell cycle (see Table 1). At least two mechanisms
have been described by which binding of pRb to E2F complexes blocks
progression through G
 
1
 
 phase. First, binding of pRb family members to
transcriptionally active E2F/DP complexes likely prevents them from
activating the transcription of S-phase genes. Second, E2F/DP can
recruit pRb to the promoters of specific genes to form actively repress-
ing complexes. Active transcriptional repression by pRb/E2F/DP most
likely involves the recruitment of chromatin remodeling complexes to
the promoter by pRb. At least three chromatin remodeling complexes
have been implicated in this process. These are complexes with histone
deacetylating activity, the Swi/Snf ATP-dependent chromatin remodel-
ing complex and histone methylases (Harbour and Dean, 2000a; Har-
bour and Dean, 2000b; Nielsen 
 
et al
 
., 2001)
.
Several additional mechanisms exist to regulate E2F activity. For exam-
ple, E2F1 can be phosphorylated on Ser-332 and Ser-337 which blocks
pRb from binding (Fagan 
 
et al
 
., 1994). Also, the transcription of certain
E2F members may depend on other E2F proteins. For example, tran-
scription of E2F-1 and E2F-2 appears to be inhibited by E2F4 and E2F5
complexes (reviewed in Dyson, 1998).
 
Table 1. 
 
Rb-family member/E2F complexes during the cell cycle
 
pRb family 
member
E2F family 
member
cell-cycle phase
pRb
p107
p130
E2F1,2,3,4
E2F4
E2F4,5
G
 
0
 
, G
 
1
 
, S
G
 
1
 
, S, G
 
2
 
G
 
0
 
, G
 
1
 
Overview of the most prevalent complexes between pRb 
and E2F family members formed in specific phases of the cell 
cycle (from Dyson, 1998).
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Taken together, the studies described above suggest a model for the reg-
ulation of G
 
1
 
 progression in which a linear Cyclin D-CDK4/6 - pRb - E2F
pathway takes center stage (summarized in Fig. 2). This model leaves
several important questions unanswered. Chief among these is the in
vivo importance of the various proposed G1 regulators. Another very
important question is the issue of functional redundancy between multi-
ple family members. Mammalian cells have three Rb family members,
six E2Fs, two DPs, three D-type cyclins and two kinase partners for cyclin
D. Do all these family members simply provide redundant functions, or
do they perform their own specialized functions? With the more recent
development of mice deficient in one or more G1 regulators, these and
other questions are starting to be addressed. Studies of these mecha-
nisms in the model organisms Drosophila melanogaster and Caenorhabditis
elegans also provide a valuable contribution. In particular, studies of G1
regulators in these organisms are aided by the fact that families of G1
regulators contain far fewer members. This reduces or eliminates poten-
tial problems in interpreting results arising from functional redundancy
between family members. In addition, powerful genetic methods are
available to analyze interactions between the various G1 regulators, and
forward genetic screens can be used to identify novel components that
act in G1 control in vivo. 
Fig. 2. Model for the control of G1 progression by D-type cyclins, pRb and E2Fs. In growth
arrested cells, pRb exists mainly in the hypophosphorylated form and binds to E2F/DP
complexes. This has two effects. On the one hand, E2F/DP transcription factors are pre-
vented from activating genes required for S-phase entry. On the other hand,
pRb/E2F/DP complexes can actively block transcription, which may involve recruitment
by pRb of additional factors such as Histone Deacetylases and chromatin modifying com-
plexes like Swi/Snf and methylases. Early in G1, D-type cyclin dependent kinases are
formed, likely in response to growth factor signaling. These initiate the phosphorylation
and inactivation of pRb. This results in release of E2F/DP transcription factors which can
now activate genes required for S-phase entry. One E2F target gene is Cyclin E, which asso-
ciates with CDK2 and helps to further inactivate pRb.
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THE CYCLIN D-CDK4/6 − PRB − E2F PATHWAY IN VIVO
In the rest of this chapter, I will discuss the functions of the pRb pathway
in multicellular organisms. I will focus on Cyclin D-CDK4/6, the pRb
family and E2F/DP transcription factors, as the studies described in this
thesis deal largely with the functions of these cell-cycle regulators in C.
elegans. It is important to realize however that many components not dis-
cussed in this Chapter also affect the pRb pathway. For example, E2F
transcription factors are just one of many potential pRb binding part-
ners, although they are the most widely studied. Other candidate Rb
partners include the chromatin remodelling complexes mentioned
above, and the Id2 protein. Id2 is a dominant-negative antagonist of
basic helix-loop-helix transcription factors. Importantly, loss of Id2 in
mice rescues the embryonic lethality associated with pRb knockout mice
(Lasorella et al., 2000). See (Morris and Dyson, 2001) for a comprehen-
sive review of potential pRb partners. 
Another important regulator of G1 progression is the INK4 family.
Members of the INK4 family inhibit CDK4/6 kinases and have been
implicated as tumor suppressors. However, no clear INK4 family mem-
bers have been identified in C. elegans, and it would therefore be beyond
the scope of this thesis to discuss this family in detail.
The Rb family
The functions of pRb in mammalian development
The first Rb family member whose function was examined in vivo was
pRb itself. Rb deficient mice complete a substantial part of embryogene-
sis, but ultimately die in mid-gestation with severe defects in erythro-
poiesis as well as neuronal and lens development (Clarke et al., 1992;
Jacks et al., 1992; Lee et al., 1992). Close examination of the defects in
pRb-/- mice indicates that pRb plays diverse roles during development in
vivo. Embryos deficient for pRb show severe defects in the differentia-
tion of multiple tissues. For example, pRb mutant mice have smaller
fetal livers and a dramatic increase in the number of immature nucle-
ated erythrocytes (Jacks et al., 1992; Lee et al., 1992). This appears to be
due to a failure of erythroid precursor cells to differentiate into mature,
enucleated red blood cells (Jacks et al., 1992; Robanus Maandag et al.,
1994). pRb deficiency also affects the differentiation of many nerve
cells, especially in the sensory ganglia. These cells do not mature prop-
erly, and fail to express many neuronal markers, such as βII tubulin, Trk
A, Trk B, and the low-affinity neurotrophin receptor p57LNGFR (Lee et al.,
1994). Differentiation of lens fiber cells is also abnormal in Rb-/- mice, as
expression of many late lens differentiation markers, such as β-crystallin
and filensin, is impaired (Liu and Zacksenhaus, 2000; Morgenbesser et
al., 1994). Finally, differentiation of cultured myotubes from pRb-/- mice
was impaired as evidenced by a reduction in the expression level of late
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muscle specific genes (Zacksenhaus et al., 1996). Thus, pRb appears to
be involved in the process of cell differentiation. Early differentiation
markers are often still expressed, but late markers are not. In general
the tissues that are most severely affected by loss of pRb are those that
normally have high pRb expression levels.
In addition to being involved in differentiation, pRb appears to be
required for cells to exit the cell cycle and to keep cells in a quiescent
state. Ectopic S phases are observed in multiple tissues of pRb-/- mice.
These include the central and peripheral nervous systems (CNS and
PNS), and lens fiber cells in the developing lens (Clarke et al., 1992;
Jacks et al., 1992; Lee et al., 1994; Lee et al., 1992; Morgenbesser et al.,
1994). In skeletal muscle cells, pRb appears to be required to keep myo-
tubes in a quiescent state. MyoD can still induce cultured skeletal mus-
cle cells from Rb-/- mice and Rb-/- MEFs to differentiate into mature
myotubes, but these myotubes can re-enter the cell cycle when stimu-
lated with growth factors, in contrast to wild type myotubes (Novitch et
al., 1996; Schneider et al., 1994).
Finally, the presence of pRb appears to protect cells from undergo-
ing apoptosis, as evidenced by the finding that many tissues in pRb defi-
cient mice demonstrate high levels of apoptosis. For example, both the
CNS and PNS show exceptionally high levels of apoptosis (Clarke et al.,
1992; Jacks et al., 1992; Lee et al., 1994; Lee et al., 1992). In addition,
increased levels of apoptosis are found in both lens fiber cells and skele-
tal muscle cells (Morgenbesser et al., 1994; Jiang et al., 2000). The p53
gene product is a potent mediator of apoptosis, and cell death in most
of the tissues of pRb-/- mice described above indeed depends on the
activity of p53 (Macleod et al., 1996; Morgenbesser et al., 1994; Tsai et al.,
1998). However, apoptosis in the PNS and skeletal muscle appear to be
independent of p53 activity (Jiang et al., 2000; Macleod et al., 1996). 
Together, these results provide strong support that pRb not only reg-
ulates G1 progression in vivo, but also is involved in processes such as
cell differentiation, cell-cycle exit and protection against apoptosis.
pRb deficiency and tumor formation
As would be expected from the loss of an important tumor suppressor,
pRb+/- mice are indeed prone to tumor development. The two most
prevalent types of tumor that develop in pRb+/- mice are thyroid C-cell
adenomas and pituitary adenocarcinoma’s of the intermediate lobe
(Hu et al., 1994; Jacks et al., 1992; Robanus Maandag et al., 1994; Will-
iams et al., 1994a; Williams et al., 1994b; Yamasaki et al., 1998). Surpris-
ingly, pRb+/- mice do not develop retinoblastomas (Clarke et al., 1992;
Jacks et al., 1992; Lee et al., 1992). However, inactivation of the Rb family
by expression of HPV-16 E7 in mice deficient for p53 does result in the
development of retinoblastomas, indicating that the activity of p53 may
prevent the formation of retinoblastomas in pRb+/- mice (Howes et al.,
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1994). A detailed description of tumor predisposition in Rb mutant
mice can be found in (Vooijs and Berns, 1999).
The functions of p107 and p130 in mammalian development
The effects of inactivation of p107 or p130 are generally much less
severe than those that result from pRb inactivation. However, the sever-
ity is dramatically affected by the genetic background; while inactivation
of p107 or p130 in a C57BL/6J background has minimal effects, much
more severe defects are observed in a Balb/c background. In a
C57BL/6J background, p107 deficient mice show a minimal thickening
of the bones of the forelimbs (Cobrinik et al., 1996; Lee et al., 1996). By
contrast, in a Balb/c background the loss of p107 results in a reduced
rate of postnatal growth combined with a compromised immune system
and a myoproliferative disorder, which results in extensive extramedul-
lary haematopoiesis in liver and spleen (LeCouter et al., 1998a). Simi-
larly, in a C57BL/6J background the loss of p130 causes no overt
phenotype, while in a Balb/c background, loss of p130 causes embry-
onic death between E11 and E13 with defects in proliferation of skeletal
and cardiac muscle and neurons in the neural tube and dorsal root gan-
glia (LeCouter et al., 1998b). These results suggest the presence of a sec-
ond site modifier in the Balb/c background that is responsible for the
more severe phenotype. Interestingly, Balb/c mice have a non-func-
tional p16INK4a gene (Zhang et al., 1998). As p107 and p130, as well as
p16INK4a, can inhibit G1 progression, the loss of p16 and p107 or p130
might produce an additive effect.
The examination of p107/p130 double knockout mice revealed a
significant functional redundancy between p107 and p130. First, such
mice die just after birth, due to an inability to breath. In addition, the
double knockout mice have far more severe defects in bone formation
than either single knockout, as evidenced by their dramatically short-
ened limbs (Cobrinik et al., 1996). The defect in bone formation is
found in all bones formed by endochondral ossification. Endochondral
ossification requires chondrocytes to exit the cell cycle and undergo
hypotrophy, which is normally followed by replacement of these cells by
invading osteocytes. In p107-/-/p130-/- mice chondrocyte density is
increased 2-fold in areas where chondrocytes should normally exit the
cell cycle, and many of these cells are still actively entering S-phase. As
these defects are not observed in the single knockouts, p107 and p130
thus appear to act redundantly in restricting chondrocyte proliferation
(Cobrinik et al., 1996). These results demonstrate that p107 and p130
have largely overlapping functions that are distinct from those of pRb. 
Functional redundancy between all three Rb family members
The observations described in the previous section clearly indicate that
although individual Rb family members appear to play distinct roles
during development, significant overlap exist between the functions of
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at least p107 and p130. Possible overlap between p107 and pRb is indi-
cated by the finding that mice that lack both Rb and p107 die earlier
and show high levels of apoptosis in the CNS and liver at an earlier time
point than Rb-/- mice (Lee et al., 1996). Recently, the effects of knocking
out all three Rb-family members have been examined in mouse embry-
onic fibroblasts (MEFs) (Dannenberg et al., 2000; Sage et al., 2000).
Complete inactivation of the Rb family leads to a dramatic decrease in
population doubling times of MEFs. The percentage of cells in G1 phase
is decreased compared to wild-type MEFs, concomitant with an
increased S-phase population. In addition, the triple knockout MEFs
are immortalized and fail to arrest in G1-phase in response to inhibitory
signals like DNA-damage, confluence, low serum or senescence. Thus,
these cells have further lost cell-cycle control compared to cells lacking
one or two Rb-family members. Loss of Rb and either p107 or p130, or
double inactivation of p107 and p130 leads to a shortening of G1 phase
that is compensated for by an extension of S phase, leaving the total
doubling time unaffected (Classon et al., 2000; Herrera et al., 1996; Hur-
ford et al., 1997). These cells are also still responsive to serum with-
drawal. From these experiments it becomes clear that pRb, p107 and
p130 perform at least partially overlapping functions.
Cell autonomous versus non cell-autonomous functions of pRb
Given the embryonic death of Rb-/- mice, it was surprising to find that
chimeric mice with high contributions of Rb-/- ES cells have only minor
defects (Robanus Maandag et al., 1994; Williams et al., 1994b). In chi-
meric mice, both Rb+ and Rb-/- cells contribute to erythropoiesis. As
these mice show normal numbers of enucleated red blood cells, the
erythropoiesis defect found in Rb-/- mice does not appear to be a
cell-autonomous defect of Rb loss (Robanus Maandag et al., 1994; Will-
iams et al., 1994b). 
Recently, the apoptosis in the CNS of chimeric pRb mice was exam-
ined in more detail (Lipinski et al., 2001). Compared to Rb-/- embryos,
the number of apoptotic cells in the CNS at E13.5 was significantly lower
in chimeric embryos. This suppression of apoptosis does not appear to
be due to complete rescue of the Rb-/- defects, as the level of ectopic cell
cycle entry of Rb-/- cells in chimeric mice is comparable to that found in
germline Rb-/- embryos. Thus, like the erythropoiesis differentiation
defect, apoptosis in Rb-/- cells is rescued by neighboring wild-type cells.
This rescue appears to occur downstream of activation of p53, as p53
protein levels and DNA binding activity are still elevated in Rb-/- chi-
meric mice. As ectopic S-phase entry is not suppressed in these chime-
ras, these data demonstrate that in mice, Rb likely has a
cell-autonomous function in cell-cycle entry and a non cell-autonomous
function in differentiation and prevention of apoptosis. In addition, the
finding that apoptosis can be suppressed independently from the
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ectopic S-phase entry may indicate that apoptosis is not a necessary con-
sequence of ectopic S-phase entry.
The function of the fly Rb family member RBF1
The Drosophila genome contains two genes homologous to Rb family
members, of which only one, rbf1, has been studied to date. rbf1 mutant
flies die at an early larval stage (Du, 2000; Du and Dyson, 1999). By
using such rbf1 mutants in combination with by heat shock induced
expression of wild-type RBF1, Du et al. demonstrated an absolute
requirement for RBF1 during early larval development, and a require-
ment for RBF1 in bristle and eye development in later stages of develop-
ment (Du, 2000). The Drosophila rbf1 mutation primarily affects the G1
arrest of epidermal cells following mitosis 16. In wild-type flies, early
development consists of a series of cell cycles that lack detectable G1
phases. Following embryonic division 16, epidermal cells enter their
first G1 phase and permanently arrest cell divisions. In rbf1 mutants, the
epidermal cells enter G1 following mitosis 16, but they are unable to
remain in G1 as evidenced by incorporation of BrdU (Du and Dyson,
1999). These cells do no appear to re-enter M-phase. In agreement with
a role for RBF1 as a negative regulator of G1 progression, ectopic
expression of RBF1 in the developing eye or wing caused a decrease in
cell divisions (Du et al., 1996a; Neufeld et al., 1998). Thus, similar to pRb
in mice, RBF1 appears to be required to keep cells in a quiescent state.
Similar to pRb deficient mice, extensive apoptosis is observed in the
epidermis of rbf1 mutant embryos. However, as the cells that enter
S-phase are not the same as those that undergo apoptosis, apoptosis is
not a direct consequence of ectopic S-phase.
The functions of lin-35 Rb in C. elegans
The C. elegans genome contains a single Rb family member, lin-35, which
was originally identified as a member of the synthetic multivulva (syn-
Muv) gene family (Lu and Horvitz, 1998). The synMuv genes counteract
a Ras-mediated signal that induces vulval cell fates. Loss of synMuv activ-
ity causes too many cells to adopt the primary vulval cell fate, leading to
the formation of multiple pseudo-vulvae along the ventral side of the
animal (Ferguson and Horvitz, 1985; Ferguson et al., 1987). Genetically
the synMuv genes fall into two classes, A and B, and the appearance of
the multivulva phenotype requires the inactivation of both a class A and
a class B gene (Ferguson and Horvitz, 1989). lin-35 Rb acts as a class B
synMuv gene. Surprisingly, lin-35 Rb mutants appear to develop nor-
mally and become fertile adults, indicating that loss of lin-35 Rb has no
effect on cell divisions. However, we recently showed that lin-35 Rb does
act as a negative regulator of G1 progression by examining the effect of
lin-35 Rb loss of function in combination with other cell-cycle mutants
(see Chapter 3). Loss of cyd-1 Cyclin D or cdk-4 CDK4/6 results in a
block of cell division in G1 phase. Inactivation of lin-35 Rb in a cyd-1 or
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cdk-4 mutant background restores several rounds of cell division,
endoreduplication in intestinal cells and expression of the S-phase
marker rnr::GFP (Boxem and van den Heuvel, 2001). Further evidence
that lin-35 Rb acts to negatively regulate G1 progression comes from the
observation that lin-35 Rb acts in a parallel pathway to the Cip/Kip fam-
ily members cki-1 and cki-2. Loss of cki-1 and cki-2 results in additional
divisions of several cell types including the intestinal nuclei. While loss
of lin-35 Rb by itself does not cause additional divisions, double inactiva-
tion of the Rb and Cip/Kip families results in a synergistic increase in
postembryonic divisions. Therefore, lin-35 Rb and cki-1 + cki-2 Cip/Kip
likely form two parallel pathways that negatively regulate proliferation
(Boxem and van den Heuvel, 2001). These result demonstrate that
lin-35 Rb acts as a negative regulator of G1 progression.
These studies on the function of the pRb family in animal models illus-
trate that Rb related genes may play diverse roles during development.
In mice, pRb family members appear to function in differentiation, dur-
ing exit from the cell-cycle and to protect against apoptosis. Similarly, in
flies, RBF1 appears to be required to keep cells in a quiescent state and
to prevent apoptosis. Finally, in C. elegans, lin-35 Rb functions as a nega-
tive regulator of G1 progression but also acts as a regulator of the vulval
cell fate.
E2F transcription factors
Functional antagonism and redundancy between mammalian E2F family mem-
bers
In mammals, six E2F genes and two DP genes have been found to date.
Several observations indicate that E2F1, E2F2 and E2F3 act predomi-
nantly as transcriptional activators, while E2F4 and E2F5 may normally
inhibit transcription (reviewed in Dyson, 1998). First, although overex-
pression of all E2F family members can activate transcription, E2F4 and
E2F5 do so much less efficiently. In addition, only E2F1, E2F2 and E2F3
can drive quiescent cells into S-phase when overexpressed. Finally, while
E2F1, E2F2 and E2F3 complexes localize to the nucleus, E2F4 and E2F5
lack a nuclear localization signal and depend on Rb family members for
translocation to the nucleus. Thus, when pRb family members become
phosphorylated, E2F4 and E2F5 actually become cytoplasmic and are
presumably inactive. The function of E2F6, which lacks a transactivation
and Rb binding domain is largely unknown. Two important questions
about the functions of mammalian E2Fs are to what extent the func-
tions of the E2F family members overlap, and which mode of action of
E2F complexes is most important for the function of E2F in vivo.
The function of E2F1 was the first to be studied in a knockout mouse
(Field et al., 1996). Surprisingly, E2F1 deficient mice show only minor
developmental abnormalities. E2F1-/- mice develop testicular atrophy,
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and exocrine glands with enlarged nuclei that are often binucleate
(Field et al., 1996; Yamasaki et al., 1996). In addition, the thymus of
E2F1-/- mice is enlarged due to a decrease in apoptosis of immature thy-
mocytes (Field et al., 1996). In agreement with these mild defects,
E2F1-/- MEFs do not have defects in cell-cycle progression or prolifera-
tion rates, and cells derived from lymph nodes proliferate normally in
response to mitogen stimulation (Field et al., 1996).
E2F3 knockout mice display more severe defects. Many E2F3-/- mice
die before birth, indicating an important role for E2F3 in embryonic
development (Humbert et al., 2000b). In contrast to E2F1-/- MEFs, MEFs
deficient for E2F3 proliferate slower with a delay in initiation of S phase
and a reduced rate of DNA replication (Humbert et al., 2000b). In addi-
tion, while in E2F1-/- MEFs only cyclin E expression is reduced, in E2F3-/-
MEFs many E2F responsive genes show delayed expression and reduced
levels. This indicates that E2F3 may be responsible for the transcription
of many E2F target genes in vivo. When cells are released from a G1
arrest, both E2F1 and E2F3 are downregulated after S-phase, but only
E2F3 is upregulated in the next G1 phase (Leone et al., 1998). In addi-
tion, of the E2F target genes that are upregulated during entry into S
from G0, only a subset is cell-cycle regulated during the second division
cycle. These data suggest a model where E2F1 functions during the exit
from G0 into G1 phase, while E2F3 is required for entry into S-phase dur-
ing normal proliferation.
Despite these differences in function, considerable overlap does
exist between E2Fs 1-3. Overlap between E2F3 and either E2F1 or E2F2
is indicated by the much more severe phenotype of E2F1/E2F3 and
E2F2/E2F3 double knockout mice, which both are embryonic lethal at
day 9.5 of embryogenesis (Wu et al., 2001). Recently, a knockout mouse
was described that lacks E2F1,2 and in which E2F3 can be conditionally
inactivated (Wu et al., 2001). Triple E2F knockout MEFs derived from
these mice were found to completely lack S-phase entry and cell prolif-
eration. This result is the first demonstration that the function of mam-
malian E2F transcription factors is essential for progression into
S-phase.
 
Mice lacking one of the second class of E2Fs, consisting of E2F4 and
E2F5, show a very different phenotype than E2F1-3 knockout mice.
E2F4 deficient mice have two limited defects. The first is a defect in dif-
ferentiation of the haematopoietic cell lineage. Red blood cells show
various abnormalities such as variation in size, increase in cell volume
and Howell-Jolly bodies (nuclear remnants of improper enucleation)
(Humbert et al., 2000a; Rempel et al., 2000). In addition, the mice have
a craniofacial defect that results in accumulation of proteinaceous
secretions in the nasal cavities, increasing the susceptibility to bacterial
infection. These mice die 3-4 days after birth from a bacterial infection
of the nasal passages (Humbert et al., 2000a). MEFs lacking functional
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E2F4 do not show defects in proliferation, cell cycle arrest in response
to serum withdrawal or cell cycle entry after serum addition (Humbert
et al., 2000a). 
E2F5 knockout mice develop hydrocephalus (abnormal buildup of
cerebrospinal fluid in the ventricles of the brain) within the first few
days of life (Lindeman et al., 1998). The cause of the hydrocephalus is
not completely known, but likely results from excess production of cere-
brospinal fluid in the choroid plexus, a tissue in which E2F5 is highly
expressed. E2F5 deficient MEFs also do not show altered cell-cycle
kinetics compared to wild-type cells, and still respond to contact inhibi-
tion. 
Mice deficient for both E2F4 and E2F5 die before birth, indicating
an overlap in function between these two E2Fs (Gaubatz et al., 2000).
Strikingly, E2F4-/-/E2F5-/- MEFs fail to arrest in G1 phase in response to
expression of the CDK4/6 inhibitor p16INK4a, even though all other
aspects of cell cycle regulation examined are normal (Gaubatz et al.,
2000). p16INK4a activity may arrest cells in G1 phase by two mechanisms.
First, it inhibits cyclin D dependent kinases, leading to an accumulation
of hypophosphorylated Rb-family members. Second, binding of p16INK4a
displaces p21Cip/Kip from cyclin D-CDK4/6, allowing it to bind to and
inactivate Cyclin E/CDK2 complexes. E2F4-/-/E2F5-/- MEFs still arrest in
response to expression of p21CIP, indicating that E2F4 and E2F5 are spe-
cifically required for the pocket protein mediated G1 arrest in response
to p16INK4a. In this function they act redundantly since ectopic expres-
sion of either E2F4 or E2F5 restores the arrest in response to p16INK4a.
The results obtained in mammalian cells thus demonstrate the exist-
ence of two distinct functions for E2Fs. While E2Fs 1-3 are positive regu-
lators of G1 progression, and their function is essential for cell division,
E2F4 and E2F5 restrict G1 progression under certain conditions.
The role of E2F in Rb induced cell-cycle entry and apoptosis
The E2F family of transcription factors is the most extensively studied
target of pRb family members. However, over the years, a large number
of proteins that can interact with pRb has been identified (Morris and
Dyson, 2001). It is important therefore to determine to what extent the
functions of pRb are affected through E2F family members in vivo.
Examining the effect of E2F loss of function on the Rb mutant pheno-
types is a powerful approach to determine the importance of E2F as an
Rb target. In mice, the effects of loss of E2F1 and E2F3 on the Rb-/- phe-
notype have been examined. Loss of E2F1 or E2F3 extends the lifespan
of Rb deficient embryos from mid-gestation (E13.5) to E17 or E18.5,
respectively. E2F1 and E2F3 appear to be involved in both the ectopic
S-phases and increase in apoptosis in Rb deficient mice. Loss of E2F1 or
E2F3 in Rb-/- embryos suppresses ectopic S-phase entry and apoptosis in
the lens and the CNS (Tsai et al., 1998; Ziebold et al., 2001). This is in
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contrast to mammalian cells in tissue culture, where only expression of
E2F1 was able to promote apoptosis (DeGregori et al., 1997). These
observations clearly established E2Fs as important pRb targets, and also
indicate that specific E2Fs may perform different functions. 
Apoptosis in the CNS and lens are p53 dependent. One mechanism
by which E2F might promote apoptosis is through transcription of
p19ARF, which results in stabilization of p53 (reviewed in Phillips and
Vousden, 2001). Consistent with this E2F function, loss of E2F1 or E2F3
do not rescue ectopic S-phase entry in skeletal muscle, which is p53
independent (Jiang et al., 2000; Tsai et al., 1998; Ziebold et al., 2001).
However, loss of E2F3 does rescue apoptosis in the PNS, which is also
p53 independent, providing in vivo support for the idea that E2Fs can
induce apoptosis through multiple mechanisms (Phillips and Vousden,
2001; Ziebold et al., 2001).
Redundancy between Rb and E2F family members plays a much
smaller role in Drosophila than in mammals. To date only two Rb-family
members, two E2F-family members and one DP homolog are known.
Several results indicate that dE2F1 is an important target for RBF1. As
mentioned earlier, Drosophila rbf1 mutants die at an early larval stage.
This rbf1 mutant phenotype can be rescued significantly by reducing the
de2f1 dosage, suggesting that dE2F1 mediates RBF1 functions during
larval development. Similarly, reducing the levels of dE2F1 can rescue
the bristle and eye defects that arise in rbf1 mutants in which the early
larval death is suppressed by briefly expressing RBF1 from a heat shock
construct during early larval stages (Du, 2000). Finally, rbf1 mutants can
even develop into adult flies when the only source of dE2F1 is a mutant
dE2F1 that lacks the Rb binding and transactivation domains (Du,
2000). Thus, the rbf1 mutant phenotype appears to be due in large part
to an increase in dE2F1 activity, and RBF1/dE2F1 appear to act
together  in vivo.  
The function of C. elegans efl-1 E2F bears striking resemblance to that
of lin-35 Rb (see Chapter 4 and below). Both efl-1 and lin-35 act as nega-
tive regulators of G1 progression downstream of or in parallel to cyd-1. In
addition, both lin-35 and efl-1 act as synMuv class B genes in vulval
cell-fate specification. Given the resemblance between efl-1 E2F and
lin-35 Rb loss-of-function phenotypes it is likely that much of the activity
of LIN-35 RB is exerted in an inhibitory complex with EFL-1.
Functional antagonism between the two Drosophila E2F homologs
To date, two E2F homologs have been identified in Drosophila. dE2F1
has similar biochemical properties as mammalian E2Fs 1-3. dE2F1 can
bind to E2F recognition sites in a complex with dDP, and expression of
dE2F1 plus dDP stimulates transcription of E2F target promoters in
Drosophila Schneider cells in tissue culture (Dynlacht et al., 1994; Ohtani
and Nevins, 1994). Drosophila dE2F1 appears to be required for progres-
sion through G1 phase. Overexpression of dE2F1/dDP in vivo drives
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normally quiescent cells into S-phase and stimulates apoptosis (Asano et
al., 1996; Du et al., 1996b). In de2f1 mutant flies, expression of many E2F
target genes is severely reduced, and DNA replication is nearly absent
after embryonic cycle 16 (Duronio et al., 1998; Royzman et al., 1997).
Larvae hatch but grow very slowly and larval development is not com-
pleted. Early embryonic cell cycles are unaffected, presumably due to
the maternal wild-type dE2F1 contribution (Duronio et al., 1995).
Finally, cells in de2f1 mutant clones in eye imaginal disks do not enter
S-phase (Brook et al., 1996). Based upon these data, de2f1 is an essential
gene for G1 progression.
The second E2F homolog in flies, dE2F2, can also cooperate with
dDP in binding to E2F consensus sites in vitro. In contrast to
dE2F1/dDP however, dE2F2/DP can repress transcription from the
PCNA promoter, a known E2F target gene (Frolov et al., 2001; Sawado et
al., 1998). Repression by dE2F2/dDP is not very strong and can be over-
come by expression of low levels of dE2F1 (Frolov et al., 2001). Overex-
pression studies also indicate that de2f1 and de2f2 perform opposing
functions. Overexpression of dE2F2 in the developing eye results in a
rough eye phenotype, which can be rescued by overexpression of dE2F1
and enhanced by the loss of one de2f1 allele. The strongest argument
for an opposing function of dE2F1 and dE2F2 comes from the analysis
of de2f1;de2f2 double mutant flies. As mentioned above, de2f1 mutant
embryos lack expression of E2F target genes, show almost no DNA syn-
thesis and fail to complete larval development. Strikingly, de2f1-;de2f2-
larvae develop normally until they reach the pupal stage, where they
finally die as mid to late pupae (Frolov et al., 2001). Furthermore, in
contrast to dE2F1 mutant eye imaginal disks, eye disks that lack both
dE2F1 and dE2F2 have normal patterns of DNA replication and express
cyclin A and a mitotic marker: phosphorylated histone H3. Although
expression levels or patterns are frequently changed, E2F target genes
are still expressed in doubly mutant eye imaginal disks, which may
explain why cell proliferation can take place in the absence of any E2F
activity. These results clearly demonstrate that dE2F1 and dE2F2 have
opposing roles during development. 
E2F functions in C. elegans
The C. elegans genome contains two E2F homologs, efl-1 and efl-2, and
one DP homolog, dpl-1. To date, no function has been demonstrated for
efl-2. efl-1 and dpl-1 mutants were independently identified by two
groups. Page et al. identified efl-1 and dpl-1 as genes required for the
asymmetric localization of early embryonic determinants (Page et al.,
2001). Ceol et al. identified dpl-1 and efl-1 as genes that act in the syn-
thetic Multivulva (synMuv) pathway for vulval cell fate specification
(Ceol and Horvitz, 2001). In both cases, efl-1 and dpl-1 antagonize a
Ras/MAPK signal. The strongest indication that these genes act in a lin-
ear pathway is that loss of efl-1 or dpl-1 causes increased MAPK activity in
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the developing oocyte. The targets of MAPK activity in the embryo
remain unknown. 
Surprisingly, a role in cell-cycle regulation for efl-1 and dpl-1 was not
described. The only effect on G1 progression described for efl-1 and
dpl-1 was a reduced number of P-neuroblast divisions in dpl-1 mutant
animals (Ceol and Horvitz, 2001). However, we recently showed that
similar to lin-35 Rb, loss of efl-1 overcomes the G1 arrest found in cyd-1
mutant animals (see Chapter 4). In addition, the role of efl-1 as a nega-
tive regulator of cell-cycle entry also becomes apparent when inactiva-
tion of efl-1 is combined with inactivation of cki-1 Cip/Kip. Inactivation
of efl-1 E2F and cki-1 Cip/Kip results in a synergistic increase in ectopic
cell divisions. These data indicate that EFL-1 acts primarily as a negative
regulator of G1 progression. In agreement with this conclusion, the clos-
est mammalian homologs of EFL-1 are E2F4 and E2F5. Closer examina-
tion of dpl-1 DP reveals a dual role as a positive and a negative regulator
of G1 progression. Inactivation of dpl-1 overcomes the G1 arrest of cyd-1
mutant animals. However, inactivation of dpl-1 in wild-type animals
results in fewer P-neuroblast and intestinal divisions. Furthermore, loss
of dpl-1 suppresses expression of GFP under control of the ribonucle-
otide reductase major subunit promoter, a known E2F target gene.
These data suggest that a second E2F forms an activating complex with
DPL-1, similar to the two E2F complexes described in Drosophila. 
The studies on the function of E2F described suggest that in higher
eukaryotes two species of E2F/DP complexes exist that perform oppos-
ing functions. One complex stimulates progression through G1 into S
phase while the other type inhibits this transition.
The role of E2F in tumorigenesis
The function of E2F1-3 as promoters of cell-cycle progression indicated
that these genes might act as oncogenes in vivo. Many tumor cells have
sustained mutations that inactivate pRb and thus result in activation of
E2F1-3. Surprisingly, E2F1 knockout mice were found to be prone to
tumor development (Yamasaki et al., 1996). Up to 34% of the mice were
found to develop tumors, mostly sarcomas of the reproductive tract,
within the first 18 months of life (Yamasaki et al., 1996). This indicated
that in vivo E2F1 acts as a tumor suppressor gene. One mechanism by
which wild type E2F1 might prevent tumor formation is by inducing
apoptosis. As described above, loss of E2F1 suppresses the high levels of
apoptosis found in Rb mutant mice.
Consistent with a role as a tumor suppressor, inactivation of E2F1 in
heterozygous Rb mutant mice, results in a general increase of tumor
incidence. However, a tissue specific component to the role of E2F in
tumorigenesis  may exist, as the number of C-cell hyperplasias/ade-
nomas was actually reduced (Yamasaki et al., 1998). Such tissue specific-
ity might be the result of a balance between two functions of E2F1: one
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promoting progression through G1 phase and one inducing apoptosis.
This conclusion is consistent with results obtained in a mouse model for
brain tumors induced by  expression of a truncated SV40 large T onco-
gene. In this system, loss of p53 leads to aggressive tumor growth due to
a large reduction in apoptosis (Symonds et al., 1994). Loss of E2F1
causes a similar reduction in apoptosis, but does not lead to aggressive
tumor growth, most likely because cell proliferation is reduced simulta-
neously (Pan et al., 1998).
A role for E2F in other phases of the cell cycle
Although most studies on E2F function have focused on a role for E2F
specifically in G1 phase, several observations indicate that the require-
ment for E2F activity is not limited to G1 phase. E2F function is required
during S-phase for the accumulation of Cyclin B1, a G2/M cyclin which
triggers mitosis (Lukas et al., 1999). Recently, micro-array analysis was
performed to identify genes whose expression is regulated by E2Fs 1-3
(Ishida et al., 2001; Muller et al., 2001). These studies revealed that in
addition to G1 cell-cycle regulators, E2F appeared to regulate the
expression of genes acting in G2/M, apoptosis and differentiation. Per-
haps the most conclusive support for a role of E2F1-3 outside of G1
phase comes from the triple knockout MEFs. Loss of E2F1, E2F2 and
E2F3 arrested cell-cycle progression in all phases of the cell-cycle, rather
than causing a specific G1 arrest (Wu et al., 2001).
Compelling evidence also exists for a role for Drosophila E2F outside
of G1 phase. Overexpression of dE2F1 results in shorter doubling times
and shorter gap phases. The two critical dE2F1 targets that appear to
mediate this effect are the Cyclin E homolog CycE and String, a
homolog of the CDC25 phosphatase which is required for entry into
mitosis (Duronio and O'Farrell, 1995; Neufeld et al., 1998). Overexpres-
sion of CycE shortens G1 phase but this is compensated for by a pro-
longed S phase. The complete dE2F1 overexpression phenotype is only
observed when both CycE and String are overexpressed.
Finally, as described above, C. elegans efl-1 E2F was originally found to
participate in two developmental processes that do not seem to relate
directly to cell-cycle regulation. These are vulval cell fate specification
and asymmetric segregation of early embryonic determinants (Ceol and
Horvitz, 2001; Page et al., 2001). Therefore, the functions of E2Fs in vivo
are not necessarily restricted to regulating G1 progression.
Cyclin D-dependent kinases
Cyclin D-dependent kinases, regulators of cell growth or proliferation?
Studies in mammalian tissue culture cells indicated that Cyclin
D-dependent kinase activity is essential for entry into S-phase. Inactiva-
tion of Cyclin D-CDK4/6 complexes in tissue culture cells by antibody
injections or overexpression of INK4 CDK inhibitors arrests cells in G1
Chapter 1.
38
phase (Baldin et al., 1993; Bruce et al., 2000; Guan et al., 1994; Koh et al.,
1995; Lukas et al., 1995a; Lukas et al., 1995b; Medema et al., 1995). In
both cases, the arrest is dependent on the function of pRb family mem-
bers.
The most direct evidence that Cyclin D-CDK4/6 complexes are
essential for entry into S-phase comes from studies in C. elegans. Muta-
tion of the C. elegans genes cyd-1 Cyclin D or cdk-4 CDK4/6 results in an
arrest of postembryonic cell divisions in G1 phase (Boxem and van den
Heuvel, 2001; Park and Krause). Similar analyses in mammals are com-
plicated by the presence of three D-type cyclins and two kinase partners.
Knockout mice lacking Cyclin D1, Cyclin D2 or CDK4 develop tissue
specific abnormalities. This demonstrates that these genes are not
essential for the development of mice into fertile adults (Fantl et al.,
1995; Rane et al., 1999; Sicinski et al., 1996; Sicinski et al., 1995; Tsutsui et
al., 1999). Cyclin D1 knockout mice grow slowly and display several
developmental defects. The retina of such mice shows a reduced cell
number in all layers, although overall retinal architecture and function
is initially unaffected (Fantl et al., 1995; Sicinski et al., 1995). Cyclin D1
deficient retinas undergo a wave of apoptosis between the second and
fourth weeks after birth, and photoreceptor cells have a differentiation
defect (Ma et al., 1998). A second tissue affected by loss of Cyclin D1 is
mammary epithelium. The dramatic expansion of mammary epithe-
lium normally observed during pregnancy does not take place in Cyclin
D1 mutant mice, even though steroid hormone and estrogen receptor
levels are normal (Fantl et al., 1995; Sicinski et al., 1995). Finally, Cyclin
D1 knockout mice have malformed jaws leading to unchecked growth
of the incisor teeth (Fantl et al., 1995), and a neurological defect, where
the mutant mice retract their limbs toward the trunk when lifted by
their tails, rather than extending them (Sicinski et al., 1995).
Loss of Cyclin D2 also results in decreased cell numbers in two spe-
cific tissues. Few layers of somatic granulosa cells are found around the
oocytes of Cyclin D2 deficient mice. These granulosa cells fail to prolif-
erate in response to follicle stimulating hormone, which normally
induces Cyclin D2 levels (Sicinski et al., 1996). In addition, the testes of
Cyclin D2 mutant mice do not grow to full size and the CNS contains
less granule cells and almost no stellate interneurons (Huard et al.,
1999; Sicinski et al., 1996). CDK4 deficient mice demonstrate tissue spe-
cific defects that appear to overlap partly with those observed in Cyclin
D1 and D2 mutant mice. CDK4 mutant mice have a growth defect and
fertility is reduced. Granulosa cell proliferation and differentiation are
abnormal, and the males develop testicular hypotrophy (Rane et al.,
1999; Tsutsui et al., 1999). In addition, loss of CDK4 causes insu-
lin-dependent diabetes, likely due to a defect in the proliferation of
β-islet cells in the pancreas (Rane et al., 1999). Thus, the loss of D-type
cyclins does affect cell proliferation to some extent. Redundancy
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between the different cyclins and CDK4/6 genes may explain the rela-
tively limited effects.
Surprisingly, Cdk4, the single Drosophila homolog of mammalian
CDK4 and CDK6 kinases, is dispensable for cell division (Meyer et al.,
2000). Flies homozygous for a Cdk4 null mutation develop into viable
adults, although fertility is greatly reduced. Additionally, Cdk4 mutant
flies are smaller than their wild-type counterparts due to decreased cell
numbers. Several lines of evidence indicate that the decreased size is
caused by an overall slower cell growth rate. First, cells in Cdk4 mutant
wing disks have a lengthened cell cycle due to proportional increases in
G1, S and G2 phases, rather than an increase in the G1 population only
(Meyer et al., 2000). In addition, overexpression of the Drosophila Cyclin
D homolog CycD and Cdk4 results in an increased number of cells,
while cell size is either not affected or increased, depending on the tis-
sue examined (Datar et al., 2000). In contrast, overexpression of Droso-
phila E2F/DP or Cyclin E results in increased cell proliferation but
decreased cell size. These results therefore indicate that in Drosophila,
Cyclin D-CDK4/6 complexes affect cell growth rather than cell-cycle
progression.
In C. elegans, the primary role of Cyclin D-dependent kinases appears
to be the promotion of G1 progression. Loss of cyd-1 Cyclin D or cdk-4
CDK4/6 blocks postembryonic cell divisions during G1 phase, while
cells continue to increase in size well past the time at which they initially
arrested in G1 phase (Boxem and van den Heuvel, 2001). In mice, two
observations argue against the retinal and mammary defects of Cyclin
D1 deficient mice being a secondary consequence of a defect in cell
growth. First, Cyclin D1 mutant MEFs have normal growth rates upon
serum stimulation of quiescent cells (Fantl et al., 1995). Second, replace-
ment of the Cyclin D1 gene with a human Cyclin E gene, or loss of
p27Kip1, which presumably results in increased Cyclin E/CDK2 activity,
overcomes all of the defects observed in Cyclin D1 mice (Geng et al.,
1999; Geng et al., 2001; Tong and Pollard, 2001). As Cyclin E/CDK2
kinases do not appear to regulate cell growth in mice or Drosophila, it is
unlikely that the rescue by Cyclin E is based on mimicking a growth reg-
ulatory function of Cyclin D1.
One possible interpretation of the different effects of loss of Cyclin D in
Drosophila compared with mammals and C. elegans is that Cyclin
D-CDK4/6 complexes perform two functions. One is to phosphorylate
pRb and thus stimulate S-phase entry. The other is to promote cell
growth. Variation in the balance between these two functions between
organisms would explain the different outward defects resulting from
inactivation of Cyclin D-dependent kinases. However, to date no direct
evidence exists to support such a model.
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The role of Cyclin D-dependent kinases in tumor formation
A role for D-type cyclins and CDK4/6 in tumorigenesis is indicated by
the presence of defects that increase Cyclin D-dependent kinase activity
in many tumor cells (reviewed in Sherr, 1996). These include overex-
pression of cyclins and CDKs, a mutation that renders CDK4 insensitive
to p16INK4a, and loss of CDK4/6 inhibitors of the INK4a family. Such
observations, however, provide only correlative evidence for a role in
tumor formation for Cyclin D-CDK4/6 complexes. More direct evi-
dence is provided by the observation that mice with increased Cyclin D
levels are prone to tumor development. For example, expression of
Cyclin D1 in mammary tissues leads to mammary adenocarcinomas
(Wang et al., 1994). In addition, mice deficient for the INK4 kinase
inhibitor p16INK4a, and mice with a targeted CDK4 alteration (Arg24Cys)
that renders CDK4 insensitive to INK4 inhibitors, are both susceptible
to tumor development, although to a lesser extent than for example
mice deficient in p14ARF (Krimpenfort et al., 2001; Sharpless et al., 2001;
Sotillo et al., 2001).
In addition to the correlation between increased Cyclin D-CDK4/6
activity and increased tumor incidence, Cyclin D1 activity also appears
to be essential for the formation of certain types of tumors. Robles et al
reported that in three models of ras-mediated mouse skin tumorigene-
sis, the loss of Cyclin D1 reduces the efficiency of tumor formation
(Robles et al., 1998). In addition, Cyclin D1 is involved in oncogenic
transformation by the neu proto-oncogene. Expression of neu increases
Cyclin D1 levels in vitro and in vivo, and inhibition of Cyclin D1 blocks
neu-induced transformation (Lee et al., 2000). Moreover, Yu et al
recently demonstrated that mammary tumor formation in mice by
expression of the ras or neu oncogenes from the MMTV promoter is
dependent on the presence of Cyclin D1 (Yu et al., 2001). Loss of Cyclin
D1, but not D2 or D3, fully protects against transformation by these two
oncogenes. Protection against transformation correlates with the Cyclin
D species induced by the oncogenic transformation, as ras and neu
induce only cyclin D1. In contrast, tumorigenesis by expression of myc
or wnt-1, which induce expression of Cyclin D2 and D3, was not affected
by loss of Cyclin D1. Thus, the presence of functional Cyclin D1 is
required for the formation of specific types of tumors, while other
tumors may depend rather on Cyclin D2 or Cyclin D3.
The importance of pRb and Cip/Kip proteins as Cyclin D-CDK4/6 targets in 
vivo
In addition to phosphorylation of pRb, Cyclin D-dependent kinases are
thought to have a second function: sequestration of the Cip/Kip family
of CDK inhibitors (p21Cip, p27Kip1 and p57Kip2), which inactivate CDK2
kinase complexes (Ekholm and Reed, 2000; Sherr, 2000). Although it
was initially thought that Cip/Kip family members also negatively regu-
late CDK4 and CDK6, it was soon realized that Cyclin D-CDK4/6/p27Kip1
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complexes are still catalytically active, and that in fact most of the Cyclin
D-CDK4/6 kinase activity in proliferating cells is found in complexes
with Cip/Kip proteins (Blain et al., 1997; Cheng et al., 1999; LaBaer et
al., 1997; Soos et al., 1996). Cip/Kip proteins were shown to facilitate
assembly of active Cyclin D-CDK4/6 complexes and promote their
nuclear localization (Cheng et al., 1999; LaBaer et al., 1997). Cyclin
E/CDK2 kinase activity is required for entry into S-phase (Ekholm and
Reed, 2000; Sherr, 1993). Sequestration of Cip/Kip family members by
Cyclin D-CDK4/6 complexes thus might promote G1/S progression by
preventing Cip/Kip kinase inhibitors from inactivating Cyclin E/CDK2. 
In addition to the functions described above, two CDK independent
functions have also been reported for Cyclin D1. First, Cyclin D1 can
bind to and activate the estrogen receptor, possibly by recruiting steroid
receptor coactivators to the estrogen receptor in the absence of ligand
(McMahon et al., 1999; Neuman et al., 1997; Zwijsen et al., 1998). Activa-
tion of the estrogen receptor is normally required for the proliferation
of mammary tissue during pregnancy, and ectopic activation of this
receptor may play a role in breast tumor formation. In addition, Cyclin
D1 can bind to the Myb-like transcription factor DMP1. This may pre-
vent the transcription by DMP1 of p19ARF,  a protein that can induce a G1
arrest by stabilizing p53 (Hirai and Sherr, 1996; Inoue et al., 1999).
Several observations indicate that sequestering of Cip/Kip family mem-
bers is important for the function of Cyclin D-dependent kinases in vivo.
First, fibroblasts that lack expression of all Cip/Kip proteins continue to
proliferate despite the absence of detectable Cyclin D-kinase activity,
and are resistant to the G1 arrest normally caused by expression of
p16INK4a (Cheng et al., 1999). Second, in mice deficient for the CDK4
gene, a higher percentage of Cyclin E is found in complexes with p27Kip1
than in WT animals (Tsutsui et al.). Serum starved MEFs from these
CDK4 knockout mice demonstrate a delayed entry into S-phase upon
restimulation, and this delay can be overcome by loss of p27Kip1 (Tsutsui
et al.). Finally, the deletion of p27Kip1 rescues essentially all phenotypes
associated with the Cyclin D1 knockout (Geng et al., 2001; Tong and Pol-
lard, 2001). These include the defects in growth, proliferation and apo-
ptosis in the retina and the abnormal proliferation of mammary
epithelium during pregnancy.
These experiments clearly demonstrate an important interaction
between Cyclin D1/CDK4 and p27Kip1, and are consistent with the major
function of Cyclin D-CDK4/6 complexes being the inactivation of
Cip/Kip proteins. However, although the elevated CDK2 activity found
in p27Kip1 knockout mice is apparently enough to bypass CDK4/6 activ-
ity, such ectopic levels of CDK2 activity likely do not accurately reflect
the level of CDK2 activity in wild-type mice. Therefore, these experi-
ments do not prove conclusively that sequestering of Cip/Kip kinase
inhibitors is the major function of Cyclin D-dependent kinases in mice.
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In contrast to the data described above, results obtained in Drosophila
and C. elegans support the idea that inactivation of pRb is an important
function of Cyclin D-dependent kinases. As described above, deletion of
Drosophila Cdk4 still allows animals to develop to adulthood but severely
reduces the fertility of females. Loss of the Drosophila Rb homolog RBF1
significantly restores this fertility defect, indicating that RBF1 acts down-
stream of Cdk4 (Meyer et al., 2000). As described in more detail above,
inactivation of the single C. elegans Rb family member also suppresses
the defects found in cyd-1 Cyclin D and cdk-4 CDK4 mutants (Chapter
3). These results strongly suggest that lin-35 Rb is an important target
for cyd-1 Cyclin D and cdk-4 CDK4/6. Interestingly, the cyd-1 and cdk-4
mutant phenotypes are not fully suppressed by loss of lin-35, suggesting
additional roles for cyd-1 and cdk-4 besides inactivation of lin-35 Rb.
 Clearly, the issue of which function of Cyclin D-dependent kinases is
most important in vivo has not been settled, and the relative importance
of each function may vary between organisms.
OUTLOOK
From the literature discussed in this chapter it is clear that considerable
insight has been gained into the functions of the major G1 regulatory
pathways in animal development. However, important questions do
remain about the different steps involved in cell-cycle entry. One such
question is how extracellular signals connect to the basic cell cycle
machinery. Perhaps the best understood example is regulation of Cyclin
D-dependent kinase activity by the Ras/MAPK pathway, which affects
Cyclin D1 production, stability and kinase activity (reviewed in Sherr,
2000). However, many other ways in which developmental signals can
influence the cell cycle likely remain to be discovered. A second impor-
tant question is what are the molecular mechanism involved in negative
regulation of G1 progression by pRb. Studies on the functions of histone
deacetylase and Swi/Snf complexes have already implicated these com-
plexes in cooperating with pRb. However, given the large number of
proteins that have been reported to associate with pRb, extensive study
will be required before we fully understand the ways in which pRb nega-
tively regulates progression through G1 phase.
Although Cyclin D-dependent kinases and Cyclin E-CDK2 can both
phosphorylate pRb, the mechanism by which full inactivation of pRb is
achieved remains unclear. Furthermore, it is not known what other tar-
gets of Cyclin D-CDK4/6 complexes are involved in controlling
cell-cycle progression. Finally, what are the E2F target genes that are
essential for G1 progression, and what E2F target genes act outside of G1
phase? In this thesis, I have made use of C. elegans to begin to address
some of these questions. Chapter 4 describes the identification of novel
genes that may cooperate with lin-35 Rb in negatively regulating G1 pro-
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gression, and Chapter 5 describes the identification of a mutant allele
that likely defines a critical target of cyd-1 Cyclin D.
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A
 
BSTRACT
 
We have identified six protein kinases that belong to the family of
 
cdc2
 
-related kinases in 
 
Caenorhabditis
 
 
 
elegans
 
. Results from RNA inter-
ference experiments indicate that at least one of these kinases is
required for cell-cycle progression during meiosis and mitosis. This
kinase, encoded by the 
 
ncc-1
 
 gene, is closely related to human
 
CDK1/Cdc2
 
, 
 
CDK2
 
 and 
 
CDK3
 
 and yeast 
 
CDC28/cdc2
 
+
 
. We addressed
whether 
 
ncc-1
 
 acts to promote passage through a single transition or mul-
tiple transitions in the cell cycle, analogous to 
 
CDKs
 
 in vertebrates or
yeasts, respectively. We isolated five recessive 
 
ncc-1
 
 mutations in a
genetic screen for mutants that resemble larval arrested 
 
ncc-1(RNAi)
 
 ani-
mals. Our results indicate that maternal 
 
ncc-1
 
 product is sufficient for
embryogenesis, and that zygotic expression is required for cell divisions
during larval development. Cells that form the postembryonic lineages
in wild-type animals do not enter mitosis in 
 
ncc-1
 
 mutants, as indicated
by lack of chromosome condensation and nuclear envelope breakdown.
However, progression through G
 
1
 
 and S phase appears unaffected, as
revealed by expression of ribonucleotide reductase, incorporation of
BrdU and DNA quantitation. Our results indicate that 
 
C. elegans
 
 uses
multiple CDKs to regulate cell-cycle transitions and that 
 
ncc-1
 
 is the 
 
C.
elegans
 
 ortholog of 
 
CDK1/Cdc2
 
 in other metazoans, required for M
phase in meiotic as well as mitotic cell cycles.
 
I
 
NTRODUCTION
 
A fundamental question in biology is how cell division, growth and dif-
ferentiation are coordinately regulated during development of multicel-
lular organisms. This coordination likely involves connections between
developmental signals and the cell-cycle machinery. Cyclin-dependent
kinases (CDKs) have been identified as key components of the cell-cycle
machinery in all eukaryotes studied (Forsburg and Nurse, 1991; Nigg,
1995; Norbury and Nurse, 1992). In yeasts, progression through the cell
cycle is controlled by a single CDK, encoded by the 
 
CDC28
 
 and 
 
cdc2
 
+
 
genes in 
 
Saccharomyces cerevisiae
 
 and 
 
Schizosaccharomyces pombe
 
, respec-
tively. The CDC28/cdc2 catalytic subunit requires association with a
cyclin regulatory partner for kinase activity, and different cyclins are
involved in progression through G
 
1
 
, S and M phase. Regulation of
cell-cycle progression is more complex in multicellular organisms; a
large family of kinases related to CDC28/cdc2 has been identified in
metazoans and several of these kinases have been implicated in
cell-cycle regulation (reviewed by Nigg, 1995). In addition, various
cyclins are expressed during distinct phases of the cell cycle in meta-
zoans. Thus, progression through the cell cycle in higher eukaryotes is
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thought to require successive activation of different CDKs, regulated in
part by transient associations with distinct cyclins. Other levels of regula-
tion include association with kinase inhibitors and activating as well as
inactivating phosphorylations.
When vertebrate cells enter a division cycle, the first CDKs to
become activated are CDK4 and/or CDK6 in association with D-type
cyclins (Sherr, 1994; Sherr, 1996). Late in G
 
1
 
, CDK2 is activated and can
be found associated first with cyclin E and subsequently cyclin A (Tsai 
 
et
al
 
., 1993a). Kinase activity of CDK1/Cdc2 in combination with A- and
B-type cyclins peaks at the G
 
2
 
/M transition (Draetta and Beach, 1988;
Tsai 
 
et al
 
., 1993a). Several lines of evidence indicate that these CDKs reg-
ulate specific cell-cycle transitions. Extracellular signals, such as growth
factors, influence expression levels of D-type cyclins and association with
CDK4 and CDK6 (Matsushime 
 
et al
 
., 1994; Matsushime 
 
et al
 
., 1991).
Ectopic expression of cyclin D, as well as cyclin E, shortens G
 
1
 
 phase and
accelerates entry into S phase (Ohtsubo and Roberts, 1993; Quelle 
 
et al
 
.,
1993). Inhibition of either cyclin A activity or CDK2 activity inhibits
DNA replication (Fang and Newport, 1991; Girard 
 
et al
 
., 1991; Pagano 
 
et
al
 
., 1993; Tsai 
 
et al
 
., 1993a; van den Heuvel and Harlow, 1993), while
inhibition of CDK1/Cdc2 prevents entry into mitosis (Fang and New-
port, 1991; Riabowol 
 
et al
 
., 1989; Th'ng 
 
et al
 
., 1990; van den Heuvel and
Harlow, 1993). The function of several other cdc2-related kinases is cur-
rently either unknown or, for CDK5, appears unrelated to cell-cycle pro-
gression (Chae 
 
et al
 
., 1997; Gilmore 
 
et al
 
., 1998; Nikolic 
 
et al
 
., 1996).
Thus far, genetic analysis of 
 
CDK
 
 loss-of-function mutations has been
limited in multicellular organisms. A family of cdc2-related kinases has
been identified in 
 
Drosophila
 
 and one of these kinases, Dmcdc2, has
been implicated in regulation of mitosis and inhibition of DNA replica-
tion (Hayashi, 1996; Sauer 
 
et al
 
., 1996; Stern 
 
et al
 
., 1993). A second
kinase, Dmcdc2c, appears active during S phase (Lehner and O Farrell,
1990).
The nematode 
 
C. elegans
 
 is uniquely suited as an animal model to
study developmental control of cell division. The transparency of these
animals allows monitoring of cell divisions in living animals. In addition,
the near invariance of the cell lineage has allowed a precise description
of the time of division for every somatic cell (Sulston and Horvitz, 1977;
Sulston 
 
et al
 
., 1983). Combined with effective genetics, these characteris-
tics allow efficient isolation and detailed examination of cell-cycle
mutants.
Genetic studies have already revealed several genetic pathways that
regulate postembryonic cell divisions. For instance, pathways that
involve TGF-
 
β
 
 and insulin-related signaling cascades control entry into
and exit from a developmentally arrested dauer stage (Massague, 1998;
Riddle 
 
et al
 
., 1997). In addition, a pathway of heterochronic genes con-
trols the timing of cell division in several postembryonic lineages
(reviewed by Slack and Ruvkun, 1997). Furthermore, a Notch-like sig-
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naling pathway that includes the 
 
lag-2
 
 ligand and 
 
glp-1
 
 receptor controls
the switch between mitotic versus meiotic division in the germline
(Francis 
 
et al
 
., 1995; Kadyk and Kimble, 1998; Kimble and Simpson,
1997). The targets of such developmental signaling pathways likely
include components of the general cell-cycle machinery, which may be
regulated through intermediates such as 
 
cki-1
 
, a developmentally regu-
lated CDK inhibitor of the CIP/KIP family (Hong 
 
et al
 
., 1998).
To be able to explore connections between developmental signals
and the cell-cycle machinery, we have initiated analysis of the
cyclin-dependent kinases present in 
 
C. elegans
 
. We have identified six
putative kinases that share extensive homology with cdc2-related kinases
in higher eukaryotes. RNA-interference of only one of these kinases
caused complete arrest of cell division. A cDNA clone of this kinase,
named 
 
ncc-1
 
 for nematode cell cycle, was previously identified and
shown to complement the 
 
CDC28-1N
 
 mutation in 
 
S. cerevisiae
 
 (Mori 
 
et
al
 
., 1994). Here we show that 
 
ncc-1
 
 is required for progression through
M phase in meiotic and mitotic cell cycles, but not for G
 
1
 
 and S phase
progression. Thus, 
 
ncc-1
 
 performs a role similar to 
 
CDK1/Cdc2
 
 in higher
eukaryotes.
 
R
 
ESULTS
 
Identification of Cdc2 family members in 
 
C. elegans 
 
Using several molecular approaches, we obtained cDNA
 
 
 
clones from
three 
 
C. elegans
 
 cdc2-related kinases (Materials
 
 
 
and Methods and Fig.
1A). The kinase most closely related to
 
 
 
human CDK1 (64% amino acid
identity) was identified
 
 
 
previously and named 
 
ncc-1
 
 (Mori 
 
et al
 
., 1994).
The predicted
 
 
 
NCC-1 protein of 332 amino acids diverges from other
CDK1
 
 
 
and CDK2 kinases at two striking positions: it has an N-terminal
extension of 18 amino acids and contains an Ile-to-Val
 
 
 
substitution in
the highly conserved PSTAIRE region of the
 
 
 
protein that is involved in
cyclin binding (Jeffrey 
 
et al
 
., 1995).
 
 
 
A second kinase gene encodes a
member of the PCTAIRE
 
 
 
subfamily and was therefore named 
 
pct-1
 
.
Within the catalytic
 
 
 
core, the predicted PCT-1 protein of 577 amino
acids shares
 
 
 
~80% identity with any one of three human PCTAIRE
kinases.
 
 
 
In addition, PCT-1 has N-terminal and C-terminal extensions
that are less conserved but similar in size to the human kinases.
 
 
 
A third
 
C. elegans
 
 kinase is a close homolog of human CDK5
 
 
 
(74% amino-acid
identity) and was named 
 
cdk-5
 
. For each of these three kinases we
sequenced the longest cDNAs and determined the genomic structure
(Fig. 1A).
Three additional kinases that are more distantly related to Cdc2
were identified in BLAST homology searches (Table 1). The predicted
gene H06A10.1 encodes a kinase that is most related to CDK4 and
CDK6. K03E5.3 encodes a kinase that is 42%, 43% and 41% identical to
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human CDK1, CDK2 and CDK3, respectively. Finally, the predicted
product of B0285.1 shares 47% amino acid identity with human CHED
kinase, and 41% with CDK2 and CDK3. As the sequencing of the C. ele-
gans genome has been completed (The C. elegans Sequencing Consor-
tium, 1998), we can conclude that these are the C. elegans kinases that
are most closely related to members of the CDK1/2/3, CDK5, CDK4/6
and PCTAIRE subfamilies of cdc2-related kinases.
ncc-1 is a candidate cell-cycle regulator
We used RNA interference (RNAi) to determine which of these kinases
may be involved in regulation of the C. elegans cell cycle. RNAi has been
shown to cause specific loss-of-function phenotypes for many different
genes in C. elegans, although the mechanism of action is not understood
(Guo and Kemphues, 1996; Tabara et al., 1998). Double-stranded RNA
(dsRNA) is at least one order of magnitude more potent in interfering
activity than either single strand (Fire et al., 1998). We transcribed both
strands of each of the six kinases in vitro and injected dsRNAs into
wild-type hermaphrodites. Injection of ncc-1 dsRNA caused a completely
penetrant embryonic arrest at the one cell stage in all progeny pro-
duced after 12 hours post-injection. In addition, some of the earlier
progeny arrested during larval development (31 larval mutants from 10
injected animals). These arrested larvae were uncoordinated, sterile,
slightly dumpy and had disproportionally large head regions. Examina-
Table 1. cdc2-related kinases in C.elegans
C. elegans 
gene
Human 
homolog
Amino acid 
identity (%)
RNAi phenotype
ncc-1 CDK1
CDK2
CDK3
64
59
60
One-cell stage embryonic arrest. In the 
first 12 hours after injection, up to 10 prog-
eny arrest cell division at the L1 stage.
K03E5.3 CDK1
CDK2
CDK3
42
43
41
Embryonic lethal, larval arrest without 
growth, larval arrest with growth, sterile 
animals with protruding vulva (see text).
H06A10.1 CDK4
CDK6
37
33
Variable cell division defects in larval devel-
opment*.
cdk-5 CDK5 74 No phenotype detected.
B0285.1 Ched
CDK2
CDK3
47
41
41
Late L3 or early L4 arrest.
pct-1 Pctaire-1
Pctaire-2
Pctaire-3
52
50
60
No phenotype detected.
*M. Park and M. Krause, personal communication.
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tion by Nomarski microscopy revealed that no or very few cells in the
postembryonic lineages had divided. Most striking was the absence of
any division of the blast cells Z1 to Z4 that normally form the somatic
gonad and germ-line. These gonad precursor cells divide multiple times
in several C. elegans cell-cycle mutants, including lin-5 and lin-6 mutants
(our unpublished observations, Sulston and Horvitz, 1981). Both the
embryonic and L1-arrest phenotypes implicated ncc-1 as an important
cell-cycle regulator.
RNAi for two Cdc2 related genes, cdk-5 and pct-1, did not result in any
apparent phenotypes (data not shown). RNAi for each of the remaining
three cdc2-related genes caused obvious developmental defects but not a
strict arrest of cell division. A clear but highly variable effect was
observed following dsRNA injection of K03E5.3: the progeny arrested
either as embryos (12%, n=69), early larvae (17%, n=98), late larvae
(9%, n=50), sterile adults (39%, n=228) or developed to wild-type adults
(24%, n=132). Progeny from B0285.1 dsRNA-injected animals arrested
late in the third larval stage (L3) or early L4 stage. Most cell divisions
have been completed at this stage with the exception of germ-line divi-
sions. Finally, H06A10.1 RNAi resulted in slightly abnormal progeny but
no apparent cell-cycle defects. Variable defects in cell division have been
observed to result from H06A10.1 RNAi by M. Park and M. Krause (per-
sonal communication). Redundancy between different kinases might
mask individual gene functions. However, injection of a mix of dsRNAs
from K03E5.3, F18H3.5, B0285.1 and cdk-5 did not cause stronger
defects: the phenotype observed closely mimicked that of K03E5.3
RNAi. Thus, based on these RNAi results, ncc-1 is the best candidate for
a general cell-cycle kinase in C. elegans.
NCC-1 is closely related to yeast CDC28/cdc2 as well as mammalian
CDK1 and CDK2. Therefore, ncc-1 could act analogously to CDC28/cdc2+
Fig. 1. (A) Gene structure of
the C. elegans cdc2-related
genes ncc-1, cdk-5 and pct-1.
Gene structures were deter-
mined by Southern blotting
and DNA sequencing. Struc-
tures have been confirmed by
the C. elegans sequencing
project. (B) NCC-1 protein
levels correlate with cell divi-
sions. Protein lysates of syn-
chronized wild-type animal
populations were immunob-
lotted and probed with
anti-PSTAIRE antibodies.
α-tubulin protein levels were
determined as a loading con-
trol.
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in yeasts and regulate multiple transitions in the cell cycle. Alternatively,
ncc-1 could play a role similar to one of the human kinases, regulating
either G1/S progression or mitosis. To distinguish between these possi-
bilities, we determined the requirements of ncc-1 in the C. elegans cell
cycle.
NCC-1 protein expression correlates with cell division and is abolished 
by RNAi
If ncc-1 is required for cell division in general, NCC-1 protein is
expected to be present in dividing cells. NCC-1 protein levels were
found to correlate with the number of cell divisions during various
stages of development, as was shown by western blot analysis (Fig. 1B).
The highest NCC-1 levels were detected in embryos and the lowest levels
in L1 larvae that were arrested by food deprivation. Upon release from
L1 arrest, and resumption of cell division, NCC-1 protein levels were
found to increase.
We used two different antibodies to detect the localization of NCC-1:
a monoclonal antibody that recognizes the PSTAIRE peptide and an
antiserum raised against a C-terminal NCC-1 peptide. Identical staining
patterns were obtained with both antibodies. NCC-1 was found in the
nucleus of oocytes and embryonic cells and, in addition, diffusely local-
ized in the cytoplasm (Fig. 2A-F). During growth of oocytes in the proxi-
mal gonad, NCC-1 levels gradually increase (Fig. 2A,H). Following
nuclear membrane breakdown, staining was diffuse in mitotic cells (Fig.
2D). NCC-1 appeared excluded from the DNA in metaphase and, to a
lesser extent, in anaphase cells. NCC-1 was not detectable in oocytes or
embryos of RNAi-treated animals (Fig. 2G,I). This result confirms the
staining specificity and supports that ncc-1(RNAi) results in strongly
reduced NCC-1 protein levels.
ncc-1 is required for meiotic maturation
To determine the cause of arrest in ncc-1(RNAi) embryos, we analyzed
gametogenesis and early embryogenesis in the injected hermaphro-
dites. In wild-type animals, germ-precursor nuclei are produced by
mitotic divisions in the distal ends of the syncytial gonad (Kimble and
White, 1981). As these nuclei move further from the distal tip cell, they
exit the mitotic cycle, initiate meiosis and progress through pachytene
of meiotic prophase I. Oocyte formation begins when germ nuclei
reach the flexure in the U-shaped gonad; they exit from pachytene, cel-
lularize, continue to enlarge and progress to diakinesis of Meiosis I.
Shortly before fertilization, meiotic maturation and nuclear envelope
degradation are initiated. Mature oocytes ovulate by entering the sper-
matheca at the proximal end of the gonad. Meiotic maturation is com-
pleted after fertilization and two polar bodies are expelled from the
fertilized egg. The maternal pronucleus subsequently migrates towards
the paternal pronucleus, while the egg undergoes pseudocleavage. The
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Fig. 2.
 
 NCC-1 protein localization in wild-type and 
 
ncc-1(RNAi) 
 
germ cells and embryos.
(A) Nuclear NCC-1 expression levels
 
 
 
increase during oocyte development (from right to
left). A close-up
 
 
 
of oocytes is shown in which DNA (B) and NCC-1 (C) are stained.
 
 
 
NCC-1
localization is cytoplasmic during mitosis. (D) a wild-type 2
 
 
 
cell embryo in which the AB
cell is in anaphase (left) and the P1 cell
 
 
 
in metaphase (right). (E) Nuclear and cytoplas-
mic NCC-1
 
 
 
localization in a 4 cell wild-type embryo. (F,G) Comparison of NCC-1
 
 
 
staining
in wild-type embryo (F) and 
 
ncc-1(RNAi)
 
 embryo (G).
 
 
 
Exposure times and processing were
identical for both images. NCC-1
 
 
 
staining is absent in 
 
ncc-1(RNAi)
 
 embryos. An arrow indi-
cates
 
 
 
condensed DNA in the paternal pronucleus. (H,I) NCC-1 and
 
 
 
DNA (PI) staining in
wild -type and 
 
ncc-1(RNAi)
 
 oocytes. NCC-1
 
 
 
accumulates in nuclei of developing oocytes
(from right to left) in
 
 
 
the wild-type (H) but not in dsRNA-injected gonads (I). Note that
chromosomes fully condense (compare the earlier (right) and later
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two pronuclei meet in the posterior of the egg, migrate to the middle
and initiate a first mitotic division.
We examined the consequences of ncc-1 dsRNA injection on these
maturation and fertilization events in live animals by Nomarski micros-
copy. Two types of abnormalities were apparent: at the distal ends of the
gonad fewer germ cells were produced (see below) and at the proximal
ends many of the events that follow ovulation and fertilization of oocytes
were aberrant (Table 2). Gonads were examined at various time points
following dsRNA injection by Nomarski microscopy of living animals
and fluorescence microscopy of fixed worms stained with DAPI for anal-
ysis of DNA organization. Formation and growth of oocytes was normal.
The morphology and progression from pachytene to late stage oocytes,
with six fully condensed bivalents in typical diakinesis arrangement, was
also normal (Fig. 2I). Based on the position of the most distal oocyte
with fully condensed chromosomes, relative to the flexure in the gonad,
progress through pachytene appeared slightly delayed in about half of
the injected animals (data not shown).
The first apparent defect was abnormal breakdown of the nuclear
membrane in the mature oocyte, which required about 20 minutes to
complete instead of 5 minutes in the wild type. Cytological analysis dem-
onstrated that the transition from diakinesis to metaphase of meiosis I
failed to occur as chromosomes did not congress to form a metaphase
plate. No polar bodies were observed consistent with a complete failure
of the meiotic divisions (Fig. 2G). However, fertilization did trigger for-
mation of an eggshell. The maternal pronucleus enlarged and became
about twice the wild-type size. Migration of the maternal pronucleus
toward the paternal pronucleus was initiated but meeting of the nuclei
was delayed and pseudocleavage did not occur (Table 2). The chromo-
somes in the paternal pronucleus failed to decondense and this nucleus
remained small (Fig. 2G). Meeting of the pronuclei was followed by sta-
 Table 2. Timing of events following ovulation
in ncc-1(RNAi) embryos
N2 (n=5)* ncc-1 RNAi (n=6)
Entry to uterus
Appearance of paternal pronucleus
Pseudocleavage
Appearance of maternal pronucleus
Pronuclear meeting
Nuclear envelope breakdown
Onset of cytokinesis
Completion of cell division
5.3±0.5
31.8±3.9
33.4±4.8
33.5±4.6
39.5±4.7
45.2±4.8
49.7±5.9
56.2±6.7
5.8±0.8  
28.5±7.9
does not occur
29.3±5.5
58.6±2.4
does not occur
does not occur
does not occur
Time is in minutes measured from ovulation.
*Similar results have been described by (Kirby et al., 1990; McCarter et al., 
1998; Rose et al., 1997).
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ble arrest: the nuclear membranes did not break down and mitosis did
not occur. By immunostaining with tubulin-specific antibodies, we
detected a bipolar spindle around the maternal nucleus in about half of
the embryos (data not shown). We cannot exclude that formation of
this spindle is dependent on residual activity of ncc-1 in the ncc-1(RNAi)
embryos (see Discussion).
The earliest defect seen in ncc-1(RNAi) animals is lack of meiotic mat-
uration. Thus, these results suggest that ncc-1 is required to promote
meiotic maturation. The subsequent abnormalities may be secondary
consequences of the meiotic maturation defect.
ncc-1 is required for mitotic divisions in the germ-line
We noticed that ncc-1 dsRNA-injected animals produced fewer oocytes
than wild-type hermaphrodites. Upon closer examination, the number
of germ cells was found to decrease gradually over time in ncc-1
RNA-injected animals. This reduction was first apparent in the mitotic
region of the gonad arms, starting at around 12 hours after injection, at
20°C. The gonad was essentially empty by day three to four. During the
same period, control injected animals did not show a noticeable change
in the number of germ cells or general appearance of the gonad.
The germ precursor nuclei that were present in the distal region at
20 hours after injection were enlarged (Fig. 3B). Mitotic cells were not
observed in gonads fixed and stained with DAPI. As metaphase cells are
not always unambiguously detected in wild-type gonads, we also exam-
ined the presence of a mitotic phosphorylated epitope. Chromosome
condensation in mitosis has been described to coincide with phosphory-
lation of histone H3 on Ser-10, which forms part of a consensus
Cdc2-phosphorylation site (Ajiro et al., 1996; Hendzel et al., 1997). A
rabbit polyclonal antiserum raised against a phosphorylated H3 peptide
also recognizes a mitotic phospho-epitope in C. elegans (Kadyk and Kim-
ble, 1998; Lieb et al., 1998). We immunostained ncc-1 dsRNA-injected
and control injected animals 20 hours after injection to examine the
presence of the phosphorylated histone H3 epitope. Staining was absent
Fig. 3. Arrest of mitotic divi-
sions in the germline by
ncc-1(RNAi). Germ cells in the
distal, mitotic region of the
gonad were stained with the
DNA stain DAPI (A,B) and
antibodies recognizing phos-
phorylated histone H3 (C,D).
Wild-type germ cells in mitosis
stain with the phosphorylated
histone H3 antibody (C),
whereas staining is not
detected following ncc-1 RNAi
(D). Scale bar approx. 10 µm.
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in ncc-1 RNA-injected germlines whereas control injected animals
stained similarly to wild type (Fig. 3C,D). NCC-1 could directly or indi-
rectly cause phosphorylation of histone H3, or be required at an earlier
step in germ cell division. In either case, when taken together, these
observations indicate that ncc-1 is required for mitotic divisions in the
distal part of the gonad.
Isolation of ncc-1 mutants based on the larval ncc-1(RNAi)phenotype
To further characterize the role of ncc-1 in cell division, we isolated ncc-1
mutations in a genetic screen. The larval arrested ncc-1(RNAi) animals
may have received functional ncc-1 maternal product yet fail zygotic
expression. Based on this interpretation, we screened for uncoordi-
nated, sterile mutants with disproportionally large head regions in the
F2 progeny of ethylmethanesulfonate (EMS) treated animals, in order
to isolate ncc-1 mutants.
In a semi-clonal screen of about 22000 haploid genomes, we
obtained 21 independent recessive mutations that caused uncoordi-
nated, sterile, large head phenotypes and defects in cell division during
the first larval stage. Based on standard complementation assays and
genetic mapping, 14 of these mutations likely affect the same gene. We
characterized 4 of these mutations in detail. In addition, we also charac-
terized n3064 which displays a very similar phenotype and was isolated
in a previous screen for potential cell-cycle mutants (S. v.d.H. and H. R.
Horvitz, unpublished results). All five of these mutations mapped in
close proximity to ncc-1 and failed to complement nDf40, a deletion that
removes the ncc-1 locus. In addition, DNA sequencing revealed muta-
tions within the ncc-1 ORF in all five mutants (Fig. 4). The mutant alleles
all contain G-C to A-T transitions, the type of mutation most commonly
induced by EMS. The best candidate null allele is he5. This allele con-
tains a deletion of 131bp, that removes the entire PSTAIRE domain, as
well as a nonsense mutation that should cause a truncated product (Fig.
4). Allele he26 also contains a nonsense mutation and encodes a prod-
uct that lacks the C-terminal 265 out of 332 kinase residues. The other
three alleles, he24, n3064 and he25, contain missense mutations at posi-
tions 75, 191 and 214, respectively, replacing negatively charged
glutamates by positively charged lysine residues. Each mutation affects a
residue that is highly conserved within the Cdc2 family, in he24 and
he25, or in all protein kinases, in n3064 (Fig. 4).
ncc-1 is required for postembryonic cell divisions
We characterized the nature of the ncc-1 alleles and cell-cycle pheno-
types in more detail. As homozygous mutants are fully penetrant sterile,
the ncc-1 mutations were maintained in heterozygous strains. Derived
from heterozygous (ncc-1/+) mothers, ncc-1 mutant progeny completed
embryogenesis, presumably as a result of maternal gene function, but
displayed no cell divisions after hatching. The percentage mutant prog-
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eny was close to 25% for all mutations, confirming the recessive nature
of the alleles (Table 3). At 25°C, homozygous mutants and trans-het-
erozygotes with nDf40 were phenotypically indistinguishable. Thus, all
five mutations cause fully penetrant strong loss-of-function phenotypes
at 25°C. Similar results were obtained at 15°C for all alleles except he25.
Homozygous he25 mutants were of more wild-type appearance at 15°C,
although shorter and fully penetrant sterile. Based on our genetic and
molecular characterizations, 4 of the 5 alleles are strong loss-of-function
or null mutations, whereas he25 causes incomplete loss of function at
15°C.
Nomarski microscopy observations indicated that all blast cells that
give rise to the postembryonic lineages in wild-type animals are present
in ncc-1 mutants. However, these cells did not initiate mitotic divisions,
with the possible exception of a rare division of an intestinal nucleus.
Examination of fixed and DNA-stained animals confirmed these
findings (Table 3). We quantified the cell-cycle defects for each of the
mutations in three postembryonic lineages, by examining the first divi-
sions of the ventral cord precursor cells (P), the intestinal cells (I) and
the precursor cells of the somatic gonad and germline (Z1, Z2, Z3 and
Z4). In wild-type animals, these cells start to divide about halfway
through L1 (P and Z1-4) or late in L1 stage (I). All five mutations
caused very similar defects in cell division. Not a single division of cells
in the gonad primordium or P1-10 was observed in 20 animals exam-
 Table 3. Characterization of ncc-1 alleles
Postembryonic blast cell divisions 
(no.)
Parental genotype % larval arrest of 
progeny (n)
P1-P10
(n=20)
I
(n=20)
Z1-Z4
(n=20)
Wild type
he5/+
he24/+
he25/+ at 15°C
he25/+ at 25°C
he26/+
n3064/+
0.0 (>2000)
23.2 (1393)
25.0 (1106)
26.4 (1346)
25.6 (1047)
25.4 (1405)
26.9 (1039)
200
0
0
ND
0
0
0
263
2
9
ND
11
7
2
80
0
0
ND
0
0
0
Total progeny of four ncc-1/+ heterozygotes was counted to determine
percentage larval arrest. Divisions of P-cells and I cells were scored in mutants
fixed and stained with the DNA stain PI. Divisions of P11 and P12 could not be
unambiguously determined and are therefore excluded. For P-cell divisions,
animals were fixed 24 hours at 15°C after release from an L1 arrest, except
ncc-1(he25) mutants, which were fixed after 9 hours at 25°C. For I-cell divisions,
animals were fixed as adults. Z-cell divisions were examined in vivo by Nomarski
microscopy, 28 hours after release from L1 arrest at 20°C, except ncc-1(he25)
mutants, which were scored 24 hours at 25°C after release from the L1 arrest.
n=number of animals examined. 
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ined (Table 3). Several observations indicate that ncc-1 is directly
required for cell division and that the lack of division was not caused by
sickness or lethality. The ncc-1 mutants were viable and continued to
grow to 80% of the wild-type size (the length of young adult ncc-1 and
wild-type animals was 0.73±0.04 mm and 0.91±0.08 mm, respectively). In
addition, the precursor cells of the ventral nerve cord migrated at the
normal time from a more lateral to a ventral position (data not shown).
Requirement for ncc-1 is not restricted to the first postembryonic or
L1 divisions, as was shown in he25ts animals. At 15°C, the P cells
undergo extensive divisions during the L1 stage in he25ts mutants and
the P3.p to P8.p (Pn.p) daughters divide in late L3 to form the vulva
(Fig. 5C). All P cells failed to divide in he25 animals shifted to 25°C dur-
ing the early L1 stage, thereby resembling ncc-1(0) animals (Table 3). In
contrast, temperature shift during the L2 or L3 stages allowed the P
cells to divide during L1 but prevented division of the Pn.p daughters
(Fig. 5B).
These results are consistent with a role for ncc-1 as a general
cell-cycle regulator, which is in agreement with the high degree of iden-
tity between NCC-1 and the CDK1 and CDK2 kinases in other species
(Fig. 4).
ncc-1 is required for mitosis, but not for DNA replication
We observed that the precursor cells of the postembryonic lineages did
not initiate chromosome condensation or nuclear envelope breakdown
in ncc-1 mutants. Apparently, the cells arrest prior to entry into mitosis,
Fig. 5. (A,B) ncc-1 is required for postembryonic blast cell divisions. DNA is stained with
propidium iodide, all panels show animals of similar age (adults). (A) An ncc-1(he5)
mutant, in which P cell divisions have not occured. P3-P7 are indicated by arrows. (B) A
temperature sensitive ncc-1(he25) mutant shifted from 15°C to 25°C in the third larval
stage, which caused the Pn.p divisions to fail. Undivided P3.p-P8.p cells are indicated by
arrows. (C) An ncc-1(he25) animal grown at 15°C, which allowed most divisions in the P lin-
eages as well as formation of a vulva (D) Wild-type adult. The bracket indicates the posi-
tion of the vulva. Scale bar approx. 10 µm.
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yet this arrest could occur in G1, S or G2 phase. We examined whether
cells in ncc-1 mutants initiate S phase to determine the point of arrest.
As a first assay, we used an S phase reporter that expresses the green
fluorescent protein (GFP) under the control of a C. elegans ribonucle-
otide reductase (rnr) promoter. Expression of rnr tightly correlates with
S phase in other eukaryotes (Fernandez-Sarabia and Fantes, 1990). In
addition, rnr::GFP expression in transgenic worms that contain the inte-
grated rnr::gfp reporter coincides with the previously reported time of S
phase (Hong et al., 1998). We examined GFP expression in L1 larvae
that were double homozygous for the ncc-1(n3064) mutation and inte-
grated rnr::gfp. Wild-type animals and ncc-1 mutants were found to
express rnr::GFP at the same time and in the same cell types (Fig. 6A).
Thus, blast cells of the postembryonic lineages complete G1 and appear
to become competent for S phase in ncc-1 mutants.
To directly address whether ncc-1 mutants synthesize DNA, we exam-
ined incorporation of the thymidine analog BrdU. Progeny from ani-
mals heterozygous for he5, he26 or n3064 were incubated with BrdU
Fig. 6. ncc-1 mutants complete G1 and S phase. (A) GFP expressed from the rnr::GFP
reporter construct in an ncc-1(n3064) mutant. Several P-cells expressing rnr::GFP are indi-
cated. (B) BrdU incorporation in an ncc-1(he5) mutant. Incorporation of BrdU can be
detected in all P-cells (arrows). (C) DNA stained with propidium iodide in adult he24 ani-
mal. Arrows indicate body wall muscle cell (2n, top) and polyploid intestinal cells (32n,
bottom). Scale bars approx. 10 µm.
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from 3 to 9 hours of L1 development at 25°C and subsequently stained
with anti-BrdU antibodies. In wild-type animals as well as ncc-1 mutants,
BrdU incorporation was detected in all cells that were previously
reported to undergo S phase during this developmental phase (Hedge-
cock and White, 1985). For example, BrdU staining was detected in the
ventral cord precursor cells W and P1-P12 (Fig. 6B), and these cells
divided in the wild-type but not in ncc-1 mutants. Other cells that stained
strongly with BrdU in wild-type as well as homozygous ncc-1 animals
include the lateral ectoblasts H1,H2, V1-V6 and T and cells in the gonad
primordium (data not shown). These results show that neither the tim-
ing of S-phase nor the specific cells that enter S-phase are affected by
the ncc-1 mutations.
The complete genome is replicated in ncc-1 mutants
The results described above indicate that ncc-1 is strictly required for M
phase and not for G1 progression or DNA replication. However, we
wished to examine two alternative explanations. First, it remained possi-
ble that cells in ncc-1 mutants initiate DNA synthesis but fail during the
elongation phase. Second, perdurance of maternal product could for-
mally allow initiation of the first division cycle in the postembryonic lin-
eages. To address these issues, we compared the amounts of DNA in
intestinal nuclei of adult wild-type animals and ncc-1 mutants. Wild-type
animals hatch with 20 diploid intestinal cells. In general, the 14 most
posterior of these undergo one round of DNA synthesis followed by
nuclear division in late L1 stage (Hedgecock and White, 1985; Sulston
and Horvitz, 1977 and Table 2). In addition, during each larval stage all
intestinal nuclei undergo S-phase without mitosis, leading to a 32n DNA
content by the adult stage.
We fixed adult wild-type and ncc-1 animals and stained them with the
DNA stain propidium iodide, and determined the DNA content of the
intestinal cells by quantitative confocal analysis. Body wall muscles are
Fig. 7. Intestinal cells in
wild-type and ncc-1 animals are
equally polyploid (black bars).
Body muscle cells are used as
an internal 2n standard (white
bars). Each bar indicates the
average DNA content ± s.d., of
10 nuclei in 2 independent
animals.
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diploid throughout postembryonic development in wild-type animals.
Using body muscle nuclei as an internal 2n DNA standard, we found
that the intestinal nuclei in ncc-1 mutants and wild-type animals were
equally polyploid and contained close to 32n amounts of DNA (Figs 6C,
7). The posterior nuclei did not have higher amounts of DNA than the
anterior nuclei, suggesting that the lack of mitosis in ncc-1 mutants pre-
vents the second S phase that normally follows this division during L1
development. Together, these results show that cells in ncc-1 mutants
can replicate their entire genome even late in development. Thus, ncc-1
appears to be required specifically for M phase.
DISCUSSION
The family of cdc2-related kinases in C. elegans
In this study, we have identified members of the family of cdc2-related
kinases in C. elegans. In vertebrates, the kinases that are most closely
related to cdc2, can be divided into 4 different groups (Meyerson et al.,
1992), and a member of each of these subfamilies appears to be present
in C. elegans.
The most extensively studied subfamily consists of CDK1/Cdc2,
CDK2 and CDK3. These kinases are closely related in sequence, and
each of the human kinases can complement CDC28 mutations in S. cere-
visiae. CDK2 and CDK1/Cdc2 are activated sequentially in the cell cycle
and studies in a number of systems indicate distinct functions. Immun-
odepletion of the Xenopus homologs showed a specific requirement for
CDK2/Eg1 during S-phase and for Cdc2 during M phase (Fang and
Newport, 1991). Antibody-injection studies and expression of domi-
nant-negative mutants implicated CDK2 and CDK3 in G1-S control and
CDK1 in G2-M regulation in mammalian cells (Pagano et al., 1993;
Riabowol et al., 1989; Tsai et al., 1993a; van den Heuvel and Harlow,
1993). Finally, a CDK1 mutation has been identified as the genetic
lesion in a mouse cell line with a temperature-sensitive G2 arrest pheno-
type (Th'ng et al., 1990). The C. elegans kinase ncc-1 belongs in this sub-
family; it shares more than 60% identity with the three human kinases
in this group and can complement the CDC28-1N mutation in S. cerevi-
siae (Mori et al., 1994). Our studies further define NCC-1 as the ortholog
of CDK1/Cdc2. At present, no homologs of CDK2 or CDK3 have been
identified, although K03E5.3 and B0285.1 are predicted to encode can-
didates that are 42% and 41% identical to CDK2 (see below).
Human CDK4 and CDK6 form a subgroup of two kinases that share
71% amino acid identity among each other. These kinases are more dis-
tantly related to the CDK1/2/3 subfamily and they have not been
observed to complement CDC28 mutations in yeast (Meyerson et al.,
1992). Based on their association with D-type cyclins and timing of acti-
vation, CDK4 and CDK6 have been implicated in G1 control. Moreover,
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the kinase inhibitor p16 can bind to and inactivate CDK4 and CDK6
and overexpression of p16 can cause G1 arrest in human cells (Sherr,
1996; Sherr and Roberts, 1995). Results from studies in mammals sug-
gest a pathway for G1 control in which the tumor suppressor p16 acts
upstream of the oncogene products CDK4, CDK6 and Cyclin D, which
negatively regulate the retinoblastoma protein, pRB (Sherr, 1996). At
present, neither CDK4 nor CDK6 have been shown directly to have
essential cell-cycle functions. In fact, deletion of the Drosophila Cdk4/6
gene was found to cause reduced fertility but not a general cell-cycle
arrest (C. Lehner, personal communication). The product of H06A10.1
is most related to this subgroup and is predicted to share 37% identity
with human CDK4 (33% with CDK6). In RNAi experiments with this
kinase, we and others have only identified very limited defects in cell
division (M. Park and M. Krause, personal communication).
A third subfamily consists of three closely related PCTAIRE kinases
in humans. C. elegans PCT-1 is ~80% identical to any one of the three
human PCTAIRE kinases within a 240 amino-acid fragment of the cata-
lytic core. Cyclin association has not been described for these kinases. In
fact, PCTAIRE kinases contain N-terminal and C-terminal extensions
that could act as regulators in cis. Such N- and C-terminal extensions are
also present in the C. elegans PCT-1 kinase, and measure 234 and 48
amino acids respectively. PCTAIRE message and protein are abundantly
expressed in human and rodent brains (Hirose et al., 1997; Le Bouffant
et al., 1998; Meyerson et al., 1992). By developmental northern blotting,
we detected pct-1 message during all developmental stages in the worm
(data not shown). The pct-1 mRNA levels were not found to correlate
with mitotic divisions but were strongly elevated in young adults. We did
not detect any abnormalities in pct-1 dsRNA-injected animals or their
progeny.
A single kinase, CDK5, that is highly conserved in metazoans defines
a distinct subfamily. CDK5 is closely related to the CDK1/2/3 kinases
and yet no cell-cycle related functions have been identified. By contrast,
CDK5 kinase activity can be detected specifically in post-mitotic neu-
ronal cells (Tsai et al., 1993b). CDK5 has been implicated in neurite out-
growth during neuronal differentiation (Nikolic et al., 1996), and mice
lacking CDK5 or its activator p35 display severe defects in cortical lami-
nation (Chae et al., 1997; Gilmore et al., 1998). We did not observe obvi-
ous defects in neural functions in cdk-5(RNAi) animals.
Implications from RNAi studies
For a remarkable number of genes RNA interference has now been
shown to cause strong loss-of-function phenotypes (e.g: Fire et al., 1998;
Tabara et al., 1998). However, absence of an RNAi phenotype is little
informative, especially because the mechanism of interference is not
understood. Two aspects of RNA interference have been particularly
useful in this study: RNAi offers the possibility to examine the function
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of maternally contributed product and RNAi phenotypes can be used to
direct the isolation of mutant alleles in genetic screens.
The first aspect relates to a common problem in studying genes that
are required in early as well as later development. A single wild-type
copy from the mother generally appears sufficient to provide maternal
function and, despite early gene requirements, loss-of-function pheno-
types may first become detectable during late embryogenesis or early
larval development (Ahnn and Fire, 1994; Storfer-Glazer and Wood,
1994). However, RNA interference is particularly efficient in blocking
maternal contribution, and RNAi allowed us to examine ncc-1 gene
function during early embryogenesis. Following RNAi, NCC-1 protein
levels were reduced below the detectable level even in the germline of
injected animals. This way, we were able to detect requirement for ncc-1
in mitotic and meiotic division in the germline.
Another application of RNAi is first demonstrated in this study: we
used RNAi to predict the ncc-1 loss-of-function phenotype and subse-
quently identified ncc-1 mutations in animals with similar phenotypes.
In an F2 screen, homozygous mutants are likely derived from mothers
with one functional gene copy and hence display zygotic phenotypes.
For three genes that are both maternally and zygotically required, lin-5,
lin-6 and ncc-1, we have observed that some of the early brood after RNA
injection closely mimic zygotic phenotypes. Such RNAi larval pheno-
types may provide a powerful reverse-genetics approach for many other
genes in C. elegans.
ncc-1 acts to promote entry into mitosis
NCC-1 is closely related to yeast CDC28/cdc2 as well as CDK1/Cdc2,
CDK2 and CDK3 kinases in vertebrates. A second kinase with such a
high degree of homology was not detected. Does ncc-1 perform a role
similar to CDC28/cdc2+, regulating multiple transitions in the cell cycle,
or does it act to regulate progression through a specific phase of the cell
cycle? The data described here show that ncc-1 is required specifically
for meiotic and mitotic M phase, indicating that ncc-1 is the ortholog of
CDK1/Cdc2 in other metazoans.
The strongest support for this conclusion stems from the cell-cycle
arrest caused by ncc-1 mutations. Several lines of evidence indicate that
four of the ncc-1 mutations create strong or complete loss of function.
Two of the alleles should produce truncated products that lack most of
the conserved kinase domains: he5 contains a deletion and nonsense
mutation and he26 contains a nonsense mutation at codon 68. In addi-
tion, the missense mutation identified in n3064 causes a Glu-to-Lys sub-
stitution of one of nine residues that are nearly invariant in protein
kinases. Based on crystal structure studies, this glutamate residue is
expected to contact an equally conserved and oppositely charged Arg in
the C-terminal end of the catalytic core (De Bondt et al., 1993; Knighton
et al., 1991). The missense mutation in he24 results in a Glu-to-Lys
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change next to the PSTAIRE motif. The corresponding Glu 57 in
human CDK2 is believed to form a hydrogen bond with Tyr 185 in cyclin
A (Jeffrey et al., 1995). Binding of cyclin A to the PSTAIRE domain prob-
ably contributes to kinase activation by changing both the orientation of
ATP and the position of a kinase domain that blocks the catalytic cleft.
The he25 allele contains a missense mutation that affects a glutamate
residue that is conserved in CDK1/Cdc2 and CDK2 but not in kinases
outside the Cdc2 family. The phenotype caused by the he25 mutation is
partly temperature sensitive, indicating that this mutation does not cre-
ate a null allele.
The ncc-1 mutants developed normally through embryogenesis and
failed all cell divisions after hatching. The first postembryonic cell cycles
in ncc-1 mutants appear to be normal in timing of G1 and S phase, based
on rnr::GFP expression and BrdU incorporation. However, chromo-
some condensation and nuclear envelope degradation do not occur.
Thus, the cells likely arrest in G2 and ncc-1 appears required to promote
progression into mitosis. This function is consistent with the role of
CDK1/Cdc2 kinases in other metazoans. One minor difference exists
with Drosophila, in which inactivation of the mitotic kinase activity has
been observed to result in polyploidy (Hayashi, 1996). This difference
may reflect the fact that many cells in Drosophila undergo endoredupli-
cation after final division.
We expect that ncc-1 is essential for all embryonic and postembryonic
divisions. This is based on the observed ncc-1 requirement for cell divi-
sions in all postembryonic lineages and the fact that homologous CDKs
are required for all mitotic divisions in other species. As explained
above, maternal ncc-1 product likely is sufficient for embryogenesis.
However, this assumption lacks formal proof, as ncc-1(RNAi) embryos
arrest prior to the zygotic division.
ncc-1 is required for meiosis I
Following ncc-1 RNAi, fertilized oocytes fail to complete meiotic matura-
tion. At the time of injection, a large number of germ precursor cells
are in pachytene of meiosis I. These nuclei progress through meiotic
prophase I but do not initiate metaphase, indicating that ncc-1 is
required to promote the transition from prophase to metaphase in mei-
osis. A role in meiosis is consistent with the function of CDK1/Cdc2 in
other eukaryotes. In fact, Xenopus p34cdc2 was discovered by the bio-
chemical characterization of maturation promoting factor (MPF), a
cytoplasmic factor that induces meiotic maturation when injected into
immature oocytes (Masui and Markert, 1971). Completion of meiosis I
and II is a two step process in amphibians. Progesterone, or injection of
MPF, triggers oocytes that are arrested in diplotene of prophase I to
progress through meiosis I. Mature oocytes will subsequently arrest in
metaphase of meiosis II and can be triggered by fertilization to com-
plete meiosis (Masui and Markert, 1971). Meiotic maturation in C. ele-
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gans is induced by a factor in sperm that is independent from the
sperm’s function at fertilization (McCarter et al., 1999). In the absence
of sperm, C. elegans oocytes arrest for prolonged periods in diakinesis
(McCarter et al., 1999). Future studies may reveal whether progesterone
and the ‘sperm factor’ activate similar pathways that induce p34cdc2 and
ncc-1, respectively, and trigger progression to meiotic metaphase I.
Does progression through meiotic prophase require ncc-1 function?
In the RNA-injected animals, oocyte development appears normal and
chromosomes become fully condensed. We cannot exclude that inacti-
vation of ncc-1 by RNAi was incomplete. However, several observations
support effective inactivation. First, upon injection of ncc-1 dsRNA,
NCC-1 protein levels were reduced below the level of detection (Fig.
2G,I). Second, ncc-1 RNAi interfered with cell division in the mitotic
part of the germ-line and neutralized phosphorylation of histone H3 in
mitotic germ cells as well as oocytes. Thus, a potent effect from RNAi
was detected throughout the entire gonad. Finally, injection of dsRNA
at a concentration of 0.01 mg/ml was sufficient to completely arrest
meiotic maturation, whereas even a 100-fold higher concentration did
not affect progression through prophase of meiosis I. If inactivation was
complete, entry into meiotic development, meiotic prophase progres-
sion, condensation of chromosomes to diakinesis bivalents and oocyte
development can all occur independent of ncc-1. If these processes do
require ncc-1 activity, this must be less activity than required for germ
cell proliferation and for the transition from diakinesis to meiosis I. As
yet, formation of diakinesis bivalents of normal morphology in the
absence of CDK1 activity has not been described in any eukaryote. Dur-
ing spermatogenesis in Drosophila, DNA condensation can occur in the
apparent absence of Dmcdc2 activity (Sigrist et al., 1995). However, male
meiosis in Drosophila does not involve meiotic recombination and attach-
ment of bivalents by chiasmata.
Nuclear envelope breakdown occurs slowly in mature ncc-1(RNAi)
oocytes; by the time it is accomplished meiosis would normally have
been completed. The fact that degradation still occurs could indicate
incomplete inactivation of ncc-1, as CDK1 is believed to phosphorylate
nuclear lamins and to trigger nuclear envelope breakdown in mitosis
(Peter et al., 1990). However, other kinases have also been implicated in
nuclear lamin phosphorylation, including S6 kinase II (Ward and Kir-
schner, 1990) and protein kinase C (Hocevar et al., 1993). Such kinases
may trigger nuclear enveloppe breakdown in the absence of ncc-1 activ-
ity. 
How is progression through G1/S regulated in C. elegans?
Our results provide an interesting paradox: ncc-1 appears specifically
required for the regulation of M phase, yet essential regulators of the
G1-S transition have not been identified. Such regulators are especially
important as regulation of cell division by developmental signals in most
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cells occurs during G1 phase. Ectopic expression of the CDK inhibitor
cki-1 causes cell division arrest prior to S phase in C. elegans (Hong et al.,
1998), which is consistent with the assumption that G1-S progression is
dependent on CDK activity. In other metazoans, CDK2 appears to pro-
mote G1/S transition, although genetic null phenotypes have not been
described as yet. As the C. elegans genome has been completely
sequenced, the C. elegans kinase that is most similar to CDK2 is likely
encoded by the K03E5.3 gene. RNAi for this gene caused severe but
highly variable developmental and cell division defects. More severe
defects where seen when the same RNA was injected into heterozygous
ncc-1/+ animals (data not shown). We are currently exploring whether
K03E5.3 and ncc-1 can act redundantly in G1/S progression.
MATERIALS AND METHODS
Culture conditions and strains
Worm strains used were derived from the wild-type Bristol strain N2 and Bergerac strain
RW7000. Worms were cultured using standard techniques as described by Brenner (Bren-
ner, 1974). We used the following mutations, descriptions of which can be found in Riddle
et al. (Riddle et al., 1997) or cited references:
LGIII: dpy-17(e164), unc-36(e251), dpy-19(e1259), unc-32(e189), glp-1(q158), ncc-1(he5,
he6, he24, he25 and n3064) (this paper), unc-47(e307), unc-49(e382), tra-1(e1099) and
dpy-18(e364). Rearrangements: qDp3(III,f) (Austin and Kimble, 1987), ctDp6(III,f) (Hunter
and Wood, 1990), nDf40 (Graham and Kimble, 1993), qC1 dpy- 19(e1259) glp-1(q339) (Edg-
ley et al., 1995). Expression of an rnr::GFP reporter was examined in strains VT774
unc-36(e251); maIs103[rnr::GFP unc-36(+)] (Hong et al., 1998) and SV61 ncc-1(
n3064)/dpy-19(e1259) unc-47(e307); maIs103[rnr::GFP unc-36(+)].
Cloning of cdc2-related genes
To clone cdc2-related genes from C. elegans, we used RT-PCR amplification with degener-
ate oligonucleotide primers, low stringency hybridization of a cDNA library and antibody
screening of an expression library. For the reverse transcriptase PCR approach, RNA was
isolated from mixed stage C. elegans cultures grown in bulk (Wood, 1988). First strand
cDNA was prepared from total RNA and amplified by PCR, using degenerate oligonucle-
otides derived from the highly conserved motifs EKIGEGTY and EGVPSTA as 5’ primers
and DLKPQNL and WYRSPEV as 3’ primers (primer sequences available upon request).
PCR fragments were cloned into pBluescript II SK (Stratagene) and sequenced by the
dideoxy method. Partial clones were obtained this way from ncc-1, cdk-5 and pct-1. To
obtain full length cDNAs, a nematode cDNA library cloned in the Uni-ZAP vector (Strat-
agene) was probed with PCR fragments labeled with [α-32P]dCTP. Although low strin-
gency conditions were used, we obtained only cDNA clones from ncc-1, cdk-5 and pct-1.
The same library was induced with IPTG and probed with a mouse monoclonal antibody
recognizing the PSTAIRE motif (a kind gift from M. Yamashita). This resulted in
identification of multiple cDNAs that were all derived from the ncc-1 gene.
We expect the predicted kinases to be full length based on the isolation of multiple
cDNAs of similar size, homology in the N terminus with the human kinases and a non-
sense codon preceding the ATG initiation codon in the pct-1 gene. The genomic localiza-
tion was identified for each gene by probing YAC contigs, followed by PCR analysis of
cosmids from the region. Cosmids T05G5, C07G1 and R11C7 were found to contain the
ncc-1, pct-1 and cdk-5 genes, respectively, and were used to determine the gene structures
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by Southern blotting and DNA sequencing. Subsequently, all sequences have been
confirmed by the C. elegans sequencing project.
RNA interference
Plasmids containing full length ncc-1, cdk-5 and pct-1 cDNAs were used for in vitro tran-
scription. For B0285.1, a genomic fragment was amplified by PCR using primers 5’-agaat-
tcacaatgcttgatcaaattggc and 5’-aaggatccagattgtttttcttttccg. For, K03E5.3 a genomic
fragment was amplified using primers 5’-aatccgcaattttgatgactccag and 5’-caaccgatatcgctc-
caggtaagc. These fragments were cloned into pBluescript SK. A plasmid containing cDNA
yk492e2, derived from H06A10.1, was kindly provided by M. Park, M. Krause and Y.
Kohara. Templates were linearized and transcribed in vitro with T3 or T7 RNA polymerase.
RNA was phenol extracted, ethanol precipitated and dissolved in TE (10 mM Tris-HCl pH
8.0, 0.1 mM EDTA) to a final concentration of 1 mg/ml. A 1:1 mixture of the two strands
was injected into young adult N2 hermaphrodites as described (Fire et al., 1998).
Screening for ncc-1 alleles
N2 animals were mutagenized with 50 mM ethylmethanesulfonate (EMS) as described by
Brenner (Brenner, 1974). Mutagenized L4 hermaphrodites were picked to 100 mm
plates, 30 per plate, and allowed to produce self progeny at 25°C. F1 animals in the fourth
larval stage were picked to 60 mm plates, four per plate, and their progeny were examined
for mutants that resemble larval-arrested ncc-1(RNAi) animals. Mutants that were sterile,
uncoordinated, slightly dumpy and had relatively large head regions were examined by
Nomarski microscopy to determine defects in cell division. Candidate mutations were
recovered from siblings and were mapped initially by PCR, making use of primers based
on polymorphic Sequence-Tagged Sites in the RW7000 Bergerac strain (Williams et al.,
1992). ncc-1 mutations mapped to chromosome III and were placed by standard three fac-
tor crosses (Wood, 1988) between dpy-19(e1259) and unc-47( e307) or dpy-17(e164) and
tra-1(e1099), about 1.06 map units to the right of dpy-19 at position 0.89. In addition, all
mutations failed to complement nDf40 and allele n3064.
Antibodies
Antibodies were used in the following dilutions: mouse monoclonal antibody DM1A
against α-tubulin (Sigma) diluted 1:1000 for western blot analysis and 1:500 for immun-
ostaining, rabbit polyclonal antibody against phosphorylated histone H3 (Upstate Bio-
technology) diluted 1:400, mouse monoclonal antibody BU-33 against BrdU (Sigma)
diluted 1:60, mouse monoclonal antibody against the PSTAIRE region of Cdc2 (a kind gift
from M. Yamashita), used 1:1000 diluted for immunoblotting and 1:250 diluted for immu-
nostaining. A polyclonal antiserum raised against the C terminus of NCC-1 was diluted
1:1000 for immunostaining (a kind gift from J. Schumacher and A. Golden). Don-
key-anti-mouse and donkey-anti-rabbit IgG secondary antibodies, rhodamine- or
FITC-conjugated, were from Jackson labs and diluted 1:200.
Western blot analysis and Immunostaining
To obtain protein samples, synchronized wild-type animals were washed 4 times in M9
buffer and dissolved by boiling for 5 minutes in 1x Laemmli protein loading buffer (Har-
low and Lane, 1988). Protein samples were separated by SDS-PAGE followed by coomassie
staining, to determine protein concentration, or immunoblotted using standard proce-
dures (Harlow and Lane, 1988).
For antibody staining of germlines and embryos, gravid wild-type hermaphrodites
were dissected in a drop of M9 buffer on a gelatin-coated slide. A coverslip was applied
and the slide frozen on dry ice. After 10 minutes the coverslip was cracked off and slides
were incubated in methanol at -20°C for 20 minutes and acetone at -20°C for 20 minutes.
For immunostaining of larvae, animals were fixed in Bouin’s solution and antibody stain-
ing was performed according to standard procedure (Harlow and Lane, 1988; Nonet et
al., 1997). For staining of DNA only, animals were fixed overnight in Carnoys solution
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(60% ethanol, 30% glacial acetic acid, 10% chloroform) and slowly rehydrated in PBS +
0.1% Tween-20. In all procedures, DNA was stained with either propidium iodide (PI) 1
mg/ml, following treatment with 200 µg/ml RNAse A for 30 minutes at 37°C, or with
1mg/ml 4,6-diamidino-2-phenylindole (DAPI) (Sigma). Samples were mounted on slides
in 10% PBS, 2.3% Dabco, glycerol.
Images were obtained using a Sensys cooled CCD camera (Photometrics, Tucson, AZ)
and a Power Macintosh computer. Image analysis and computational deconvolution was
performed with Openlabs software version 1.7.8 (Improvision, Boston, MA). Images were
pseudocolored and merged using Adobe Photoshop.
BrdU labeling
Synchronized cultures were obtained from embryos isolated by hypochlorite treatment
and hatched in the absence of food (Wood, 1988). The resulting early L1 arrested larvae
were transferred to plates with bacteria, which triggers highly synchronized development.
DNA synthesis was visualized by incorporation of BrdU. A solution of BrdU in S-medium
was added to plates with synchronized larvae to a final concentration of 0.5 mg/ml. Ani-
mals were fixed in Bouin’s fixative and stained with anti-BrdU antibodies. The staining
procedure was as described above with one addition; prior to preadsorbtion, DNA was
denatured by incubating the fixed animals for 2 hours at room temperature in a 1:1 mix-
ture of 4 M HCl and PBS + 1% BSA + 0.5% Triton X-100.
DNA quantitation
To quantitate DNA content, series of 32 Z-sections were taken of propidium iodide-stained
animals with a confocal scanning laser microscope (Leica). Total pixel intensities were cal-
culated for each section on a Macintosh computer using the public domain NIH Image
program (developed at the U.S. National Institutes of Health and available on the Inter-
net at http://rsb.info.nih.gov/nih-image/). Pixel intensities of all 32 sections were added
and recalculated to DNA content, using body wall muscle nuclei as a 2n DNA standard.
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A
 
BSTRACT
 
We have investigated the regulation of cell-cycle entry in 
 
C. elegans
 
, tak-
ing advantage of its largely invariant and completely described pattern
of somatic cell divisions. In a genetic screen, we identified mutations in
 
cyd-1 
 
Cyclin D and 
 
cdk-4 
 
CDK4/6. Recent results indicated that during
 
Drosophila 
 
development, Cyclin D-dependent kinases regulate cell
growth rather than cell division. However, our data indicate that 
 
C. ele-
gans cyd-1 
 
primarily controls G
 
1
 
 progression. To investigate whether
 
cyd-1 
 
and 
 
cdk-4 
 
solely act to overcome G
 
1
 
 inhibition by retinoblastoma
family members, we constructed double mutants that completely elimi-
nate the function of the retinoblastoma family and Cyclin D-CDK4/6
kinases. Inactivation of 
 
lin-35 
 
Rb, the single Rb-related gene in 
 
C. ele-
gans
 
, substantially reduced the DNA replication and cell-division defects
in 
 
cyd-1 
 
and 
 
cdk-4 
 
mutant animals. These results demonstrate that 
 
lin-35
 
Rb is an important negative regulator of G
 
1
 
/S progression and probably
a downstream target for 
 
cyd-1 
 
and 
 
cdk-4
 
. However, as the suppression by
 
lin-35 
 
Rb is not complete, 
 
cyd-1 
 
and 
 
cdk-4 
 
probably have additional tar-
gets. An additional level of control over G
 
1
 
 progression is provided by
Cip/Kip kinase inhibitors. We demonstrate that 
 
lin-35 
 
Rb and 
 
cki-1
 
Cip/Kip contribute nonoverlapping levels of G
 
1
 
/S inhibition in 
 
C. ele-
gans
 
. Surprisingly, loss of 
 
cki-1
 
, but not 
 
lin-35
 
, results in precocious entry
into S phase. We suggest that a rate limiting role for 
 
cki-1 
 
Cip/Kip rather
than 
 
lin-35 
 
Rb explains the lack of cell-cycle phenotype of 
 
lin-35 
 
mutant
animals.
 
I
 
NTRODUCTION
 
The development of a multicellular organism requires the careful coor-
dination of cell division with growth and differentiation. In part, this
coordination is achieved through integration of extracellular signals
during the G
 
1
 
 phase, to which cells respond by either advancing into or
withdrawing from another division cycle (Pardee, 1989). Ultimately,
mitogenic and antiproliferative signals affect the cell-intrinsic cell-cycle
machinery, of which the cyclin-dependent kinases (CDKs) are key com-
ponents. The importance of the G
 
1
 
 control mechanisms is underscored
by the finding that most, if not all, tumor cells have defects in one or
more genes involved in G
 
1
 
 progression (Sherr, 1996). Despite extensive
research, the 
 
in vivo
 
 functions of such genes have been poorly charac-
terized. 
Significant insights have been gained from studying mammalian
cells in tissue culture and gene alterations in human cancer. Members
of the retinoblastoma (Rb) tumor suppressor family (pRb, p107 and
p130 in mammals) have been found to inhibit progression through the
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G
 
1
 
 phase (Sherr, 1996). This negative-regulatory function of the pRb
protein is constrained by phosphorylation at multiple CDK phosphory-
lation sites. Sequential phosphorylations disrupt the binding between
pRb and transcription factors such as E2F, thereby allowing these tran-
scription factors to activate genes required for DNA synthesis and
removing active transcriptional repression by pRb (Dyson, 1998). One
of the critical targets of the E2F transcription factor is Cyclin E (Dyson,
1998), which together with its partner CDK2 is required for the initia-
tion of DNA replication (Duronio and O'Farrell, 1995; Knoblich 
 
et al
 
.,
1994; Ohtsubo 
 
et al
 
., 1995; Tsai 
 
et al
 
., 1993; van den Heuvel and Harlow,
1993). 
CDKs appear to act at multiple levels of this G
 
1
 
 control pathway. The
first CDKs to become active in the cell cycle consist of a CDK4 or CDK6
catalytic subunit and a D-type cyclin regulatory subunit (Sherr, 1993). It
is generally thought that Cyclin D-dependent kinases initiate pRb phos-
phorylation in mid G
 
1
 
, while the subsequent activation of Cyclin
E-CDK2 kinases leads to completion of this process (Mittnacht, 1998).
However, the presence of multiple D-type cyclins, CDK4/6 kinases and
pRb-related proteins has hampered a direct demonstration of their
functions 
 
in vivo
 
. For example, it is not clear to what extent Cyclin
D-CDK4/6 kinases are essential for pRb inactivation and cell-cycle pro-
gression 
 
in vivo
 
. Moreover, it remains unknown whether Cyclin D has
critical targets other than proteins of the pRb family. Potential targets
include cyclin-dependent kinase inhibitors (CKIs) of the Cip/Kip family
(Sherr and Roberts, 1999). p21
 
CIP1
 
 and p27
 
KIP1
 
 associate with Cyclin
E-CDK2 complexes and prevent their kinase activity. The same inhibi-
tors also bind Cyclin D and CDK4/6, but apparently mediate their
assembly rather than inhibiting kinase activity (Cheng 
 
et al
 
., 1999;
LaBaer 
 
et al
 
., 1997). This association may result in sequestering the
Cip/Kip inhibitors from Cyclin E-CDK2 complexes, which further pro-
motes progression through the G
 
1
 
/S transition. 
Studies in genetic model systems should contribute further insights
in the 
 
in vivo
 
 functions of G
 
1
 
 regulatory genes. Such analyses have
already provided surprising results. For example, recent studies in 
 
Droso-
phila 
 
revealed a requirement for CDK4 in cell growth, rather than cell
division (Datar 
 
et al
 
., 2000; Meyer 
 
et al
 
., 2000). The nematode 
 
C. elegans
 
provides an attractive animal model for cell-cycle studies. The somatic
cell-lineage of 
 
C. elegans 
 
is largely invariant and has been completely
described; thus, the timing of division is known for every cell (Sulston
and Horvitz, 1977; Sulston 
 
et al
 
., 1983). In addition, most of the
cell-cycle regulators mentioned above are represented by single genes
in 
 
C. elegans
 
, which simplifies their functional analysis. For example, a
single D-type cyclin (
 
cyd-1
 
), CDK4/6-related kinase (
 
cdk-4
 
), Cyclin E
(
 
cye-1
 
) and pRb family member (
 
lin-35 
 
Rb) are present (Fay and Han,
2000; Lu and Horvitz, 1998; Park and Krause, 1999; The 
 
C. elegans
 
Sequencing Consortium, 1998). In addition, two genes, 
 
cki-1 
 
and 
 
cki-2
 
,
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encode cyclin-dependent kinase inhibitors of the Cip/Kip family (Feng
 
et al
 
., 1999; Hong 
 
et al
 
., 1998; The 
 
C. elegans
 
 Sequencing Consortium,
1998). Inhibition of gene function by RNA interference has revealed
roles for 
 
cyd-1/cdk-4 
 
and 
 
cki-1 
 
as positive and negative regulators of the
G
 
1
 
/S transition, respectively (Hong 
 
et al
 
., 1998; Park and Krause, 1999).
However, the network of gene activities that regulates G
 
1
 
 progression in
 
C. elegans 
 
remains entirely unknown. In fact, 
 
lin-35 
 
Rb was identified as a
member of the ‘synthetic Multivulva’ (synMuv) genes that inhibit the
expression of vulval cell fates (Ferguson and Horvitz, 1989), and a func-
tion in cell-cycle regulation has not been reported for 
 
lin-35 
 
Rb. 
To identify G
 
1
 
 regulators in 
 
C. elegans
 
, we performed a screen for
mutants that arrest cell-division in G
 
1
 
 phase. In this screen we isolated
mutations in 
 
cyd-1 
 
Cyclin D and 
 
cdk-4 
 
CDK4/6. We used these alleles to
address the interaction between Cyclin D-dependent kinases and pRb
family members, by creating double mutant animals that lack activity of
 
cyd-1/cdk-4 
 
and 
 
lin-35
 
. Our results demonstrate that 
 
lin-35 
 
Rb is an
important negative regulator of cell division and probably a major
downstream target of 
 
cyd-1
 
/
 
cdk-4
 
. However, 
 
lin-35 
 
Rb did not appear to
be the only target of 
 
cyd-1
 
/
 
cdk-4
 
. In addition, we provide evidence that
the Cip/Kip family members 
 
cki-1 
 
and 
 
cki-2 
 
cooperate with 
 
lin-35 
 
Rb in
controlling cell-cycle entry, and that these two pathways provide
non-overlapping levels of cell-cycle control.
 
R
 
ESULTS
 
Identification of a D-type cyclin and CDK4/6 related kinase in a screen 
for positive regulators of G
 
1
 
 progression
To identify positive regulators of G1 progression, we used a reporter con-
struct with S phase-specific transcription; the green fluorescent protein
(GFP) expressed under the control of ribonucleotide reductase promoter
sequences (rnr::GFP, Hong et al., 1998). The F2 progeny from
mutagenized animals carrying the rnr::GFP transgene were examined
for the presence of mutants that lack postembryonic cell division and
expression of the rnr::GFP marker (Fig.1A,B). We identified six inde-
pendent mutations that fulfill these criteria. Initial mapping placed two
mutations (he112 andhe116) on chromosome II and four mutations
(he109, he110, he111 and heDf1) on the X chromosome.
he112 and he116 failed to complement each other, indicating they
may affect the same locus. Standard three-factor mapping placed both
mutations in the proximity of the cell-cycle regulatory gene cyd-1, which
encodes the sole D-type cyclin in C. elegans (Park and Krause, 1999).
Molecular lesions that affect the cyd-1 gene were identified by DNA
sequence analysis (he112) and by PCR and Southern blotting experi-
ments (he116). cyd-1(he112) contains a nonsense mutation predicted to
truncate the C-terminal 114 amino acids (Fig. 2). The cyd-1(he116) muta-
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Fig. 1. Identification and characterization of cyd-1 and cdk-4 mutant animals. (A) Positions
of cells in the ventral cord precursor (P) and intestinal (I) lineages in late L1 wild type
(top) and cell-cycle mutant (bottom) larvae. The lineages of an individual P and I cell are
indicated for each genotype (right). (B) Postembryonic blast cells remain undivided in
cyd-1 and cdk-4 mutants, as indicated for intestinal and P precursor cells in the enlarged
sections (right). The panels show a late L1 wild-type larva (top) and similar stage
cyd-1(he112) mutant (bottom) after fixation and DNA staining with propidium iodide. (C)
Expression of the rnr::GFP S-phase marker in wild-type animal (left) and cyd-1(he112)
mutant (right). Nomarski images (top) and corresponding epifluorescent images (bot-
tom) show several cells of the P and intestinal lineages. In the cyd-1 animal, only autofluo-
rescence of the intestinal cells is detectable. (D) Quantitative measurements of DNA
content in the intestinal nuclei (gray bars) of wild-type animals and mutant strains of indi-
cated genotype. Body wall muscle cells (black bars) serve as 2n DNA standards. Scale bars:
10 µm. Values indicated are mean±s.e.m.
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tion deletes the cyd-1 promoter region as well as the first two exons (Fig.
2). 
The predicted partner for CYD-1 is CDK-4, a CDK4- and CDK6-
related kinase encoded by the cdk-4 gene located on the X-chromosome
(Park and Krause, 1999). Introduction of a wild-type cdk-4 transgene in
germline transformation experiments completely suppressed the
defects caused by three X-linked mutations, he109, he110, and he111.
Sequence analysis identified point mutations within the cdk-4-codingse-
quences in each of the three mutant strains. Alleles he109 and he111
contain nonsense mutations that should terminate translation after 207
and 291 amino acids, respectively (Fig. 2). The he110 allele contains a
missense mutation that converts a glutamate at position 85, which is
conserved in protein kinases, to lysine (Fig. 2).
The mutant phenotype associated with heDf1, the fourth X-linked
mutation, was not rescued by a wild-type cdk-4 transgene. However, this
mutation did map in the proximity of cdk-4, and failed to complement
the cdk-4(gv3) allele. PCR and Southern blotting experiments revealed
that heDf1 is a deletion that removes the entire cdk-4 gene (Fig. 2). In
addition to the cell-cycle arrest, heDf1 mutant animals displayed defects
in growth and morphology that were not observed in animals homozy-
gous for any of the other cdk-4 alleles, including animals homozygous
for the cdk-4(gv3) deletion. Because of the lack of rescue and pleiotropic
defects, we conclude that heDf1 deletes cdk-4 and probably another gene
required for larval development. heDf1 was not analyzed further.
All mutations isolated were recessive and conferred fully penetrant
cell-cycle defects (Table 1). Moreover, the defects observed in both cdk-4
and cyd-1 mutants were at least as severe as those caused by RNA-medi-
ated interference (RNAi) of these genes (Park and Krause, 1999). Based
on these genetic and molecular characterizations, the cyd-1 and cdk-4
alleles confer strong loss-of-function or null phenotypes.
cyd-1 and cdk-4 are required for G1/S progression in postembryonic cell 
divisions
Following a reverse genetics approach, Park and Krause (Park and
Krause, 1999) previously identified essential roles for cyd-1 and cdk-4 in
cell division. We compared the cyd-1 and cdk-4 mutant phenotype to the
reported defects caused by cyd-1 RNAi and the cdk-4(gv3) deletion allele.
Animals homozygous for the cyd-1 alleles he112 and he116 or cdk-4 alleles
he109, he110, and he111 completed embryogenesis. The only embryonic
Fig. 2. Molecular lesions in
cyd-1 and cdk-4 mutant alleles,
illustrated with respect to the
genomic structure. Exons are
shown as boxes, introns as
lines.
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defect we observed was a failure of cyd-1 mutants, but not cdk-4 mutants,
to complete the final few embryonic intestinal divisions. Consequently,
cyd-1(he112) and cyd-1(he116) larvae hatched with 16 intestinal cells
(16.0, n=10), rather than the 20 cells present in wild-type animals.
Although wild-type maternal product could mask an embryonic role of
cyd-1 and cdk-4 in homozygous mutants, RNAi of cyd-1 or cdk-4 also did
not cause embryonic lethality and prevented cell division only during
larval development (Park and Krause, 1999). As RNAi usually impedes
both maternal and zygotic gene function, cyd-1 and cdk-4 appear to be
predominantly required for postembryonic somatic cell cycles. 
Two observations indicate that cyd-1 and cdk-4 mutant larvae arrest
cell divisions prior to S phase. As first observed in the screen, each cyd-1
or cdk-4 mutant lacked detectable expression of the rnr::GFP S-phase
reporter in the postembryonic lineages(Fig. 1C; Z1 and Z4, the somatic
gonad precursor cells, were the only exception). In addition, we found
no evidence of DNA replication in postembryonic cell lineages. Specifi-
cally, we determined the DNA content of cells in two postembryonic lin-
eages: precursor cells of the ventral nerve cord (P), which undergo four
rounds of cell division during the first larval stage, and intestinal nuclei,
14 of which divide once after hatching (Sulston and Horvitz, 1977).
After this division, all intestinal nuclei go through a round of endoredu-
plication during each larval stage, resulting in a 32n DNA content
(Hedgecock and White, 1985). The P and intestinal cells arrested with a
2n DNA content in both cyd-1 and cdk-4 mutants (Fig. 1D and not
shown). By contrast, 4n and 32n DNA contents were found in the P and
intestinal lineages, respectively, of ncc-1/cdk-1 mutants whose cells arrest
Table 1. Characterization of cyd-1 and cdk-4 alleles
Parental genotype
% larval arrest of 
progeny (n)*
Postembryonic blast cells that ini-
tiate division during the L1 stage
P2-P10 I
Wild type
cyd-1(he112)/mnC1
cyd-1(he116)/+
cdk-4(he109)/+
cdk-4(he110)/+
cdk-4(he111)/+
0.0 (>1000)
25.50 (697)
24.14 (994)
25.16 (930)
24.73 (1314)
23.65 (985)
9/9
0/9
0/9
0/9
0/9
0/9
14/20
0/16
0/16
0/20
0/20
0/20
*The percentage larval arrest was determined by counting the total prog-
eny from three to five heterozygous animals of the indicated genotype.
Divisions of P and I cells were scored in L3 stage mutants fixed and 
stained with the DNA stain PI. Divisions of P1, P11 and P12 could not be 
unambiguously determined and, therefore, are excluded.
Cell divisions are represented as number of cells divided/number of 
cells present in individual animals.
More than 10 animals of each genotype were examined.
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after DNA synthesis in the G2 phase (Boxem et al., 1999, Fig. 1D).
Expression of ribonucleotide reductase normally coincides with DNA repli-
cation, but does not depend on it (Duronio and O'Farrell, 1994). The
fact that cells arrest with 2n DNA amounts and lack rnr::GFP expression
shows that the cell-cycle arrest occurs before S phase. 
Although our results largely correspond to those described by Park
and Krause (Park and Krause, 1999), the cyd-1 mutant phenotype was
slightly more severe than the reported cyd-1(RNAi) phenotype. The
cyd-1(RNAi) animals hatched with 20 intestinal cells that arrested with a
4n DNA content (Park and Krause, 1999), while cyd-1(he112) and
cyd-1(he116) mutant larvae have 16 intestinal cells that arrest with a 2n
DNA content. The simplest explanation for the difference is that RNAi
did not completely inactivate cyd-1 function. Our data further support
the conclusion that cyd-1 and cdk-4 are essential for G1/Sprogression in
all postembryonic cell divisions.
cyd-1 and cdk-4 are primarily required for cell division and not cell 
growth
An essential role for cyd-1 and cdk-4 in G1 progression contrasts with
results obtained in the fruit fly. Drosophila cdk4 is not essential for most
divisions; rather the Cdk4/Cyclin D complex has been implicated in
regulation of cell growth (Datar et al., 2000; Meyer et al., 2000). To
examine the possibility that the cell-division defects observed in cyd-1
and cdk-4 mutants are a secondary consequence of a cell-growth defect,
we compared the growth rates of cyd-1(he112) and cdk-4(gv3) mutants
with wild-type larvae. Until approximately 20 hours of larval growth at
15°C, cyd-1(he112) and cdk-4(gv3) mutants and wild-type siblings were
indistinguishable in size (Fig. 3). After 20 hours, the growth rate of the
wild-type siblings increased, whereas cyd-1(he112) and cdk-4(gv3)mutants
continued to grow at a slow rate. The first larval (L1) stage ends with a
molt at approximately 16 hours of postembryonic development at 15°C.
Fig. 3. cyd-1 and cdk-4 cell division defects precede growth defects. Size of cyd-1(he112) and
cdk-4(gv3) homozygous mutants and wild type siblings (genotypes: cyd-1(he112)/mnC1 and
cdk-4(gv3)/+ or +/+) is plotted as a function of time of postembryonic development at
15°C. The growth retardation of cyd-1 and cdk-4 mutants becomes first apparent in the L2
stage, subsequent to failure of some late embryonic and all postembryonic L1 divisions.
Points indicate mean of five measured animals±s.d.
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Cells in a variety of cell lineages divide during this stage in the wild-type,
starting with the Q neuroblasts at approximately 5 hours of postembry-
onic development at 15°C. As none of these divisions occur in cyd-1 and
cdk-4 mutants, the cell-division defects precede the growth-retardation
phenotype. Moreover, the embryonic divisions take place in the absence
of growth, yet the final intestinal divisions failed to occur during
embryogenesis in cyd-1 mutants. Together, our results indicate that cdk-4
and cyd-1 primarily promote cell-cycle entry in C. elegans, in agreement
with the view derived from mammalian tissue culture experiments.
lin-35 Rb is an important negative regulator of G1/S progression and a 
major downstream target of cyd-1 and cdk-4
Mammalian D-type cyclins in association with the CDK4 and CDK6
kinases phosphorylate members of the pRb protein family in vitro (Kato
et al., 1993; Meyerson and Harlow, 1994). However, it has been difficult
to test whether this phosphorylation is crucial in vivo for inactivation of
the G1/S inhibitory function of the pRb protein, as multiple genes of
each type (D-type cyclins, CDK4/6 kinases and Rb-family members) are
present in mammals. By contrast, these different regulators are encoded
by single genes in C. elegans (The C. elegans Sequencing Consortium,
1998), making this organism an ideal system in which to address
whether Cyclin D and CDK4/6 are solely required to overcome G1/S
inhibition by pRb family members. 
The single Rb-related gene in C. elegans, lin-35, was previously identi-
fied as a regulator of vulval cell-fate specification (Lu and Horvitz,
1998). Surprisingly, animals homozygous for lin-35 presumed null muta-
tions are viable and show no cell-division defects. If cyd-1 and cdk-4 only
act to inhibit lin-35 Rb, then the cell-cycle arrest of cyd-1 and cdk-4
mutants should be fully overcome by lin-35 Rb inactivation. To test this
hypothesis, we used several assays. First, we examined whether inactiva-
tion of lin-35 in a cyd-1 mutant background restores expression of the
rnr::GFP S-phase marker. Mutations in lin-35 had previously been shown
to result in general suppression of transgene expression (Hsieh et al.,
1999). However, the rnr::GFP transgene was not silenced in the F1 prog-
eny of animals injected with lin-35 dsRNA (M. B. and S. v.d.H., unpub-
lished). Importantly, inactivation of lin-35 by RNAi efficiently restored
rnr::GFP expression in cyd-1 and cdk-4 homozygous mutants (Fig. 4A).
Next we tested whether inactivation of lin-35 could restore DNA rep-
lication in the intestinal nuclei. We constructed lin-35;cyd-1 and
lin-35;cdk-4 double mutant strains, using two different alleles of lin-35,
n745 and n2239, which contain early nonsense mutations that probably
completely eliminate lin-35 function (Lu and Horvitz, 1998). Quantita-
tive DNA measurements of intestinal nuclei showed that lin-35(n745 or
n2239);cyd-1(he112) and lin-35(n745);cdk-4(gv3) double mutant larvae
were able to undergo multiple rounds of DNA replication, giving rise to
a level of polyploidy in the double mutants that is similar to wild-type
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animals (Fig. 4B). In addition to DNA replication, lin-35;cyd-1 and
lin-35;cdk-4 double mutants reached near wild-type body and gonad
size(not shown) and lin-35(n745);cdk-4(gv3) double mutants occasionally
produced viable progeny. Thus, loss of function of lin-35 Rb overcomes
the G1 arrest of cells in cyd-1 and cdk-4 mutants. These results demon-
strate that lin-35 Rb is an important inhibitor of the G1/S transition and,
by analogy with other systems, probably a major target of cdk-4 and cyd-1.
Fig. 4. lin-35 acts as a negative regulator of cell-cycle progression. (A) Expression of the
rnr::GFP S-phase marker in cyd-1(he112) (left) and lin-35(RNAi); cyd-1(he112) (right).
Nomarski images (top) and corresponding epifluorescent images (bottom) show several
cells of the P and intestinal lineages. In the cyd-1 animal, only autofluorescence of the
intestinal cells is detectable, whereas lin-35 RNAi resulted in expression of rnr::GFP in the
P cells and other lineages. (B) Quantitative measurements of DNA content in the intesti-
nal nuclei (gray bars) of wild-type (WT) and mutant animals of indicated genotype. Body
wall muscles (black bars) serve as 2n DNA standard. (C) Rescue of postembryonic cell
divisions by lin-35. The cell number in the P2-P10 and intestinal lineages were counted in
animals of indicated genetic backgrounds. Scale bars: 10 µm. Values indicated are
mean±s.e.m. 
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The C. elegans genome contains single members of the D and E sub-
families of G1 cyclins. Inactivation of cye-1 Cyclin E by RNAi causes
embryonic arrest at approximately the 100-cell stage (Fay and Han,
2000). Homozygous cye-1 mutant larvae derived from heterozygous
mothers display late larval defects and complete sterility (Fay and Han,
2000). RNAi for lin-35 did not affect the cye-1(eh10) mutant phenotype.
Similarly, the embryonic arrest caused by cye-1 RNAi was equally severe
in a wild-type or lin-35(n745) mutant background (data not shown).
Thus, lin-35 inactivation specifically suppresses cyd-1 and not cye-1 loss of
function. Although other interpretations are possible, these results are
consistent with a model in which lin-35 Rb acts downstream of
cyd-1/cdk-4 and upstream of cye-1.
lin-35 is probably not the only target of cyd-1 and cdk-4
Although we observed substantial rescue of DNA replication, the num-
ber of cell divisions in the postembryonic lineages was not restored to
wild-type levels in lin-35;cyd-1 or lin-35;cdk-4 double mutants (Fig. 4C).
The double mutant animals also remained largely sterile. It appears
unlikely that this lack of complete rescue resulted from incomplete
inactivation of lin-35 Rb, as probable null mutations were introduced
(alleles n745 and n2239) (Lu and Horvitz, 1998), and identical effects
were observed following lin-35 RNAi. Incomplete rescue is also unlikely
to be caused by inactivation of a positive cell-cycle function of lin-35 Rb,
as lin-35 single mutants do not display apparent cell division defects.
These results strongly suggest that cdk-4 and cyd-1 do not act exclusively
upstream of lin-35 Rb but most probably activate or inactivate additional
targets.
lin-35 Rb is not rate limiting for S-phase entry
Because our results demonstrate that lin-35 Rb acts as a negative regula-
tor of cell division, we examined homozygous lin-35 mutants in more
detail for the presence of any defects in cell division. Using both Nomar-
ski microscopy of live lin-35 mutant larvae and fluorescence microscopy
of fixed animals stained with propidium iodide (PI), we did not observe
premature or additional cell divisions (data not shown). Alternatively,
loss of lin-35 might cause premature entry into S phase, which could be
Fig. 5. lin-35 is not rate limit-
ing for S-phase entry. DNA
content of intestinal cells of
wild-type, lin-35(n745) and
cki-1(RNAi) animals was deter-
mined at 1 hour intervals from
the start of postembryonic
development. Bars indicate
mean of 10 intestinal
nuclei±s.d.
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compensated for by expanding later cell-cycle phases. We compared the
timing of DNA replication in wild-type and lin-35(n745) mutant animals
to examine this possibility. Using quantitative DNA measurements at dif-
ferent times of L1 development, we determined that the first round of
DNA synthesis in the intestinal cells occurs between 6 and 8 hours of
postembryonic development in wild-type animals. This timing was iden-
tical in lin-35(n745) mutants (Fig. 5). Thus, in contrast to mouse embryo
fibroblasts that lack Rb family members, inactivation of lin-35 Rb is not
rate limiting in the normal regulation of S-phase initiation in vivo, and
additional regulatory pathways probably control the timing of DNA rep-
lication in the absence of lin-35.
The Cip/Kip family members cki-1 and cki-2 cooperate with lin-35 in G1 
regulation
Two observations suggest that lin-35 Rb cooperates with other regula-
tory pathways in controlling progression through G1 phase. First, loss of
lin-35 did not fully overcome the cell division defects of cyd-1 and cdk-4
mutants. Second, the timing of S-phase entry and cell division remained
intact in mutants lacking lin-35 function.
Several levels of control may converge at the level of Cyclin E/CDK2,
as Cyclin E-CDK2 kinase activity is necessary and sufficient to induce
S-phase in a variety of systems (Duronio and O'Farrell, 1995; Knoblich et
al., 1994; Ohtsubo et al., 1995; Tsai et al., 1993; van den Heuvel and Har-
low, 1993). In addition to transcriptional suppression by pRb, Cyclin
E/CDK2 kinases are also regulated by CDK inhibitors of the Cip/Kip
family (Ekholm and Reed, 2000; Sherr and Roberts, 1999).The C. ele-
gans genome contains two Cip/Kip family members, cki-1 and cki-2
(Feng et al., 1999; Hong et al., 1998). Several observations suggested that
cki-1 and possibly cki-2 have conserved functions as CDK inhibitors.
Ectopic expression of CKI-1 has been shown to arrest the cell cycle in G1
phase (Hong et al., 1998). Moreover, inactivation of cki-1, but not cki-2,
by RNAi resulted in supernumerary divisions in various cell lineages
(Feng et al., 1999; Hong et al., 1998). We confirmed the cki-1 RNAi phe-
notype and observed low penetrant postembryonic cell divisions in cyd-1
mutant animals after cki-2 RNAi (see below and data not shown). Finally,
CKI-1 was found to interact with CYD-1 and CYE-1 in two-hybrid assays
(Materials and Methods). Together, these observations suggested that
cki-1 and cki-2 (collectively referred to as cki-1,2) are C. elegans Cip/Kip
family members with conserved functions in the regulation of G1/S pro-
gression.
We examined if cki-1,2 Cip/Kip activity is sufficient to control
cell-cycle progression in the absence of lin-35 Rb function. In contrast to
lin-35 inactivation, cki-1 RNAi caused premature entry into S phase (Fig.
5). A significant number of intestinal nuclei obtained 4n DNA amounts
even without stimulation of L1 development (Fig. 5, 0 hour). Interest-
ingly, RNAi for cki-1 alone or cki-1 and cki-2 together resulted in only a
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single round of DNA replication in cyd-1(he112) mutant animals (Fig.
6A). Thus, inactivation of the cki-1,2 inhibitors appears rate limiting for
S-phase entry and allows one round of DNA duplication even in the
absence of cyd-1/cdk-4 function. However, subsequent rounds of DNA
synthesis require the activity of cyd-1 and cdk-4 or inactivation of lin-35
Rb. These results demonstrate that cki-1,2 Cip/Kip and lin-35 Rb con-
tribute non-overlapping levels of control over the G1/S transition.
Next we determined whether lin-35 and cki-1,2 cooperate in nega-
tively regulating cell division. As shown above, inactivation of lin-35
partly restored postembryonic cell division in cyd-1 and cdk-4 mutant ani-
mals (Figs 4C, 7B). Similarly, cki-1,2 RNAi caused rescue of cell division
in cyd-1 mutants, resulting in an approximately normal number of P cell
divisions and a limited number of intestinal divisions (Figs. 6B, 7C).
Importantly, we observed dramatically increased numbers of cell divi-
sions when inactivation of lin-35 and cki-1,2 were combined. Even in a
cyd-1 mutant background, this resulted in a total number of intestinal
nuclei that far exceeded the number in wild-type animals (Figs. 6B, 7D).
Double inactivation of lin-35 Rb and cki-1,2 Cip/Kip also caused a syner-
Fig. 6. cki-1 and cki-2 cooperate with lin-35 Rb in
regulating G1 progression. (A) Quantitative mea-
surements of DNA content in the intestinal nuclei
(gray bars) of wild-type and mutant animals of indi-
cated genotype. Body wall muscles (black bars)
serve as 2n DNA standard. (B) Rescue of postem-
bryonic cell divisions. The cell numbers in P2-P10
and intestinal lineages were counted in strains of
indicated genotype. Genes that do not carry allele
designations were inhibited by RNAi. (C) Addi-
tional cell divisions in a wild-type background
caused by inactivation of the indicated genes. The
wild type is defined as zero supernumerary divi-
sions. In all three panels, bars indicate mean±s.e.m. 
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gistic increase in the number of supernumerary divisions in a wild-type
background (Fig. 6C). Although the absolute effects vary between dif-
ferent cell lineages, cki-1,2 Cip/Kip and lin-35 Rb cooperate in regulat-
ing G1/S phase progression.
DISCUSSION
Control of G1 progression is crucial to the development of all eukary-
otes. We followed a genetic approach in the nematode C. elegans to learn
more about the pathways that regulate G1 progression in vivo. A screen
for positive regulators of G1 progression identified a D-type cyclin and a
CDK4/6 related kinase. Characterization of the mutant phenotypes
confirmed the previous conclusion by Park and Krause (Park and
Krause, 1999) that cyd-1 and cdk-4 are essential for entry into S-phase
during postembryonic development. We used the mutant alleles of cyd-1
and cdk-4 to directly address whether Cyclin D and/or CDK4/6 act in a
linear pathway with Rb family members in vivo. We found that although
lin-35 Rb is an important negative regulator of G1 progression and prob-
ably acts downstream of cyd-1 and cdk-4, lin-35 does not provide the only
level of regulation of S-phase entry. An additional level of control is con-
tributed by the CDK inhibitors cki-1 and cki-2, which were found to act
in parallel to lin-35, and to cooperate with lin-35 in controlling the G1/S
transition. Below we discuss our results in light of the existing knowl-
edge about G1 control in other animal systems.
Considering the nature of the screen, it is somewhat surprising that
we identified only a D-type cyclin and CDK4/6 related kinase as essen-
tial positive regulators. Although few genes may be essential for both
Fig. 7. Cip/Kip and Rb family members cooperate in regulating G1 progression. Epifluo-
rescent images demonstrating the number of intestinal divisions in (A) cyd-1(he112);
elt-2::GFP mutant larvae and animals of the same genotype after (B) lin-35 RNAi, (C)
cki-1,2 RNAi and (D) lin-35; cki-1,2 double RNAi. Intestinal nuclei express the GFP under
the control of the elt-2 promoter region. Scale bars: 25 µm.
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rnr::GFP expression and cell division, there are several reasons why some
regulators may have been missed. First, although multiple alleles of
cyd-1 and cdk-4 were identified, it is unlikely that the screen was saturat-
ing. Moreover, mutation of some positive regulators may not have
resulted in a prominent phenotype, owing to functional redundancy
with other genes. In addition, a mutation may not result in a cell-cycle
specific phenotype if the gene affected has additional essential func-
tions. Finally, mutations will have been missed that cause a cell-cycle
arrest before or after the L1 stage. In the presence of wild-type maternal
product, the stage at which a mutant phenotype first becomes apparent
is determined by the requirement for zygotic gene function. Although
many C. elegans cell-cycle regulators display their mutant phenotype in
the first larval stage (e.g. ncc-1, lin-5, cul-1 Boxem et al., 1999; Kipreos et
al., 1996; Lorson et al., 2000), zygotic expression of other genes is
required during embryonic development or after the first larval stage.
For example, mutations in cye-1, the C. elegans Cyclin E homolog, result
in late larval defects, although RNAi experiments revealed an essential
function during embryogenesis (Fay and Han, 2000 M. B. and S. v.d.H.,
unpublished). We did not identify mutations in candidate positive regu-
lators of the E2F/DP transcription factor families. Accordingly, the
recent analysis of efl-1 E2F and dpl-1 DP mutations revealed that these
genes are not generally needed for cell division in C. elegans (Ceol and
Horvitz, 2001; Page et al., 2001).
The Cyclin D kinase is essential for G1 progression
A large number of observations have implicated Cyclin D-CDK4/6
kinases in G1 control (Sherr, 1996; Sherr and Roberts, 1999). Most stud-
ies have documented the effects of ‘gain of function’ of kinase activity.
For example, increased activity of D-type kinases is found in tumor cells,
can shorten G1 phase of cells in tissue culture and can overcome the G1
arrest induced by ectopic pRb expression. Such observations do not
establish whether or not these kinases are essential for cell cycle pro-
gression. Indirect evidence in support of an essential role has been pro-
vided by overexpressing the CDK4/6 inhibitor p16INK4a (Bruce et al.,
2000; Koh et al., 1995; Lukas et al., 1995; Medema et al., 1995). This has
been shown to arrest G1 progression of pRb-positive cells, but not of
cells lacking either pRb or p107 and p130. Mice nullizygous for Cyclin
D1 or CDK4 develop to adults with growth defects (Fantl et al., 1995;
Rane et al., 1999; Sicinski et al., 1995; Tsutsui et al., 1999). However, the
effects have yet to be described of gene knockout of all three D-type
cyclins, or of CDK4 and CDK6. The most complete inactivation of
Cyclin D kinase activity may have been achieved in mice double null for
p21 and p27 Cip/Kip, which act as assembly factors for CDK4/6-Cyclin
D kinases (Cheng et al., 1999; LaBaer et al., 1997). Double inactivation
of p21 and p27 has been found to reduce CDK4/6 kinase activity below
the level of detection, yet these double mutant animals do not show
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cell-division defects (Cheng et al., 1999). Such results have challenged
the prevalent view about the requirement for Cyclin D kinase activity.
C. elegans and Drosophila are thus far the only organisms in which the
effects of complete loss of Cyclin D-dependent kinase activity have been
studied. Inactivation of the sole CDK4/6-related kinase in Drosophila did
not affect cell division in a general way (Datar et al., 2000; Meyer et al.,
2000). Homozygous Cdk4 mutant flies develop into small adults with
reduced fertility (Meyer et al., 2000). The small size did not appear to be
caused by a decrease in cell numbers. Rather, based upon the analysis of
Cdk4 mutants and ectopic expression of CycD-Cdk4, the primary role of
CycD-Cdk4 appears to be stimulation of cell growth in Drosophila (Datar
et al., 2000; Meyer et al., 2000). By contrast, the cell-division defects in
the C. elegans cyd-1 and cdk-4 mutants precede a detectable growth defect
and first appear in late embryogenesis before growth takes place. Thus,
the rate limiting function of Cyclin D-CDK4/6 kinases may vary between
species, demonstrating the value of using multiple model organisms in
studying gene function.
lin-35 Rb probably acts downstream of cdk-4/cyd-1 in cell-cycle control
Upon inactivation of the retinoblastoma family member lin-35 Rb, cells
were able to complete multiple rounds of S phase in the apparent
absence of CYD-1/CDK-4 activity. This clearly establishes lin-35 Rb as a
negative regulator of S phase which acts downstream of or in parallel to
cyd-1/cdk-4. Previously, lin-35 was identified as a member of a set of genes
that negatively regulate vulval cell fate (Ferguson and Horvitz, 1989; Lu
and Horvitz, 1998). These genes are known as the ‘synthetic multivulva’
(synMuv) genes that form two functionally redundant classes. Inactiva-
tion of both a class A and a class B synMuv gene causes inappropriate
induction of vulval fates, resulting in a Multivulva phenotype (Ferguson
and Horvitz, 1985; Ferguson and Horvitz, 1989). Genetic epistasis
experiments have shown that the synMuv genes act to antagonize a
receptor tyrosine kinase/Ras-mediated signaling pathway (Lu and Hor-
vitz, 1998). A role in cell-division has not been described previously for
the class B synMuv gene lin-35 Rb. lin-35 null mutants are viable and
appear to develop normally (Lu and Horvitz, 1998). In addition, the
absence of lin-35 function did not affect the timing of S-phase entry.
These findings are surprising as lin-35 is the only member of the Rb fam-
ily in C. elegans, and loss of Rb is lethal in mice (Jacks et al., 1992) as well
as in Drosophila (Du and Dyson, 1999). Moreover, mouse embryonic
fibroblasts that lack all three Rb family members show severe cell-cycle
defects in tissue culture (Dannenberg et al., 2000; Sage et al., 2000).
Interestingly, in chimeric mouse experiments, adult mice with largely
normal tissues were found to contain high percentages of Rb-/- cells
(Robanus Maandag et al., 1994; Williams et al., 1994). Thus, the develop-
mental requirement for a functional Rb gene may be limited to specific
tissues or cell types.
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lin-35 Rb and cki-1 Cip/Kip cooperate in G1/S control
Our results demonstrate that in the absence of lin-35 Rb function addi-
tional levels of control are sufficient to maintain the correct timing of S
phase in C. elegans. Based on results in other systems, we reasoned that
such controls are likely to involve inhibitors of the Cip/Kip family.
Indeed, several results indicate that cki-1,2 Cip/Kip and lin-35 Rb coop-
erate in controlling the G1/S transition in C. elegans. The strongest argu-
ment for cooperation between cki-1,2 and lin-35 is the observed
synergistic effect of double inactivation on supernumerary cell divisions.
Most strikingly, animals contained on average 84 intestinal nuclei fol-
lowing inactivation of cki-1,2 as well as lin-35, while adult wild-type ani-
mals, lin-35 mutants, and cki-1,2(RNAi) animals averaged 34, 34 and 47
nuclei, respectively. Such increased numbers of intestinal divisions have
not been reported previously in C. elegans. That cki-1 and lin-35 act at
least in part in parallel pathways is further indicated by their distinct
loss-of-function phenotypes. Loss of lin-35 does not lead to precocious S
phase but does allow multiple rounds of DNA replication in cyd-1 or
cdk-4 mutant animals. By contrast, inactivation of cki-1 by RNAi results in
premature S phase, yet permits only a single round of DNA synthesis in
cyd-1 and cdk-4 mutants. These results agree well with those obtained for
dacapo, a Cip/Kip inhibitor in Drosophila (de Nooij et al., 1996; Lane et
al., 1996). The dacapo mutant phenotype has been proposed to result
from failure to inactivate residual Cyclin E kinase (de Nooij et al., 1996).
For further rounds of cell division, Cyclin E needs to be transcribed,
which requires inactivation of RBF/E2F-mediated transcriptional
repression. We expect that similar mechanisms explain the cooperative
effects of cki-1 and lin-35 Rb in C. elegans. 
Several observations in mammalian systems also suggest coopera-
tion. In tissue culture, p21-/-;pRb-/- mouse cells are more defective in G1
control than cells lacking either single gene (Brugarolas et al., 1998).
Moreover, double inactivation of genes in both pathways increases
tumor formation in mouse models (Brugarolas et al., 1998; Franklin et
al., 1998; Park et al., 1999). As p21 is an important downstream target of
the p53 tumor suppressor, cooperation between p21 and pRb in cell
cycle control may contribute to the strong selective pressure for dual
inactivation of p53 and pRb in human cancer. Thus, although control
by Cip/Kip inhibitors may be more rate limiting in C. elegans, coopera-
tion between Cip/Kip and pRb family members in G1/S control is prob-
ably shared among metazoans.
Additional functions of Cyclin D-CDK4/6 kinases
The absence of pRb family proteins in lin-35 putative null mutants was
not sufficient to fully overcome the requirement for a Cyclin D-depen-
dent kinase in C. elegans. This indicates that cyd-1 and cdk-4 do not act
solely to inactivate lin-35. A second activity described for Cyclin
D-CDK4/6 complexes is sequestration of Cip/Kip inhibitors, which
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allows activation of Cyclin E/CDK2 complexes (Sherr and Roberts,
1999). It is possible that sequestering CKI-1 and CKI-2 is the detected
additional function of the CYD-1/CDK-4 kinase. Consistent with this
idea, we found that CYD-1, as well as CYE-1, interacts with CKI-1 in the
two hybrid system. Interestingly, the single Drosophila Cip/Kip family
member Dacapo does not bind to CycD-Cdk4 (Meyer et al., 2000). Possi-
bly, alternative ways to control Cip/Kip activity have been developed in
Drosophila, which may explain the reduced role of the Cyclin D-CDK4/6
kinase in cell-cycle progression. 
MATERIALS AND METHODS
Culture conditions and strains
We used the wild-type strains N2 and RW7000 and the following mutations, descriptions of
which can be found elsewhere (Riddle et al., 1997):
LGI: dpy-5(e61), lin-35(n745 and n2239) (Lu and Horvitz, 1998), unc-29(e403).
LGII: dpy-10(e128), rol-1(e91), cyd-1(he112 and he116) (this study).
LGX: lon-2(e678), unc-9(e101), cdk-4(he109, he110, he111 and gv3) (this study) (Park and
Krause, 1999).
Deficiency: heDf1.
Rearrangements: mnC1(II) (Wood and the community of C. elegans researchers, 1988).
Integrated arrays: maIs103[rnr::GFP unc-36(+)]X (Hong et al., 1998), rtIs14[elt-2::GFP;
osm-10::HT150Q]IV (a gift from P. W. Faber and A. Hart).
Screen for positive regulators of G1/S progression
Animals of genotype unc-36(e251);maIs103[rnr::GFP unc-36(+)](Hong et al., 1998), express-
ing GFP controlled by ribonucleotide reductase (rnr) promoter sequences, were mutagenized
with 25 mM ethylmethanesulfonate as described (Brenner, 1974). Individual mutagenized
F1 animals were picked to plates and their progeny examined for the presence of 1/4 ster-
ile uncoordinated animals. Such mutants were further examined for absence of postem-
bryonic cell divisions and GFP expression. Candidate mutations identified from ~10,000
haploid genomes were recovered from heterozygous siblings and mapped to chromo-
somes by PCR, making use of primers based on polymorphic Sequence-Tagged Sites in the
RW7000 Bergerac strain (Williams et al., 1992). Two mutations (he112 and he116) were
placed on chromosome II and three mutations (he109, he110 and he111), as well as the
deletion heDf1, were placed on the X chromosome. Standard two- and three-factor map-
ping with dpy-10(e128) and rol-1(e91) or lon-2(e678) and unc-9(e101) was performed for fur-
ther mapping. DNA sequence analysis revealed molecular lesions in cyd-1 (he112,
Q292->stop) and cdk-4 (he110, E85->K; he111: W208-> STOP; he109: Q292-> STOP). PCR
and Southern blotting experiments revealed that he116 and heDf1 are deletions.
Quantitation of DNA and cell division
Quantitative determination of DNA content was performed essentially as described before
(Boxem et al., 1999), by measuring the pixel intensity of serial z-sections taken on a confo-
cal microscope (Zeiss) of animals stained with propidium iodide. The number of cell divi-
sions was determined by counting nuclei in fixed specimens. The daughter cells of P2 to
P10 as well as the intestinal nuclei could be recognized unambiguously and are therefore
used in the figures. Owing to partial rescue of cell division, cyd-1 and cdk-4 mutants were
recognizable and formed 1/4 of the total offspring. Strains carrying the elt-2::GFP reporter
were used to recognize intestinal nuclei in the experiments shown in Figs 6 and 7.
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Two-hybrid assays
A full-length cki-1 cDNA was obtained from C. elegans cDNA by PCR using primers 5’-ggg-
gaccactttgtacaagaaagctgggtgtatggagagcatgaagatcg and 5’-ggggacaagtttgtacaaaaaagcaggct-
tgtcttctgctcgtcgttgc. Sequence analysis confirmed the obtained PCR product
corresponded to the wild-type cki-1 sequence. The cki-1 cDNA was cloned into pPC97 and
used as bait in a two-hybrid experiment as described (Vidal, 1997). CYE-1 and CYD-1 were
each isolated independently five times as a CKI-1 interacting protein, out of a total of
2×106 yeast colonies transformed with the cki-1 bait construct.
Timing of DNA replication
N2 animals were injected with lin-35 dsRNA or cki-1 dsRNA, and allowed to produce prog-
eny for 24 hours. Eggs produced in the next 24 hours at 15°C were hatched in the absence
of food, which results in a developmental arrest immediately after hatching. Subsequently,
synchronous development was induced by transferring the arrested larvae to fresh agar
plates containing E. coli bacteria. Developing larvae were fixed in Carnoys fixative at 1
hour intervals and stained with the DNA stain propidium iodide. DNA contents of 10 In
cells were determined as described above.
Growth rate of cyd-1 mutants
Embryos were collected by hypochlorite treatment of gravid cyd-1(he112)/mnC1 adults and
allowed to hatch in S-medium without food (Wood and the community of C. elegans
researchers, 1988). Synchronous L1 development was initiated 24 hours later by transfer-
ring the starved L1 animals to agar plates containing E. coli bacteria. We determined the
total body size of five cyd-1 mutants and five heterozygous siblings at various times, using
the size measurement function of the Openlab software package. The software was cali-
brated using a size standard slide.
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A
 
BSTRACT
 
The single Rb family member in 
 
C. elegans
 
, 
 
lin-35
 
, was originally identi-
fied as a member of the synthetic Multivulva (synMuv) genes (Lu and
Horvitz, 1998). These genes form two redundant classes, A and B, that
repress ectopic vulval cell fate induction (Ferguson and Horvitz, 1985;
Ferguson et al., 1987). Recently, we demonstrated that 
 
lin-35
 
 Rb also
acts as a negative regulator of G
 
1
 
 progression, and likely is the major tar-
get of 
 
cyd-1
 
 Cyclin D and 
 
cdk-4
 
 CDK4/6 (Boxem and van den Heuvel,
2001). To identify additional G
 
1
 
 control genes, we examined other syn-
Muv genes and observed cell-cycle functions for several class B genes.
We found that 
 
efl-1
 
 E2F negatively regulates cell-cycle entry, while 
 
dpl-1
 
DP appears to act both as a positive and negative regulator. In addition,
we identified a negative G
 
1
 
 regulatory function for 
 
lin-9
 
 ALY, as well as
 
lin-15
 
B and 
 
lin-36
 
, which encode novel proteins. Inactivation of 
 
lin-35
 
Rb, 
 
efl-1
 
 or 
 
lin-36
 
 allowed S phase entry in the absence of 
 
cyd-1/cdk-4
 
 and
increased ectopic cell division when combined with 
 
cki-1
 
 Cip/Kip RNAi.
These data are consistent with 
 
lin-35
 
 Rb, 
 
efl-1
 
 and 
 
lin-36
 
 acting in a com-
mon pathway or complex that negatively regulates G
 
1
 
 progression. In
contrast, 
 
lin-15
 
B appeared to act in parallel to 
 
lin-35
 
. Our results demon-
strate the potential for genetic identification of novel G
 
1
 
 regulators in 
 
C.
elegans.
 
R
 
ESULTS
 
 
 
AND
 
 
 
DISCUSSION
 
The tumor suppressor pRb acts as a negative regulator of cell-cycle
entry. This function is thought to require interaction with sequence-spe-
cific transcription factors, such as E2F/DP heterodimers, that attract
pRb to the promoter regions of genes required for S phase. In turn,
pRb likely recruits chromatin remodeling complexes, such as histone
deacetylases (HDACs), that promote transcriptional repression. As
many protein associations have been described for pRb, it remains
unclear which interactions are of critical importance for pRb-mediated
G
 
1
 
 regulation 
 
in vivo
 
 (Morris and Dyson, 2001). Demonstration of such
 
in vivo
 
 functions requires genetic studies in model organisms. 
The nematode 
 
Caenorhabditis elegans
 
 contains a single Rb-related
gene, 
 
lin-35 
 
(Lu and Horvitz, 1998). This gene was identified originally
as a synthetic Multivulva (synMuv) gene that prevents ectopic vulval cell
fate specification (Ferguson and Horvitz, 1985; Ferguson 
 
et al
 
., 1987).
Inactivation of 
 
lin-35
 
 Rb does not cause obvious cell-cycle defects, since
cyclin-dependent kinase (CDK) inhibitor(s) of the Cip/Kip family are
rate limiting for G
 
1
 
/S progression (Boxem and van den Heuvel, 2001).
However, a cell-cycle role for 
 
lin-35 
 
Rb became evident when examined
in combination with inactivation of other cell-cycle regulators (Boxem
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lin-8, lin-15
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d
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B
 
, lin-35, lin-36, lin-37, lin-53,
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orvitz, 1998), 
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u an
d H
orvitz, 1998), 
 
lin-8(n111)
 
 II, 
 
lin-38(n751)
 
 II,
 
cyd-1(he112)
 
 II (B
oxem
 an
d van
 den
 H
euvel, 2001), 
 
lin-36(n766)
 
 III, 
 
lin-37(n758)
 
 III, 
 
cdk-4(gv3)
 
 X
 (Park an
d K
rause, 1999),
 
lin-15
 
A
 
(n767)
 
 X
, 
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B
 
(n374)
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 (Ferguson
 an
d H
orvitz, 1989).
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 expression
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and van den Heuvel, 2001). Loss of function of 
 
cyd-1
 
, the only D-type
cyclin gene in 
 
C. elegans
 
, or of 
 
cdk-4
 
, the single CDK4/6 kinase gene,
causes arrest of postembryonic cell divisions in G
 
1
 
 phase (Boxem and
van den Heuvel, 2001; Park and Krause, 1999). Inactivation of 
 
lin-35
 
 Rb
in 
 
cyd-1
 
 or cdk-4 mutants overcomes this cell-cycle arrest (Boxem and
van den Heuvel, 2001). Moreover, inactivation of lin-35 Rb together with
cki-1,2 Cip/Kip causes a synergistic increase in the number of ectopic
cell divisions (Boxem and van den Heuvel, 2001) (see cki-1,2 footnote
Table 1). These results established that lin-35 Rb acts as a negative regu-
lator of G1 progression, most likely downstream of cyd-1/cdk-4 (Boxem
and van den Heuvel, 2001).
To identify additional G1 regulators, we examined whether synMuv
genes other than lin-35 Rb function in cell-cycle regulation. We moni-
tored whether inactivation of synMuv genes in a cyd-1 mutant back-
ground restored expression of an S-phase reporter (rnr::GFP, Hong et
al., 1998), whether it allowed DNA synthesis, and whether it rescued the
cell division arrest (see Supplementary Experimental Procedures). In
addition, we examined the effects of double inactivation of synMuv
genes and lin-35 or cki-1,2 to further examine functional similarity with
lin-35 Rb. Mutations in lin-35 Rb pathway genes that act as G1/S inhibi-
tors are expected to increase the number of ectopic cell divisions caused
by cki-1,2 inactivation, but should not affect the lin-35 mutant pheno-
type. The results of these assays are summarized in Table 1 and dis-
cussed in detail below.
No apparent G1 function for synMuv class A genes
lin-35 Rb is a class B synMuv gene which acts redundantly with class A
synMuv genes in vulval fate determination. Interestingly, we did not
observe a role for class A genes in cell-cycle control (Table 1). Mutations
in the class A genes lin-8, lin-15A and lin-38 did not restore cell division
or S phase entry in cyd-1 mutant animals. Moreover, the partial rescue of
postembryonic cell divisions in lin-35(n745);cyd-1(he112) double mutant
animals was not affected by further introduction of the lin-8(n111) or
lin-15A(n765) mutations or by lin-15A RNAi (not shown). Therefore, the
observed functional redundancy between class A and class B genes in
vulval fate determination does not appear to apply to G1 regulation.
Regulation of G1 progression by efl-1 E2F and dpl-1 DP
Two of the class B synMuv genes are C. elegans homologs of E2F and DP
(Ceol and Horvitz, 2001). RNAi of efl-1 E2F caused a cell-cycle pheno-
type that was strikingly similar to the lin-35 Rb phenotype (Table 1, Fig.
1). Inactivation of efl-1 resulted in multiple rounds of DNA synthesis in
the intestinal nuclei (Int) of cyd-1(he112) mutant larvae (average 20.5
n±2.1 s.e.m, Fig. 1A). RNAi of efl-1 also allowed expression of the
rnr::GFP S-phase marker in the postembryonic blast cells of cyd-1
mutants (Fig. 1B). In addition, efl-1 RNAi partially restored postembry-
G1 control by synMuv class B genes
111
onic cell divisions (Fig. 1C). Finally, RNAi for efl-1 and cki-1,2 simulta-
neously resulted in a far greater number of intestinal nuclei than
inactivation of either efl-1 or cki-1,2 alone (up to 70 ectopic divisions,
compared to at most 3 and 26, respectively) (Fig. 1D). This effect was
observed both in a wild-type and a cyd-1 mutant background, and closely
resembled the effect of simultaneous inactivation of lin-35 and cki-1,2.
As expected, efl-1 RNAi in a lin-35(n745) mutant background did not
Fig. 1. dpl-1 DP and efl-1 E2F regulate G1 progression. (A) Loss of efl-1 or dpl-1 results in
multiple rounds of DNA synthesis in cyd-1 mutant larvae, as demonstrated by quantitative
measurements of DNA content. The total DNA content of 10 intestinal cells (Int) was
determined for animals of indicated genotypes as described previously (Boxem and van
den Heuvel, 2001). Int cells in wild-type animals undergo endoreduplication and accumu-
late a 32n DNA content. Body wall muscle cells (bwm) are used as a 2n standard. (B) Loss
of efl-1 restores rnr::GFP expression in cyd-1 mutants. Nomarski (top) and epifluorescent
(bottom) images show several “P” cells of the ventral cord precursor lineage expressing
rnr::GFP in an efl-1(RNAi); cyd-1(he112) mutant animal (right), but not in a cyd-1 mutant
animal (left). Scale bar corresponds to 10 µm. (C) Loss of efl-1 and dpl-1 partially restores
cell division in cyd-1 mutant larvae. The number of ventral cord neurons (vcn) formed
during larval development was counted between the retrovesicular ganglion and P10.p, as
well as the number of intestinal nuclear divisions (Int) for 10 animals of each indicated
genotype. Wild-type numbers correspond to those reported previously (Sulston and Hor-
vitz, 1977) (D) efl-1 and dpl-1 cooperate with cki-1 and cki-2 in negatively regulating G1 pro-
gression. Postembryonic intestinal divisions were determined for 10-20 animals of
indicated genotypes. An elt-2::GFP reporter was used to mark intestinal nuclei. To distin-
guish cyd-1 mutants from siblings, cyd-1 was marked in trans with mIn1 which contains an
integrated array expressing GFP in the pharynx, controlled by the myo-2 promoter (Edgley
and Riddle, 2001). In all panels, bars indicate mean± s.e.m.
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cause any increase in postembryonic cell divisions (not shown).
Together, these data indicate that efl-1 acts as a negative regulator of
cell-cycle entry, either downstream of or in parallel to cyd-1. Based on
the similarity in phenotype, most of the G1 control function of lin-35 Rb
appears to be mediated in concert with efl-1 E2F.
The presumed protein partner of EFL-1 E2F is encoded by the syn-
Muv B gene dpl-1 DP (Ceol and Horvitz, 2001). Interestingly, dpl-1
showed aspects of a positive regulator as well as a negative regulator of S
phase entry. In cyd-1(he112) mutant larvae, dpl-1 RNAi resulted in several
rounds of DNA replication (Fig. 1A), and restored cell division at a level
that was limited (Fig. 1C) but synergistically enhanced by simultaneous
RNAi of cki-1,2 (Fig. 1D, left). On the other hand, when examined in a
wild-type background, dpl-1 inactivation resulted in a decreased number
of ventral cord and intestinal divisions (Fig. 1D, right, Ceol and Horvitz,
2001). Moreover, dpl-1 RNAi caused repression of rnr::GFP expression in
wild-type animals (see Supplementary Material). Together, these results
indicate that dpl-1 acts both as a negative and a positive regulator of G1
progression.
Studies in other systems demonstrated that some E2F/DP het-
erodimeric transcription factors repress E2F responsive genes in coop-
eration with Rb, while others are predominantly transcriptional
activators (Frolov et al., 2001; Trimarchi and Lees, 2002). Our results
indicate that the same model applies to developmental cell-cycle control
in C. elegans. We wished to examine whether the only other C. elegans
E2F-like gene, efl-2 (Ceol and Horvitz, 2001), acts as a transcriptional
activator. However, we did not observe suppression of rnr::GFP expres-
sion following efl-2 RNAi, and double RNAi for efl-1 and efl-2 was found
to resemble efl-1 RNAi rather than dpl-1 RNAi. It remains unclear
whether the lack of phenotype was caused by ineffective RNAi or lack of
efl-2 requirement. Thus, although the partly opposite effects of efl-1 and
dpl-1 RNAi suggest the presence of an activating E2F in C. elegans, no
such E2F has yet been identified.
Our results are the first demonstration of a general cell-cycle function
of C. elegans efl-1 E2F. In combination with the observed formation of a
trimeric complex of EFL-1, DPL-1 and LIN-35 in vitro (Ceol and Horvitz,
2001), our results support the model that EFL-1 and DPL-1 het-
erodimers recruit LIN-35 Rb for transcriptional repression of S phase
genes (Fig. 3). These observations stress the importance of specific E2Fs
as inhibitors of G1 progression.
NuRD Components and G1 regulation
Several synMuv gene products are structurally similar to components of
the nucleosome remodeling and histone deacetylase (NuRD) complex
(Ahringer, 2000; Lu and Horvitz, 1998; Solari and Ahringer, 2000; von
Zelewsky et al., 2000). LIN-35 can interact with the NuRD components
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HDA-1 and LIN-53 in vitro (Lu and Horvitz, 1998). These results indi-
cated that recruitment of the NuRD complex is critical to the role of
lin-35 Rb in vulval development. To address if NuRD recruitment is also
critical in G1 regulation, we examined homologs of the histone deacety-
lase, RbAp46/48 (Rb-associated protein), MTA1 and Mi-2 subunits
(Table 1). In general, the cell-cycle effects of lin-35 Rb inactivation were
not reproduced by loss of function of NuRD genes (see Supplementary
Material). The interpretation of these results is complicated by redun-
dancies and pleotropic functions of NuRD genes, and the possibility of
incomplete loss of function in our experiments. We consider two possi-
ble explanations for the lack of cell-cycle phenotype: NuRD compo-
nents may not be generally required for cell-cycle inhibition, or a lower
level of NuRD function may be needed for cell-cycle inhibition than for
vulval development.
The synMuv class B genes lin-9, lin-15B and lin-36 encode novel negative 
G1 regulators
In addition to cognate components of the mammalian Rb regulation
pathway, we tested five synMuv class B genes with unknown molecular
functions: lin-9, lin-15B, lin-36, lin-37, and tam-1. Examination of
lin-37(n758); cyd-1(he112) and cyd-1(he112); tam-1(RNAi) double mutant
larvae did not reveal a G1/S control function for the lin-37 and tam-1
genes (Table 1). However, three other synMuv B genes, lin-9, lin-15B
and lin-36, displayed a cell-cycle phenotype.
A surprising result was obtained for lin-15B: although lin-15B and
lin-35 Rb act in a common synMuv B pathway, these genes do not appear
to act in the same G1 control pathway. lin-15B RNAi weakly rescued the
postembryonic cell divisions in cyd-1(he112) mutant larvae (Fig. 2A; 4.7 P
cell divisions, no Int divisions, n = 10). However, in double inactivation
experiments, cooperation was observed between lin-15B and lin-35 Rb,
rather than lin-15B and cki-1,2 Cip/Kip (Fig. 2D, not shown). Loss of
either lin-15B or lin-35 alone did not cause additional cell division, while
lin-35; lin-15B double RNAi resulted in supernumerary cell divisions
(Fig. 2D, on average 9.5 extra Int divisions, n = 10 animals). This syner-
gistic effect could result from inactivation of two redundant pathways,
or from combining partial loss of function of two genes within the same
pathway. To distinguish between these possibilities, we used the strong
or complete loss-of-function alleles lin-35(n745) and lin-15B(n374), and
obtained similar results (Fig. 2D). Therefore, we conclude that lin-35
and lin-15B act in at least partially non-overlapping pathways for G1 con-
trol.
Inactivation of lin-9 or lin-36 restored several rounds of endoredupli-
cation in cyd-1(he112) mutant larvae (Fig. 2A). In addition, lin-36
loss-of-function caused significant rescue of postembryonic cell division
in cyd-1 mutants, while lin-9 loss-of-function allowed an occasional divi-
sion (Fig. 2B). Introduction of the strong loss-of-function alleles
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lin-36(n766) and lin-9(n942) caused similar results as RNAi, but rescue
was not obtained with the hypomorphic allele lin-9(n112) (Fig. 2A,B and
data not shown). Inactivation of lin-9 or lin-36 restored cell division and
endoreduplication in cdk-4(gv3) and cyd-1(he112) mutant larvae to the
same extent (Fig. 2A,B). These results indicate that lin-9 and lin-36 act
as negative regulators of G1 progression downstream of or in parallel to
cyd-1 Cyclin D/cdk-4 CDK4/6.
To examine whether lin-9 and lin-36 may act in the lin-35 Rb G1 con-
trol pathway, we created double loss-of-function combinations with
Fig. 2. Cell-cycle roles for lin-9, lin-15B and lin-36. (A) Loss of lin-9 or lin-36 results in mul-
tiple rounds of endoreduplication in cyd-1 or cdk-4 mutant larvae. (B) Loss of lin-9, lin-15B
or lin-36 partly rescues cyd-1 cell division defects. (C) lin-36 cooperates with cki-1,2 in nega-
tively regulating G1 progression. Postembryonic intestinal divisions were determined for
10-20 animals of indicated genotypes. (D) lin-15B cooperates with lin-35 Rb. Postembry-
onic intestinal divisions were determined for 10-20 animals of indicated genotypes. (E)
Example of the dramatically increased intestinal divisions in a cki-1,2(RNAi); cyd-1(he112);
lin-36(RNAi) animal. See the legend of Fig. 1 for methods. In panels C, D and E, an
elt-2::GFP reporter was used to mark intestinal nuclei. Error bars indicate mean± s.e.m.
G1 control by synMuv class B genes
115
lin-35(n745) and cki-1,2(RNAi). Inactivation of lin-9 did not increase the
number of intestinal divisions when combined with inactivation of
either lin-35 or cki-1,2 (data not shown). However, RNAi for lin-36 and
cki-1,2 together resulted in a far greater number of postembryonic cell
divisions than inactivation of cki-1,2 alone, both in a cyd-1(he112) mutant
(Fig. 2C, left) and in a wild-type background (Fig. 2C, right). This effect
closely resembled lin-35; cki-1,2 double inactivation. Single RNAi of
lin-35 or lin-36 did not cause supernumerary cell divisions, while cki-1,2
RNAi resulted in on average 13 extra divisions in the intestinal lineage.
Simultaneous inactivation of cki-1,2 with either lin-36 or lin-35 resulted
in on average 59 and 52 extra postembryonic intestinal divisions, respec-
tively (Fig. 2C,E). In contrast, lin-35; lin-36 double mutants behaved sim-
ilar to lin-35 single mutants in all assays (not shown). Thus, lin-35 Rb
and lin-36 are both required for normal vulval fate determination as
well as cell-cycle regulation, and both genes likely act downstream of
cyd-1/cdk-4 and parallel to cki-1,2 Cip/Kip. These results are all consis-
tent with lin-36 acting in the lin-35 Rb pathway as an inhibitor of G1 pro-
gression (Fig. 3). 
The sensitized genetic backgrounds that previously allowed us to detect
the G1 control function of lin-35 Rb (Boxem and van den Heuvel, 2001)
were used here to identify cell-cycle regulatory functions of other syn-
Muv genes. Our results demonstrate several important aspects of G1 reg-
ulation in C. elegans. We identified for the first time a role for efl-1 E2F
and dpl-1 DP in regulating G1 progression. This validates our assays and
emphasizes the conservation of the Rb pathway for G1 control in C. ele-
gans. In addition, we detected novel roles as cell-cycle regulators for
Fig. 3. Model for the regulation of S phase entry in
C. elegans. Activity of a kinase complex consisting of
CYD-1 Cyclin D and CDK-4 CDK4/6 is essential for
entry into S phase (Boxem and van den Heuvel,
2001). This kinase appears to exert at least two func-
tions in cell-cycle control: it antagonizes LIN-35 Rb,
EFL-1, DPL-1 and LIN-36, possibly by phosphoryla-
tion of one or more of these components. In addi-
tion, it inhibits CKI-1 (and CKI-2) Cip/Kip family
members, possibly by sequestration. In analogy with
other systems, the lin-35 Rb branch of the pathway
likely inhibits transcription of genes required for
the G1/S transition. CKI-1,2 Cip/Kip likely inhibits a
Cyclin E/CDK complex through direct protein
interaction. Cell-cycle roles were also observed for lin-9 and lin-15B. lin-9 did not act syner-
gystically with lin-35 Rb or cki-1,2 Cip/Kip, and was therefore not placed in a pathway.
lin-15B acts in parallel to lin-35 Rb, and could therefore potentially act in the cki-1,2
Cip/Kip pathway. However, lin-15B mutants do not display the additional cell divisions
found in cki-1,2(RNAi) animals, and cki-1,2(RNAi) was not observed to cause a synMuv phe-
notype. It is therefore also possible that lin-15B acts in a third pathway. DPL-1 also acts as a
positive regulator, which is not indicated. See text and cited references for further discus-
sion of these genes. 
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three additional synMuv B genes: lin-9 Aly, lin-15B and lin-36. LIN-9 is a
member of a family of proteins conserved from plants to humans (Bei-
tel et al., 2000; White-Cooper et al., 2000). The aly (always early) gene in
Drosophila encodes a member of this family and has been implicated in
transcriptional control of genes required for spermatid differentiation
and cell-cycle progression during male gametogenesis (White-Cooper et
al., 2000). lin-15B and lin-36 each encode proteins with no obvious
orthologs in other organisms. Interestingly, the LIN-36 protein contains
an exceptionally high number (19) of potential CDK phosphorylation
sites (S/T P) and a conserved cyclin binding domain (ARARLFGE, com-
pare to AKRRLFGE in p107). These properties make it tempting to
speculate that LIN-36 is directly regulated by CDKs. Finally, our finding
that lin-15B acts in parallel to lin-35 in G1 regulation provides the first
demonstration of a role for lin-15B separate from the lin-35 Rb pathway. 
What is the relationship between inhibition of vulval fate specifica-
tion and inhibition of cell-cycle progression? Regulation of both pro-
cesses apparently involves transcriptional repression mediated by
Rb/E2F complexes. However, the lin-35 Rb pathway cooperates with dis-
tinct regulators to control cell fate specification (class A synMuv genes)
and cell division (cki-1,2 Cip/Kip genes). Moreover, only a subset of the
class B genes was found to act in cell-cycle regulation. Therefore, the
function of Rb/E2F in cell-fate determination versus cell division con-
trol appears to be specified by different sets of coregulators.
Supplementary Material
Supplementary Material including the Experimental Procedures and
additional data and discussion is available at http://images.cell-
press.com/supmat/supmatin.htm.
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BSTRACT
 
Taking advantage of the conserved G
 
1
 
 regulatory mechanisms in 
 
C. ele-
gans
 
, we have designed forward genetic screens to identify novel genes
involved in G
 
1
 
 control. In a screen for novel 
 
cyd-1
 
 target genes, we iden-
tified the 
 
he121
 
 allele. Combining 
 
he121
 
 with loss of 
 
lin-35
 
 Rb restores
fertility to 
 
cyd-1
 
 Cyclin D and 
 
cdk-4
 
 CDK4/6 mutants. Therefore, 
 
he121
 
likely defines a critical downstream effector of 
 
cyd-1
 
 and 
 
cdk-4
 
. In a sec-
ond screen, we identified mutations whose phenotype is rescued by loss
of 
 
lin-35
 
 Rb. Such mutations may define genes that act upstream of or in
parallel to 
 
lin-35
 
 Rb in G
 
1
 
 control. Finally, we identified a mutation that
is viable by itself, but lethal in combination with loss of 
 
lin-35
 
 Rb. This
latter type of mutation may help define targets for cancer therapeutics
that specifically eliminate cells that lack Rb function.
 
I
 
NTRODUCTION
 
Regulation of progression through G
 
1
 
 phase of the cell cycle plays a crit-
ical role in the development of multicellular organisms and in the pre-
vention of tumor formation. The decision of a cell to withdraw from the
cell cycle or enter a new division cycle is made largely during G
 
1
 
 phase.
Cells become committed to go through a division cycle at a certain
point in G
 
1
 
 phase, after which they are relatively unresponsive to mito-
genic and antimitogenic signaling (Pardee, 1989). The importance of
G
 
1
 
 regulation is demonstrated by the fact that most, if not all, tumor
cells have sustained defects in one or more G
 
1
 
 regulators (Sherr, 1996).
 At the heart of the molecular machinery that controls progression
through G
 
1
 
 phase stands the retinoblastoma family, consisting of pRb,
p107 and p130 in mammals (reviewed in Planas-Silva and Weinberg,
1997; Weinberg, 1995). In order for a cell to progress into S-phase, pRb
needs to be inactivated by phosphorylation on several different residues
(Mittnacht, 1998; Weinberg, 1995). Inactivation of pRb is brought about
by the activities of cyclin dependent kinases (CDKs). Cyclin D-CDK4/6
and Cyclin E-CDK2 phosphorylate pRb on partially overlapping sites,
and the activity of both appears to be required for full inactivation of
pRb (Mittnacht, 1998). While Cyclin E levels peak shortly before the
onset of S phase, the levels of D-type cyclins are much more constant.
Cyclin D levels drop when growth factors are withdrawn, and increase
when growth factors are added. For this reason, Cyclin D is often
thought of as a growth factor sensor (reviewed in Sherr, 1996). One
model for G
 
1
 
 progression is that initial phosphorylation by Cyclin
D-dependent kinases inactivates pRb sufficiently to allow transcription
of Cyclin E, which then complexes with CDK2 and fully inactivates pRb
(Harbour 
 
et al
 
., 1999). 
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The pRb family is currently the only known target for phosphoryla-
tion by Cyclin D-dependent kinases. However, Cyclin D-CDK4/6 com-
plexes may fulfill a kinase independent function which involves
sequestration of CDK inhibitors of the Cip/Kip family. Members of the
Cip/Kip family, which consists of p21
 
Cip1
 
, p27
 
Kip1
 
 and p57
 
Kip2
 
, bind to and
inactivate CDK2 kinases. In addition, Cip/Kip family members are
essential for the assembly and activity of Cyclin D-CDK4/6 complexes,
and most Cyclin D-CDK4/6 is found in complexes with Cip/Kip pro-
teins (Ekholm and Reed, 2000; Sherr, 2000). Thus, Cyclin D-CDK4/6
complexes have been proposed to promote G
 
1
 
 progression in two ways.
First, they can phosphorylate and inactivate pRb and second, they can
bind to Cip/Kip kinase inhibitors, and thereby prevent them from inac-
tivating Cyclin E-CDK2. 
Two additional functions for Cyclin D have been described that do
not depend on association with a CDK partner. First, Cyclin D1 can bind
to and activate the estrogen receptor, which might play a role in the for-
mation of breast tumors (Neuman 
 
et al
 
., 1997; Zwijsen 
 
et al
 
., 1998). Sec-
ond, Cyclin D1 can bind the Myb-like transcription factor DMP1 (Hirai
and Sherr, 1996). Binding of Cyclin D1 to DMP1 is thought to promote
G
 
1
 
 progression by inhibiting transcription of p19
 
ARF
 
, which can induce a
G
 
1
 
 arrest by stabilizing p53 (Inoue 
 
et al
 
., 1999). The importance 
 
in vivo
 
for these and other functions of Cyclin D still remains largely unknown.
Therefore, we have initiated a genetic approach to identify Cyclin D tar-
get genes in 
 
C. elegans
 
.
The 
 
C. elegans
 
 genome contains single homologs of D-type cyclins,
CDK4/CDK6 kinases and pRb family members. We and others have
demonstrated that loss of function of either 
 
cyd-1
 
 Cyclin D or 
 
cdk-4
 
CDK4/6, causes arrest of postembryonic cell divisions in G
 
1
 
 phase
(Boxem and van den Heuvel, 2001; Park and Krause, 1999). Inactiva-
tion of 
 
lin-35
 
 Rb in a 
 
cyd-1
 
 or 
 
cdk-4
 
 mutant background partially restores
cell division and DNA synthesis. In addition, loss of 
 
lin-35 
 
 restores
expression of the S phase marker 
 
rnr::GFP
 
 in 
 
cyd-1
 
 and 
 
cdk-4
 
 mutants.
These results indicated that 
 
lin-35
 
 is an important negative regulator of
G
 
1
 
 progression and likely acts downstream of 
 
cyd-1/cdk-4
 
 (Boxem and
van den Heuvel, 2001). The finding that the rescue of cell division is
incomplete indicates that inactivation of 
 
lin-35
 
 Rb is not the only func-
tion of 
 
cyd-1/cdk-4
 
. Here, we describe the identification of a mutation
 
(he121)
 
 that restores viability to 
 
cyd-1
 
 mutants when combined with inac-
tivation of 
 
lin-35 
 
Rb.
In an alternative approach to identify genes that act to regulate G
 
1
 
progression, we performed a genetic modifier screen that is aimed at
identifying mutations whose phenotype is either enhanced or sup-
pressed by loss of 
 
lin-35
 
 Rb function. Several different classes of genes
can potentially be identified in this screen. First, we can identify genes
that act upstream of 
 
lin-35
 
 in G
 
1
 
 regulation. Thus far, 
 
cyd-1
 
 and 
 
cdk-4
 
 are
the only known G
 
1
 
 regulators that act upstream of 
 
lin-35
 
 in 
 
C. elegans
 
.
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Mutations whose phenotype is suppressed by loss of 
 
lin-35
 
 function may
define additional genes that act in the 
 
lin-35
 
 pathway for G
 
1
 
 control. Sec-
ond, we may identify novel G
 
1
 
 regulators that act in parallel to 
 
lin-35
 
 Rb.
We have previously demonstrated that loss of 
 
lin-35
 
 affects cell-cycle pro-
gression only when combined with mutations in other cell-cycle regula-
tors such as 
 
cyd-1
 
 Cyclin D
 
, cdk-4
 
 CDK4/6
 
 
 
or
 
 cki-1
 
 Cip/Kip. Therefore,
mutations that display a synthetic cell-division phenotype in double
mutant combinations with 
 
lin-35
 
 Rb are likely to define genes in the
Cip/Kip and other parallel pathways (Fig. 3). A final, and particularly
interesting, class of mutations causes a very limited phenotype as single
mutants yet results in a lethal phenotype in combination with inactiva-
tion of 
 
lin-35
 
. The gene products defined by such mutations are candi-
date targets for therapeutics that may kill tumor cells that have lost pRb
function, without affecting normal cells.
 
R
 
ESULTS
 
 
 
AND
 
 D
 
ISCUSSION
 
Identification of a candidate critical 
 
cyd-1
 
 target
 
To identify novel 
 
cyd-1
 
 target genes we screened for mutations that con-
fer viability to 
 
lin-35; cyd-1
 
 double mutants. Animals of genotype
 
lin-35(n745); rol-1(e91) cyd-1(he112)/mnC1
 
 were mutagenized with 25 mM
ethylmethanesulfonate as described (Brenner, 1974). Individual F1 ani-
mals were placed onto 60 mm agar plates, and their F2 progeny was
examined for the presence of fertile rolling animals. 
 
lin-35; rol-1 cyd-1
 
mutants are fully penetrant sterile, despite completing a significant
number of postembryonic cell divisions and occasionally producing
oocytes. The 
 
mnC1
 
 rearrangement in the parental strain prevents
recombination between 
 
rol-1
 
 and 
 
cyd-1. 
 
Therefore, fertile rollers are
likely to be homozygous for 
 
cyd-1(he112) 
 
and to contain a mutation that
confers fertility to 
 
lin-35; rol-1 cyd-1
 
 mutants. In a screen of ~20,000 hap-
loid genomes we identified three mutations that resulted in viable roll-
ing animals. Two of these mutations were not characterized further as
the resulting rolling animals could only be propagated for a few genera-
tions. The third mutation, designated 
 
he121
 
, resulted in healthy rolling
animals that produced a high number of viable progeny over several
generations. Continuous culture of 
 
lin-35(n745)
 
 mutant animals leads to
severely decreased fertility (our unpublished observation). Therefore,
 
he121
 
 was maintained in a heterozygous strain of genotype 
 
lin-35/dpy-5
unc-29; rol-1 cyd-1/mnC1; he121.
 
Initially we considered two trivial explanations for the effects of
 
he121
 
. First, we determined if the 
 
he121
 
 mutation represented an
intragenic revertant of the cyd-1(he112) allele. As such revertants are
expected to be dominant, rol-1(e91) cyd-1(he112)/mnC1; he121 hermaph-
rodites were crossed to rol-1(e91) cyd-1(he112)/mnC1 males and placed on
agar plates seeded with E. coli that express double stranded lin-35 RNA.
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The feeding of double stranded RNA in this fashion has recently been
demonstrated to induce RNA mediated interference of gene expression
(Kamath et al., 2000; Timmons et al., 2001), and causes efficient inactiva-
tion of lin-35 Rb function (data not shown). If the he121 mutation
reverts cyd-1(he112) to a wild type acting cyd-1 allele, one quarter of the
cross progeny would be of the genotype rol-1(e91) cyd-1(he112
he121)/rol-1(e91) cyd-1(he112) and display a fertile Rol phenotype. Fertile
rollers were not found in the cross progeny, which indicates that he121 is
a recessive mutation, and not simply an intragenic revertant of
cyd-1(he112). 
A second possibility for the rescue of cyd-1(he112) by he121 is that
he121 is an informational suppressor, such as an amber suppressor, or a
smg suppressor. Amber suppressors are tRNAs that decode UAG stop
codons as sense, thus allowing translation to continue past premature
UAG codons (Riddle et al., 1997). smg mutations affect nonsense-medi-
ated mRNA decay, which is responsible for degradation of mRNAs that
contain premature stop codons. Stabilization of such mRNAs by smg
mutations has been shown to suppress the phenotypes of several
mutants (Riddle et al., 1997). The cyd-1(he112) allele contains a prema-
ture TAG termination codon in the final exon of cyd-1. Therefore,
cyd-1(he112) could in theory be suppressed by an amber or smg suppres-
sor. To test this hypothesis we injected cyd-1 double stranded RNA into
lin-35(n745); rol-1(e91) cyd-1(he112)/mnC1; he121 animals. Whereas
wild-type animals injected with cyd-1 dsRNA produced a high percent-
age cyd-1 mutant progeny, lin-35; rol-1 cyd-1/mnC1; he121 injected with
cyd-1 dsRNA (n=5) produced only fertile rollers. Control injection of
cyb-3 RNA into lin-35; rol-1 cyd-1/mnC1; he121 animals (n=3) resulted in
embryonically arrested progeny, demonstrating that the lin-35; rol-1
cyd-1/mnC1; he121 strain is not insensitive to RNAi in general. Thus, the
he121 mutation specifically overcomes the cyd-1(RNAi) phenotype,
which makes it highly unlikely that he121 is an amber or smg suppressor
mutation. In addition, we did not observe rescue of the cyd-1(he112)
mutant phenotype by the smg-6(r896) allele among the progeny of rol-1
cyd-1; smg-6 animals.
Finally, we tested whether he121 could also overcome the cell divi-
sion defects of cdk-4 CDK4/6 mutants. We observed viable progeny from
several lin-35(n745); rol-1(e91) cyd-1(he112)/mnC1; he121 animals injected
with dsRNA corresponding to cdk-4. In the same experiment, control
injected wild-type animals produced a high percentage of larval lethal
and sterile progeny. In addition, lin-35(n745)/+; cdk-4(gv3)
rnr::GFP/he121 animals segregated fertile cdk-4 rnr::GFP progeny. This
result further strengthens the conclusion that he121 is not an informa-
tional suppressor or a genetic revertant of cyd-1(he112). Moreover, the
fact that he121 suppresses both the cyd-1 and cdk-4 phenotype is consis-
tent with this mutation defining a downstream target of cyd-1/cdk-4.
Genetic identification of novel G1 regulators
125
To examine if the rescue of the cyd-1(he112) phenotype by he121
requires simultaneous inactivation of lin-35, we placed rol-1(e91)
cyd-1(he112)/mnC1; he121 animals on normal agar plates and on lin-35
RNAi feeding plates. Fertile rollers were only observed among the prog-
eny on the lin-35 RNAi plates, demonstrating that inactivation of lin-35
is required for viability of cyd-1(he112);he121 double mutants.
Mapping of he121
he121 was mapped to the X chromosome using polymorphic
Sequence-Tagged Sites between the N2 Bristol and RW7000 Bergerac
chromosomes (Williams et al., 1992). To further define the map position
of he121, we are making use of single nucleotide polymorphisms
between the N2 background and the Hawaiian strain CB4856, which
allows for rapid gene mapping in fine detail (Wicks et al., 2001). In this
procedure, rol-1(e91) cyd-1(he112)/mnC1; dpy-6(e14) he121 animals are
mated with the CB4856 strain and the cross-progeny is allowed to
self-fertilize on lin-35 RNAi feeding plates. From the F2 animals, fertile
rolling non-Dpy animals are selected and used to establish homozygous
Rol non-Dpy strains. Such recombinant strains are either of genotype
rol-1(e91) II; CB4856 X or rol-1(e91) cyd-1(he112) II; he121 CB4856 X. To
select the latter strains we remove homozygous animals from the lin-35
RNAi plates. Their progeny should display the cyd-1 phenotype, as res-
cue requires both lin-35 inactivation and the he121 mutation. Recombi-
nant rol-1(e91) cyd-1(he112) II; he121 CB4856 X strains will be analyzed for
the presence of the CB4856 or N2 sequence at multiple single nucle-
otide polymorphisms along the X chromosome.
Functional characterization of he121
As a first step in the functional characterization of the gene defined by
he121, we examined whether he121 alone was able to rescue aspects of
the cyd-1 mutant phenotype. cyd-1; he121 double mutants showed a sig-
Fig. 1. (A) The he121 allele
partially restores cell divisions
in cyd-1(he112) mutants. Post-
embryonic intestinal (Int) and
P neuroblast (P) divisions
were determined for 10 ani-
mals of the indicated geno-
types. (B) he121 may co-
operate with cki-1,2 in nega-
tively regulating G1 progres-
sion. Postembryonic intestinal
divisions were determined for
20 animals of indicated geno-
types. Intestinal nuclei were
marked with elt-2::GFP. Bars
represent mean ± s.e.m.
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nificant number of postembryonic cell divisions of, among other cell
types, the ventral cord precursor (P) cells (Fig. 1A) and the hypodermal
(V) cells (not shown). Divisions of the intestinal nuclei were barely
affected by he121 (Fig. 1) and endoreduplication did not take place in
the intestinal nuclei of cyd-1; he121 mutants (not shown). These results
further demonstrate that the gene defined by he121 likely acts down-
stream of cyd-1.
As described in the introduction, Cyclin D-CDK4/6 complexes are
thought to affect progression through G1 phase by two distinct mecha-
nisms: phosphorylation of pRb and sequestration of Cip/Kip kinase
inhibitors. Both of these mechanisms may be conserved in C. elegans as
loss of lin-35 Rb or loss of cki-1,2 Cip/Kip partially rescues the cyd-1 and
cdk-4 mutant phenotype (Boxem and van den Heuvel, 2001). The gene
defined by he121 might act in a cki-1,2 Cip/Kip pathway, or may be part
of a third, parallel pathway (Fig. 2). However, he121 is not an allele of
cki-1 or cki-2, as both these genes map to chromosome II. To address if
he121 acts in parallel to cki-1,2, we examined the effect of double inacti-
vation of cki-1,2 and he121 on intestinal divisions (Fig. 1B). Combining
cki-1,2 RNAi and the he121 allele resulted in a higher number of intesti-
nal divisions in cyd-1 mutants than cki-1,2 RNAi or the he121 allele alone.
This may indicate that he121 acts in parallel to cki-1,2. However, a syner-
gistic effect may be also be obtained by combining partial loss-of-func-
tion of two genes that act in the same pathway. At present, we do not
know whether he121 is a null allele or whether cki-1,2 RNAi completely
eliminates cki-1,2 function. Therefore, it remains possible that he121 acts
in the cki-1,2 Cip/Kip pathway.
Fig. 2. Model for the function of he121. LIN-35 and CKI-1,2 act downstream of
CYD-1/CDK-4 in two parallel pathways. he121 may act downstream of CYD-1/CDK-4 in a
third pathway (A), or, alternatively, may act upstream or downstream of CKI-1,2 (B). he121
cannot be a mutant allele of cki-1 or cki-2, as both cki-1 and cki-2 are located on chromo-
some II, while he121 was mapped to the X chromosome.
Genetic identification of novel G1 regulators
127
In summary, we have identified a highly interesting mutation, he121.
This mutation likely defines a gene that acts in parallel to lin-35 Rb, and
needs to be downregulated by cyd-1/cdk-4 for the development of C. ele-
gans. The molecular characterization of this gene will help to elucidate
which Cyclin D-CDK4/6 targets are essential for the development of
multicellular organisms.
A screen for the identification of genes that cooperate with lin-35 Rb 
during development of C. elegans
As outlined in the introduction and Fig. 3, mutations that genetically
interact with lin-35 loss of function may help define genes in several
important developmental pathways. To identify such mutations, wild
type animals were mutagenized with 25 mM ethylmethanesulfonate as
described (Brenner, 1974). Single F2 progeny, which are potentially
homozygous for the induced mutations, were allowed to produce
self-progeny for 24 hours and subsequently transferred to lin-35 RNAi
feeding plates. The first plates were kept at 15°C while the lin-35 RNAi
feeding plates were kept at 25°C. After four days, the normal and lin-35
RNAi plates were compared and strains that displayed a developmental
abnormality on one plate but not the other were selected for further
examination. Because of the temperature difference between the nor-
mal and RNAi plates, many strains were discarded early on as their phe-
notype was simply due to a temperature sensitive mutation and not to
the presence or absence of lin-35. In future screens all plates will be
maintained at the same temperature to avoid this problem. Also note
that due to the nature of the screen we could not identify fully pene-
trant lethal or sterile mutations that were only partly suppressed by loss
Fig. 3. A screen for mutations
that genetically interact with
lin-35 Rb may define genes in
multiple important pathways.
Mutations that demonstrate a
synthetic interaction with loss
of lin-35 Rb may define genes
that act in parallel to lin-35
Rb, either in the cki-1,2
Cip/Kip pathway (A) or in
other pathways (C). In addi-
tion, mutations whose pheno-
type is suppressed by lin-35 Rb
loss of function may define
genes that act upstream of
lin-35 Rb (B).
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of lin-35, as F2 animals homozygous for such mutations would not pro-
duce progeny.
In an initial screen of approximately 1225 haploid genomes we iden-
tified 10 candidate mutations. In addition, three class A synMuv alleles
were found, which further validates the screen. Nine of the 10 muta-
tions actually represent mutations whose phenotype is rescued by loss of
lin-35. Two classes among these are maternal effect embryonic lethal
mutations that survive to fertile adults on lin-35 RNAi plates (2/10) and
partially penetrant sterile mutations that are nearly wild type on lin-35
RNAi plates (3/10). One of the mutatant strains displayed a more
severe phenotype on lin-35 RNAi plates. Animals of this strain were
largely fertile on normal plates and fully penetrant sterile when placed
on lin-35 RNAi feeding plates. As this screen has the potential to isolate
several important classes of developmental regulators (Fig. 3) and has
already been shown to be successful, it will be carried out at a compre-
hensive level.
Genetic identification of novel G1 regulators
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 D
 
ISCUSSION
 
In this thesis, I describe experiments in which 
 
C. elegans
 
 was used as an
animal model to study developmental control of cell divisions. The
results we obtained contributed to our understanding of the basic cell-
cycle machinery in 
 
C. elegans
 
, and demonstrated that the functions of
key cell-cycle regulators are conserved between 
 
C. elegans
 
 and mammals.
This indicates that further research into the regulation of cell division
in 
 
C. elegans
 
 will translate into improved knowledge of the mammalian
cell cycle. In addition, the findings on the basic cell-cycle machinery
enabled us to design genetic screens to identify novel regulators of G
 
1
 
progression. In a reverse genetic approach, we identified several novel
negative regulators of G
 
1
 
 progression. In forward genetic screens we
identified a mutation that likely defines a critical target for Cyclin D-
CDK4/6 kinases, and several mutations that may define genes that
cooperate with the Rb family during development of 
 
C. elegans
 
. Below, I
briefly discuss our results and the contributions they made to our
understanding of the mammalian cell cycle.
 
Similar mechanisms regulate cell division in 
 
C. elegans
 
 and mammals
 
Traditionally, the regulation of the cell cycle received little attention in
 
C. elegans
 
 and few cell-cycle genes were previously described for this
organism. Therefore, our goal was to identify and characterize compo-
nents of the core cell-cycle machinery in 
 
C. elegans
 
. We demonstrated
that 
 
ncc-1
 
 CDK1 is required specifically for entry into mitosis and pro-
gression through meiosis (Boxem 
 
et al
 
., 1999). In addition, an ortholog
of CDK4/CDK6 kinases (
 
cdk-4
 
), and a D-type cyclin (
 
cyd-1
 
) are required
for G
 
1
 
 progression of postembryonic somatic cells (Boxem and van den
Heuvel, 2001; Park and Krause, 1999). Furthermore, a homolog of the
mammalian Cip/Kip kinase inhibitors, 
 
cki-1
 
, was shown to negatively
regulate cell-cycle progression (Boxem and van den Heuvel, 2001; Feng
 
et al
 
., 1999; Hong 
 
et al
 
., 1998). Finally, we determined the role of 
 
lin-35
 
Rb, 
 
efl-1
 
 E2F and 
 
dpl-1
 
 DP in G
 
1
 
 progression and found that 
 
lin-35
 
 and
 
efl-1
 
 are negative regulators of G
 
1
 
 progression while 
 
dpl-1
 
 has aspects of
both a positive regulator and a negative regulator. In each case, the 
 
C.
elegans
 
 cell-cycle gene acts in a similar fashion as its mammalian counter-
part. This establishes 
 
C. elegans
 
 as an attractive genetic system in which
to study cell-cycle regulation, as results obtained in 
 
C. elegans
 
 will likely
be applicable to cell-cycle regulation in mammals.
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The functions of Cyclin D-CDK4/6 kinases in vivo
 
Mammalian Cyclin D-dependent kinase complexes are thought to act in
at least two ways. First, they can phosphorylate and inactivate pRb family
members (Mittnacht, 1998; Sherr, 1993). Second, they can sequester
members of the Cip/Kip family of CDK inhibitors, which inhibit CDK2
kinases (Sherr and Roberts, 1999). To date, no experiments have
directly determined the relative importance of these mechanisms for
the function of D-type cyclins and CDK4/6 kinases 
 
in vivo
 
. Inactivation
of 
 
lin-35
 
 Rb, the single 
 
C. elegans
 
 Rb-related gene, significantly rescued
the cell division defects in 
 
cyd-1
 
 Cyclin D and 
 
cdk-4
 
 CDK4/6 mutants.
Thus, in 
 
C. elegans
 
, inactivation of LIN-35 Rb appears to be one critical
function of the CYD-1/CDK4 complex. This is the first demonstration
that inactivation of pRb family members is an important function of
Cyclin D-CDK4/6 kinases 
 
in vivo
 
.
As the rescue of the 
 
cyd-1
 
 Cyclin D mutant phenotype by loss of 
 
lin-35
 
Rb is not complete, other 
 
cyd-1
 
 targets likely exist. Indeed, in a forward
genetic screen we identified a mutation that rescues 
 
lin-35
 
 Rb
 
; cyd-1
 
Cyclin D double mutants to fertile adults. Although sequestration of
Cip/Kip proteins is a possible second function of Cyclin D-CDK4/6
kinases, this mutation is not an allele of the 
 
C. elegans
 
 Cip/Kip family
members 
 
cki-1
 
 or 
 
cki-2
 
. Identifying the gene affected by this mutation
should help define the nature of the second function of 
 
cyd-1
 
 Cyclin D.
lin-35
 
 Rb acts primarily in a negative regulatory complex with 
 
efl-1
 
 E2F
 
An important question about the function of mammalian pRb family
members is to what extent the E2F transcription factors mediate their
function. Mammalian E2Fs likely act both as transcriptional activators
and, in a complex with pRb family members, as transcriptional repres-
sors. It is currently unknown which of these two mechanisms is most rel-
evant for the function of E2F 
 
in vivo
 
. In addition, it is unknown to what
extent pRb is recruited to the DNA through factors other than E2F. We
found that loss of 
 
efl-1
 
 E2F rescued the cell division defects of 
 
cyd-1
 
Cyclin D mutants to a similar extent as loss of 
 
lin-35
 
 Rb. Therefore, most
of the G
 
1
 
 inhibitory function of 
 
lin-35
 
 Rb appears to be mediated by 
 
efl-1
 
E2F. Ceol 
 
et al
 
. (Ceol and Horvitz) recently demonstrated the possibility
of a ternary LIN-35/EFL-1/DPL-1 complex. LIN-35 Rb is, therefore,
likely part of an inhibitory complex containing EFL-1 and DPL-1. 
 
Using 
 
C. elegans
 
 to isolate novel cell-cycle regulators
 
The major strength of studies in 
 
C. elegans
 
 is the ability to use genetic
techniques to identify novel genes. We performed several screens to
identify novel regulators of G
 
1
 
 progression. 
 
lin-35
 
 Rb, 
 
efl-1
 
 E2F and 
 
dpl-1
 
DP each regulate G
 
1
 
 progression as well as vulval cell fate specification
(Ceol and Horvitz, 2001; Ferguson and Horvitz, 1985; Ferguson 
 
et al
 
.,
1987 and Chapter 4). Using a reverse genetic approach, we identified a
role for 3 additional synMuv genes (
 
lin-9
 
 Aly
 
, lin-15
 
B
 
 
 
and
 
 lin-36
 
) as nega-
tive regulators of G
 
1
 
 progression. These genes all encode proteins for
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which no function in G
 
1
 
 regulation had previously been described. 
 
lin-
15
 
B and 
 
lin-36
 
 both encode novel proteins. 
 
lin-9
 
 is a member of a family
of proteins conserved from plants to humans. A 
 
Drosophila
 
 homolog of
 
lin-9
 
, 
 
always early
 
 (
 
aly
 
), is required for the transcription of genes
required for spermatid differentiation and the transition from G
 
2
 
 to
meiosis during the formation of male gametes (White-Cooper 
 
et al
 
.,
2000). Both LIN-9 and LIN-36 contain an exceptionally large number of
candidate CDK phosphorylation sites, indicating that these proteins
may be directly regulated by CDKs.
In Chapter 5 I described forward genetic screens to identify novel
targets of 
 
cyd-1
 
 and genes that cooperate with 
 
lin-35
 
 Rb during develop-
ment. One of the identified mutations likely defines a gene that acts
downstream of 
 
cyd-1.
 
 In addition, we have already identified mutations
whose phenotype is suppressed by loss of 
 
lin-35
 
, and mutations that are
lethal only when combined with inactivation of 
 
lin-35
 
. I expect that such
mutations define several classes of genes. First, similar to 
 
cyd-1
 
 and 
 
cdk-4
 
,
mutations whose phenotype is suppressed by loss of 
 
lin-35
 
 may define G
 
1
 
regulators acting upstream of 
 
lin-35
 
. Second, mutations whose pheno-
type is enhanced by loss of 
 
lin-35 
 
may define genes that act in parallel to
 
lin-35
 
, similar to 
 
cki-1
 
 and the synMuv class A genes. Finally, mutations
that are viable by themselves but lethal in combination with loss of 
 
lin-35
 
may ultimately define genes that are candidate targets for therapeutics
that specifically kill tumor cells that lack pRb. These results show that
these screens have great potential to identify novel cell-cycle regulators.
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